Anne Louise Coleman, MD, PhD - Jules Stein Eye Institute

Anne Louise Coleman, MD, PhD 

Curriculum Vitae 

Office: Jules Stein Eye Institute 

David Geffen School of Medicine at UCLA 

100 Stein Plaza 

Los Angeles, CA 90095-7004 

Contacts: Phone: 310-825-5298 

Fax: 310-206-7773 

Email: doctor_coleman@yahoo.com 

Citizenship: United States 

ACADEMIC APPOINTMENTS CURRENT 

2004– The Fran and Ray Stark Professor of Ophthalmology 

Department of Ophthalmology 

University of California at Los Angeles - Los Angeles, CA 

2003– Professor in Department of Epidemiology 

School of Public Health 


2003– Professor in Department of Ophthalmology 

David Geffen School of Medicine 


1998– Associate Professor in Department of Ophthalmology 

Charles Drew University School of Medicine - Los Angeles, CA 

MEDICAL LICENSURE 

1990 California 

1988 Maryland 

1987 Illinois 

BOARD CERTIFICATION 

1990 American Board of Ophthalmology 

1985 National Board of Medical Examiners 

updated 25 March 2010 Page 1 of 68 

doctor_coleman@yahoo.com

ALC100325 

Anne L. Coleman, MD, PhD 

EDUCATION 

UNDERGRADUATE/ GRADUATE/ DOCTORAL 

1976–1980 Duke University - Durham, NC 

Bachelor of Arts: Chemistry 

1980–1984 Medical College of Virginia - Richmond, VA 

Doctor of Medicine 

1989 The Johns Hopkins School of Hygiene and Public Health - Baltimore, MD 

Graduate Summer Program in Epidemiology and Biostatistics 

1991 National Eye Institute - Longboat Key, FL 

Clinical Vision Research Course: Epidemiological and Biostatistical Approaches 

1991–1994 University of California at Los Angeles - Los Angeles, CA 


Master of Science: Epidemiology 

1994–1997 University of California at Los Angeles - Los Angeles, CA 


PhD: Epidemiology 

POSTDOCTORAL TRAINING 

1984–1985 Medical College of Virginia - Richmond, VA 

Department of Surgery 

Internship in General Surgery 

1985–1988 University of Illinois School of Medicine - Chicago, IL 

Department of Ophthalmology / Illinois Eye Center 

Residency in Ophthalmology 

1988–1990 The Johns Hopkins University School of Medicine - Baltimore, MD 

Department of Ophthalmology / 

Wilmer Ophthalmologic Institute and Krieger Eye Institute / 

Sinai Hospital of Baltimore 

Fellowship in Glaucoma (Drs. Harry A. Quigley, Irvin P. Pollack, 

Alfred Sommer, Henry D. Jampel, Alan Robin) 

RESEARCH FELLOWSHIP 

1988–1990 National Eye Institute - Individual National Research Service Award 

updated 25 March 2010 

doctor_coleman@yahoo.com Page 2 of 68

ALC100325 

1976 National Honor Society 

1977 Phi Eta Sigma 


HONORS AND SPECIAL AWARDS 

Phi Lambda Upsilon 

1980 Magna Cum Laude - Duke University 

1982 Merck and Lange Awards for highest academic performance 

1983 Sigma Zeta - Medical College of Virginia 

Alpha Omega Alpha - Medical College of Virginia 

1984 Phi Kappa Phi - Medical College of Virginia 

MCV-King’s College Hospital Fellowship Award 

1993 Honorary Member - Ecuadorian Society of Ophthalmology 

Pan-American Association of Ophthalmology Lecturer - 

Escola Paulista de Medicina – Såo Paulo, Brazil 

1994 Graduate Student Support Award 

1994–97 Physician Scientist Award - National Eye Institute 

1996 Los Angeles Magazine Best Doctors in LA 

1996–97 The Best Doctors in America: Pacific Region 

1997 Delta Omega Society - UCLA School of Public Health 

American Academy of Ophthalmology Honor Award 

1999–2000 Who’s Who in America 

2002 America’s Registry of Outstanding Professionals 

Who’s Who in America 

2003 Illinois Society for the Prevention of Blindness Lecturer for Chicago Ophthalmological 

Society 55 th Annual Clinical Conference - Chicago, IL 

Albert D. Frost Memorial Lecture - Ohio State University - Columbus, OH 

The Collegiate High Schools Distinguished Alumni Award - Richmond, VA 

American Academy of Ophthalmology Secretariat Award 

Special Invited Lecturer - University of Illinois - Chicago, IL 

Wilmer Distinguished Lecturer - Johns Hopkins - Bethesda, MD 

Best Doctors Database 

American Journal of Ophthalmology - Distinguished Editorial Board Member Award 



ALC100325 


2004 Woman of the Year - American Biographical Institute 

37 th Panhellenic Ophthalmological Meeting Honorary Award - 

Thessaloniki-Porto Carras, Greece 

American Academy of Ophthalmology - Secretariat Award 

American Academy of Ophthalmology - Senior Achievement Award 

Deborah A. Iverson MD Lectureship in Ophthalmology - Kresge Eye Institute - 

Detroit, MI 

2005 Chairman’s Special Lecturer - Duke University Eye Center - Durham, NC 

American Glaucoma Society Lecturer, World Glaucoma Congress - 

Association of International Glaucoma Society – Vienna, Austria 

2005–09 Best Doctors in America 

2006 14 th Annual Arthur Light, MD, Memorial Lectureship in Ophthalmology - Loyola 

University Chicago, Stritch School of Medicine - Chicago, IL 

D. Polichronakou Memorial Lecturer – 39 th Panhellenic Ophthalmological Congress - 

Thessaloniki, Greece 

2007 LA Super Doctors - Tu Ciudad Magazine 

2007– American Ophthalmological Society 

2008 Clinician Scientist Lecturer - American Glaucoma Society - Washington DC 

Research to Prevent Blindness - Manpower Award for Superior Scientific Endeavor 

AMA Women Physicians Congress - Physician Mentor Recognition Program 

The Ronald Lowe Medal - Australian and New Zealand Glaucoma Interest Group 

(ANZGIG) 

2009 Gold Anagnostakis-Trantas Medal - Greek Glaucoma Society - 15 th International 

Glaucoma Congress of the GGS, Athens, Greece 

2010 Silver Fellow of ARVO Class of 2010 - Association for Research in Vision and 

Ophthalmology [FARVO designation] 

2010 The 2010 Irving H. Leopold Lecturer - Allergan Pharmaceuticals [lecture series honoring 

leaders in ophthalmology] 



ALC100325 


KEYNOTE ADDRESSES & NAMED LECTURESHIPS 

1. Keynote Lectures–Pan-American Association of Ophthalmology - 

University of Såo Paulo/Escola Paulista de Medicina: “Ahmed Glaucoma Valve Implants.” 

Såo Paulo, Brazil, Apr 19, 1993. 

2. Keynote Lecture–National Symposium of the Ecuadorian Society of Ophthalmology: 

“The Role of Optic Nerve Head Imaging in the Diagnosis and Management of Glaucoma.” 

Quito, Ecuador, Jun 4, 1993. 


“New Anti-Glaucomatous Medications.” Quito, Ecuador, Jun 4, 1993. 

4. Keynote Lecture– National Symposium of the Ecuadorian Society of Ophthalmology: 

“Mitomycin C Trabeculectomies and Seton Implants.” Quito, Ecuador, Jun 4, 1993. 


“Uses of Lasers in the Treatment of Glaucoma.” Quito, Ecuador, Jun 4, 1993. 

6. Invited Keynote Lecturer–13 th National Symposium: 

“Glaucoma: Changing Concepts in Management.” Ahmedabad, India, Sep 26-28, 1997. 

7. Albert D. Frost Memorial Lecture–Ohio State University: 

“OHTS, Glaucoma 2003: Practical Solutions to Complicated Problems.” Columbus, OH, Feb 28, 2003. 

8. Illinois Society for the Prevention of Blindness Lecture–55 th Annual Chicago Ophthalmological 

Society Clinical Conference: “Risk Factors for Blindness in Glaucoma.” Chicago, IL, Apr 25, 2003. 

9. Special Invited Lecture–27 th Annual Resident Staff Alumni Day, University of Illinois: 

“Is Screening for Glaucoma Cost Effective?” Chicago, IL, Jun 11, 2003. 

10. Wilmer Distinguished Lecture–Johns Hopkins University: 

“Evidence-Based Ophthalmology.” Baltimore, MD, Sep 12, 2003. 

11. The Deborah A. Iverson, MD, Memorial Lecture–Kresge Eye Institute: 

“Societal Relevance of Glaucoma.” Birmingham, MI, Nov 3, 2004. 

12. Chairman’s Special Lecture–Duke University Eye Center: 

“Managing the Glaucoma Patient in Light of Recent Clinical Trials.” Durham, NC, Feb 8, 2005. 

13. American Glaucoma Society Lecture–World Glaucoma Congress, Association of International 

Glaucoma Societies: “Societal Impact of Glaucoma.” Vienna, Austria, Jul 7, 2005. 

14. D. Polichronakou Memorial Lecture–39 th Panhellenic Ophthalmological Congress: 

“Nutrition and Glaucoma.” Thessaloniki, Greece, Jun 10, 2006. 

15. Arthur Light, MD, Memorial Lecture in Ophthalmology (14 th Annual)–Loyola University Medical Center/ 

Stritch School of Medicine: “Predicting Glaucomatous Progression with Imaging.” 

Chicago, IL, Sep 6, 2006. 

16. Arthur Light, MD, Lecture in Ophthalmology (14 th Annual)– Loyola University Medical Center/ 

Stritch School of Medicine: “Societal Relevance of Glaucoma.” Chicago, IL, Sep 6, 2006. 

17. Clinician-Scientist Lecture (9 th Annual)–American Glaucoma Society: 

“A Public Health Perspective on Glaucoma.” Washington DC, Mar 8, 2008. 

18. Keynote Speaker–2 nd Annual Women in Ophthalmology-New York Chapter Meeting: 

“A Public Health Perspective on Glaucoma.” New York, NY, Sep 10, 2008. 



ALC100325 


19. Peter C. Kronfeld, MD, Memorial Lecture–University of Illinois Eye and Ear Infirmary, UIC Department of 

Ophthalmology and Visual Sciences: “The Role of Public Health in Ophthalmology.” Chicago, IL, 

Jun 19, 2009. 

20. The Bernice Brown Memorial Lectureship–Women in Ophthalmology Summer Symposium: “Public 

Health and Ophthalmology.” San Diego, CA, Aug 6, 2009. 



ALC100325 

APPOINTMENTS–CHRONOLOGY 


PROFESSIONAL ACTIVITIES 

1990–95 Attending Ophthalmologist 

Sepulveda Veterans Administration Hospital - Sepulveda, CA 

1990–97 Assistant Professor in Department of Ophthalmology 

University of California at Los Angeles School of Medicine - Los Angeles, CA 

1991–02 Consultant 

Los Angeles County Harbor-UCLA Medical Center - Los Angeles, CA. 

1995–98 Consultant 

Kaiser Permanente - Woodland Hills, CA 

1997–03 Associate Professor in Department of Ophthalmology 

University of California at Los Angeles School of Medicine - Los Angeles, CA 

1998– Associate Professor in Department of Ophthalmology 

Charles Drew University School of Medicine - Los Angeles, CA 

2003– Professor in Department of Ophthalmology 

David Geffen School of Medicine 


2003– Professor in Department of Epidemiology 



2004– The Fran and Ray Stark Professor of Ophthalmology 





ALC100325 


GRANTS & RESEARCH SUPPORT 

Jul 88–Jun 90 National Research Service Award Training Grant: EY 07047-120021 ($52,750) 

Jun 90–Jul 92 Karl Kirchgessner Foundation: The metabolism of the optic nerve head ($20,000) 

Dec 90–Jun 91 University of California Academic Senate Grant: Effect of metabolic stressors in tissue 

culture metabolism ($3,395) 

1990–92 Allergan Pharmaceuticals: A double-masked, multi-center evaluation of the efficacy and 

dosing requirements of brimonidine in attenuating elevations in intraocular pressure after 

laser trabeculoplasty ($7,100) 

1992–93 Merck Sharp & Dohme: An active-controlled, randomized, double-masked parallel 

multicenter study of the administration of timpilo 2 %/bid vs timolol 0.5%/bid with pilocarpine 

2%/qid to patients with open angle glaucoma requiring two topical agents for control of 

intraocular pressure ($27,871) 

Jul 92–Jun 93 University of California Academic Senate Grant: Research study on optic nerve head 

changes before and after lowering intraocular pressure in patients with glaucoma, or who are 

suspicious for developing glaucoma ($2,040) 

Jul 93–Jun 94 Stein/Oppenheimer Endowment Award: Development of a prognostic test for glaucoma 

($15,000) 

Jul 93–Jun 94 Permanent Charities Committee for Entertainment Industries Award: Detection of early 

glaucomatous optic nerve head damage with a laser scanning image detection system 

($20,000) 

Jan 94–Jan 95 Eleanor and Richard Dwyer Award: Detection of glaucomatous Optic nerve head damage 

with a laser scanning image detection system ($10,000) 

Jun 94–Aug 94 Howard Hughes Summer Undergraduate Research Fellowship: Faculty sponsor of Frank 

Peng, recipient ($1,000) 

Aug 94–Jul 97 PHS/National Eye Institute(NEI) 5 K-11 EY00339-01: Outcomes of glaucoma surgeries— 

Principal Investigator, 75% effort ($219,052) 

Jan 94–Aug 98 NIH/NEI: Ocular Hypertension Treatment Trial, NEI 5 U10 EY010428-01—Wilson/Co-PI, 7% 

effort ($906,418 direct costs) 

Jul 95–May 97 NIH/NEI: Ocular Hypertension Treatment Trial - Ancillary Study, NEI 5 U10 EY1115 

(Coleman)— Principal Investigator on subcontract, 5% effort ($73,741) 

Jul 96–Jun 99 Robert Wood Johnson Foundation: Use of vision services and unmet need for ophthalmic 

care among community-based Medicare beneficiaries (Mangione)—Ophthalmic Consultant 

($240,000) 

Aug 96–Jul 99 NIH/Agency for Health Care Policy and Research (AHCPR): Use of vision services and 

unmet need for ophthalmic care among community-based Medicare beneficiaries 

(Mangione)—Ophthalmic Consultant, 5% effort ($793,662) 

Sep 96–Apr 97 NIH/National Institute on Aging(NIA): Study of Osteoporotic Fractures - Eye Survey NIH/NIA 

R01-AR35582 (Cauley; Mangione as PI on subcontract)—Co-PI, 25% effort ($759,193) 

May 97–Apr 02 NIH/NIA: Study of Osteoporotic Fractures- Eye Survey, NIH/NIA 5 R01-AG05407 

(Cummings; Mangione as PI on subcontract)—Co-PI, 25% effort ($1,407,779 direct costs) 

Jul 97–Jun 98 Glaucoma Research Foundation—Faculty sponsor of Fotis Topouzis, MD, fellowship 

recipient ($43,000) 

May 98–Aug 99 Screening for Memantine Phase 3 Clinical Trial in Ocular Hypertensive Patients 

(Coleman)—Principal Investigator ($3,092) 



ALC100325 


Jul 98–Jun 99 Robert Wood Johnson Foundation: Diabetes Services Study (Mangione)— Ophthalmic 

Consultant, 5% effort ($146,780) 

Jul 98–Jun 00 Glaucoma Research Foundation: Study on reasons that glaucoma patients go blind (Lee)— 

Investigator, 10% effort ($51,473) 

Jul 98–Feb 01 Research to Prevent Blindness Manpower Award: 018544 RPB Award (Coleman)—Principal 

Investigator ($5,000) 

Aug 98–Dec 99 NIH/NEI: Ocular Hypertension Treatment Trial, NEI 5 U10 EY010428-01— Principal 

Investigator, 12% effort ($388,464 direct costs) 

Jan 00–Mar 01 A multi-center investigator-masked, randomized, parallel study of the safety and efficacy of 

AGN 19024 0.03%/qd ophthalmic solution compared with Cosopt/bid ophthalmic sollution 

in subjects with glaucoma or ocular hypertension, Award #192024-013-00 (Coleman)— 


Jan 00–Dec 03 NIH/NEI: Ocular Hypertension Treatment Trial, NEI 5 U10 EY010428-01 (Coleman)— 


Jan 01–Dec 05 NIH/NEI: Clinical measurements of optic nerve damage in glaucoma - NEI R01 (Caprioli)— 

Co-Investigator, 5% effort ($1,000,000 direct costs) 

Jul 01–Jun 04 NIH/NIA: Multidimensional intervention for vision-impaired elders - Project Center Grant 

(Reuben, PI) —Project Leader, 5% effort ($305,587 direct costs) 

Jun 02–Jan 04 Alcon Laboratories, Inc.: Study to compare IOP lowering effect of Travatan- Award 

#CM-01-08 (Coleman)—Principal Investigator ($20,000 direct costs) 

Jun 02–Feb 09 NIH/NEI: Ocular Hypertension Treatment Study II, NEI 5 U10 EY010778-13 (Coleman)— 

Principal Investigator ($806,451) 

Aug 02–Jul 08 NIH/NEI: Incidence of macular degeneration in older women, NEI U10 EY 13626 

(Coleman)—Principal Investigator, 20% effort ($2,781,595 direct costs) 

Dec 03–Dec 06 Gerald Oppenheimer Family Foundation Center for the Prevention of Eye Disease: 

Effect of nutrition on glaucoma—Principal Investigator ($33,000) 

Dec 03–Dec 10 Gerald Oppenheimer Family Foundation Center for the Prevention of Eye Disease: 

Effect of yoga on glaucoma—Principal Investigator ($59,000) 

Jan 04–Jan 05 Joyce J. Cammilleri Family Fund: Glaucoma and age-related macular degeneration 

($10,000) 

Jan 04–Jan 05 Pfizer: Analysis of wet AMD utilizing CMS - Award #2004-063 (Coleman)—Principal 

Investigator ($36,750) 

2005–2010 NIH/NEI: Vision Research Training Grant, NEI EY00702633 (Travis)—Mentor ($352,998) 

Sep 07–Dec 09 American Health Assistance Foundation: A study of selected candidate genes in the 

genetics of age-related maculopathy in older women—Principal Investigator ($100,000) 

2007–2009 Gerald Oppenheimer Family Foundation Center for the Prevention of Eye Disease: Case 

control study on vitamins and glaucoma (Shen and Coleman)—Co-Principal Investigator 

($30,000) 

2009– Fogarty International Clinical Research Fellowship (Fafowora): The genetics of juvenile open 

angle glaucoma in Ibadan, Nigeria—Mentor 

2009-2011 Gerald Oppenheimer Family Foundation Center for the Prevention of Eye Disease: 

Prevention of visual Impairment and blindness among school-aged children (Kodjebacheva 

and Coleman)—Co-Principal Investigator ($30,000) 



ALC100325 


TEACHING ACTIVITIES 

University of California (UCLA) 

/Jules Stein Eye Institute (JSEI) 

/UCLA School of Medicine (School of Med) 

/David Geffen School of Medicine at UCLA (Geffen School of Med) 

1990– Clinical Attending - UCLA Dept.Ophthalmology/Outpatient Department and Glaucoma Division: 

supervision of ophthalmology residents 

1990– Clinical Attending - JSEI/Operating Room: supervision of ophthalmology residents’ and fellows’ 

surgery 

1990– Faculty - Glaucoma Weekly Specialty Conference 

1990–93 Instructor - UCLA School of Med: Ophthalmology Basic and Clinical Science Course for 1 st -year 

residents-Glaucoma, Lens, and Anterior Segment Trauma 

1990–95 Clinical Attending - Sepulveda VA Hospital: supervision of ophthalmology residents 

1991– Coordinator, Faculty - UCLA School of Med: Course M201-Clinical Fundamentals of 

Ophthalmology (required for 2 nd -year medical students) 

1991– Instructor - UCLA School of Med: Course OP200-Advanced In-depth Elective in Ophthalmology (1month 

course for 4 th -year medical students) 

1994– Faculty Advisor - UCLA School of Medicine 

1994– Instructor - UCLA School of Med: Ophthalmology Basic and Clinical Science Course for 1 st- year 

residents-Glaucoma 

1994–98 Faculty - Department of Ophthalmology: Glaucoma Journal Club 

Sep 29, 93 Instructor - UCLA Operating Room In-Service: Glaucoma Treatment and Surgery 

Oct 9, 93 Faculty - JSEI & UCLA School of Med: Essential Epidemiology and Biostatistics for 

Ophthalmologists 

Mar 4, 94 Moderator/Glaucoma Section - JSEI: Residents and Fellows Research Day 

Sep 10, 94 Faculty - JSEI: Laser Certification Workshop 

Dec 10, 94 Faculty - JSEI & UCLA School of Med: Essential Epidemiology and Biostatistics for 


Feb–Mar 95 Faculty - UCLA School of Med: Ophthalmology Basic and Clinical Science Course, Section 10- 

Glaucoma 

Apr 7–8, 95 Faculty, Moderator - UCLA School of Med: Annual Post-graduate Ophthalmology Seminar 

Dec 16, 95 Coordinator, Faculty - JSEI & UCLA School of Med: Essential Epidemiology and Biostatistics for 


Sep 20, 97 Course Coordinator - JSEI: Eye on Digital Technology 

Feb 7, 98 Course Coordinator - JSEI & UCLA School of Med: Ophthalmic Outcomes–What You Need to 

Know about Quality of Life and Health Services Research 

Sep 2, 98 Instructor - JSEI & UCLA School of Med: Glaucoma/Advanced Ophthalmology Clerkship for 

medical students 

Oct 21, 98 Faculty - UCLA School of Med: Ophthalmology Basic and Clinical Science Course, Section 2- 

Statistics and Epidemiology 

Mar 6, 99 Moderator/Glaucoma Section - JSEI & UCLA Dept. Ophthalmology: Research and Alumni Day 

Program 



ALC100325 


Apr 9-10, 99 Program Co-Chair - JSEI & UCLA School of Med: Glaucoma Management 2000 

May 26, 99 Faculty - JSEI & UCLA School of Med: Ophthalmology Basic and Clinical Science Course-Uveitic 

Glaucoma 

Sep 1, 99 Instructor - JSEI & UCLA School of Med: Ophthalmology Basic and Clinical Science Course- 

Glaucoma 

Jan 26, 00 Invited Lecturer - UCLA School of Med/Dept. Medicine Kennamer Fellows: Screening for Vision 

Problems 

Feb 15, 00 Invited Lecturer - UCLA School of Med/Dept. Internal Medicine: Outpatient Morning Report-The 

Red Eye 

Mar 15, 00 Instructor - JSEI & UCLA School of Med: Ophthalmology Basic and Clinical Science Course- 

Pediatric Glaucoma 


Epidemiology of Glaucoma 


Congenital Glaucoma 

Oct 10, 01 Faculty - JSEI Glaucoma Weekly Conference: Practicing Evidence-Based Ophthalmology in 

Glaucoma 

April 25, 01 Instructor - JSEI & UCLA School of Med: Ophthalmology Basic and Clinical Science Course- 

Epidemiology of Cataracts 

Aug 11, 01 Course Co-Director - Jules Stein Eye Institute Program (Beverly Hills, CA): Clinical Applications of 

Ocular Blood Flow 


Statistics and Epidemiology 

Feb 13, 02 Speaker/Grand Rounds - JSEI & UCLA School of Med: Practicing Evidence-Based Medicine in the 

Therapy of Ophthalmic Diseases 

Sep 25, 02 Faculty - JSEI & UCLA School of Med -Glaucoma Weekly Conference : Drainage Devices 

Dec 18, 02 Speaker/Grand Rounds - JSEI & UCLA School of Med: Risk Factors for Blindness from Glaucoma 

Feb 22, 03 Facilitator/Ophthalmology Panel - UCLA School of Med/UCLA Medical Alumni Association: 

Conference on Career Choices in Medicine (for medical students) 

May 14, 03 Instructor - JSEI & UCLA School of Med: Ophthalmology Basic and Clinical Science Course- 

Pediatric Glaucomas 

Aug 11, 03 Moderator - JSEI Residents Journal Club-Santa Monica, CA 

Dec 17, 03 Speaker/Grand Rounds - JSEI & UCLA School of Med: Applying Evidence-Based Medicine in an 

Ophthalmic Practice: Diagnostic Tests 

Jun 23, 04 Lecturer - David Geffen School of Med: Introductory Ophthalmology Lecture for 1 st and 2 nd -year 

medical students: Disturbances of Vision (I and II) 

Sep 21, 04 Invited Lecturer - Geffen School of Med: OP205.01 Elective-Glaucoma 

Jan 19, 05 Speaker/Grand Rounds - JSEI & Geffen School of Med: Learning the Art of Optic Nerve Evaluation 

Jan 26, 05 Faculty - JSEI & Geffen School of Med: Glaucoma Weekly Conference: Applying Evidence-Based 

Medicine in Ophthalmology 

Aug 15, 05 Moderator - JSEI Residents Journal Club / Santa Monica, CA 

Nov 15, 05 Speaker - Geffen School of Med: American Medical Women’s Association—Women in Medicine 

Lunchtime Panel 

Jan 4, 06 Invited Lecturer - JSEI & Geffen School of Med: Glaucoma Weekly Conference: Ahmed Glaucoma 

Valve Implant 

Sep 17, 06 Invited Lecturer - JSEI/UCLA/AUPO Introductory Course on Clinical Research for Ophthalmology 

Residents, Fellows, and Faculty: How to Read the Literature Critically 

Feb 7, 07 Invited Lecturer - JSEI & Geffen School of Med: Ophthalmology Basic and Clinical Science Course- 

Epidemiology, Heredity, and Genetics of Glaucoma 



ALC100325 


Feb 7, 07 Speaker/Grand Rounds - JSEI Ophthalmic Clinical Conference/Glaucoma Specialty Service 

Program: Optic Nerve and Glaucoma Progression 

Feb 8–11, 07 Invited Faculty - Jules Stein Eye Institute Glaucoma Summit IV (Yosemite, CA) 

Apr 25, 07 Invited Speaker - Geffen School of Med/ UCLA Medical Auxiliary: Focus-Glaucoma 

Sep 24, 07 Instructor - JSEI & Geffen School of Med: OP205.01 Elective Course-Glaucoma 

Oct 17, 07 Lecturer - JSEI & Geffen School of Med/ Glaucoma Weekly Conference: Epidemiology in 

Glaucoma 

Oct 22, 08 Lecturer - JSEI & Geffen School of Med/ Glaucoma Weekly Conference: Quality of Life and 

Glaucoma 

Mar 25, 09 Speaker/Grand Rounds - JSEI & Geffen School of Med: A Public Health Perspective on Glaucoma 

GLAUCOMA FELLOWS TRAINED…AFFILIATION 

1990–91 Vincent Lee, MD....................................Director of Eye Center 

Hong Kong Adventist Hospital 

Hong Kong 

1990–91 Jeff Rabowsky, MD ...............................Staff Member - Department of Ophthalmology 

The Permanente Medical Group 

Sacramento, CA 

1990–91 Jose Noregia, MD .................................Clinical Assistant Professor 

Medico Cirujano Oftalmologo 

Benavides Miraflores, Chile 

1991–92 Cordell Adams, MD ...............................Associate Attending 


Baylor University Medical Center - Dallas, TX 

1992–93 Jason Bacharach, MD...........................Assistant Clinical Professor 

California Pacific Medical Center 

San Francisco, CA 

1992–93 Ronit Kotas-Neumann, MD ...................Staff Member - Eye Clinic 

Kfar-Saba, Israel 

1993–94 Mae Tam, MD .......................................Associate Staff Member 


Peace Arch Community Hospital 

Vancouver, Canada 

1993–94 Manolito Reyes, MD..............................Consultant Ophthalmologist 

Reyes Eye Clinic / St. Victoria Hospital 

Metro Manila, Philippines 

1994–95 Irene Sasaki, MD...................................Clinical Instructor 

Jules Stein Eye Institute/ 

UCLA School of Medicine 

1994–95 Michael Kook, MD .................................Visiting Professor - Department of Ophthalmology 

University of Ulsan /College of Medicine 

Seoul, Korea 

1995–96 Nicolas Hamush, MD ............................Staff Member - McFarland Eye Clinic 

Ames, IA 

1995–96 Mary Bhavsar, MD ................................Staff Member - Phillips Eye Institute 

Edina, MN 



ALC100325 


1996–97 John Marsh, MD....................................Staff Member - Hartland Eye Center 

Topeka, KS 

1996–97 Hung Huy Le, MD..................................Private Practice 

Houston, TX 

1996–97 Pedro Quevedo, MD .............................Assistant Professor 

Clinica De Oftalmologia 

Cali, Colombia 

1997–98 Fotis Topouzis, MD ...............................Associate Professor - Department of Ophthalmology 

Aristotle University of Thessaloniki 


1997–98 Simon Law, MD, PharmD......................Associate Professor - Glaucoma Division 



1997–98 Hyong S. Choe, MD ..............................Staff Member - Neyva Eye Associates 

Bala Cynwood, PA 

1998–99 Mamdouh Nakla, MD ............................Staff Member - Department of Ophthalmology 

The Permanente Group 

Harbor City, CA 

1998–99 Baber Ali, MD ........................................Clinical Instructor 



1999–00 Rick Huo, MD ........................................Senior Medical Liaison 

Amgen 

Thousand Oaks, CA 

1999–00 Frank La Rosa, MD, PhD ......................Staff Member 

Virginia Eye Institute 

Richmond, VA 

2000–01 Luca Brigatti, MD...................................Retired - Washington, DC 

2000–01 Keith Stevens, MD, OD .........................Staff Member - Eye Center 

Huntsville, AL 

2001–02 Michelle Banks, MD ..............................Assistant Professor 

King Drew Medical Center 

Los Angeles, CA 

2001–03 Dana Tannenbaum, MD........................Clinical Instructor 



2003–04 Joann A. Giaconi, MD ...........................Assistant Professor - Glaucoma Division 



2003–04 Satvinder K. Gujral, MD ........................Staff Member 

Harriman Jones Medical Group 

Long Beach, CA 

2004–05 Eleftherios Anastasopoulos, MD ...........Instructor 

University of Aristotle 


2004–05 Kimberly D. Davis, MD ..........................Head of Glaucoma Services 

Naval Medical Center 

San Diego, CA 

2004–05 Joanna D. Lumba Sarracino, MD..........Clinical Assistant Professor 

Stanford Eye Center 

Palo Alto, CA 



ALC100325 


2004-05 Scott C. So, MD ....................................Assistant Clinical Professor 

California Pacific Medical Center 


2005–06 Annette L. Giangiacomo, MD ................Assistant Professor 

Emory University 

Atlanta, GA 

2005–06 Mark H. Kramar, MD .............................Private Ophthalmic Practice 

Ophthalmology Associates of the Valley 

Encino, CA 

2006–07 Duc A. Tran, DO....................................Private Ophthalmic Practice 

Coastal Eye Associates 

Webster, TX 

2006–07 Jane V. Loman, MD ..............................Private Ophthalmic Practice 

Eye Physicians of East Bay 

Oakland, CA 

2007–08 Ryan Taban, MD ...................................Private Ophthalmic Practice 

Facey Medical Group 

Mission Hills, CA 

2007–08 Priya Desai, MD, MBA ..........................Private Ophthalmic Practice 

Matossian Eye Associates 

Ewing, NJ 

2008–09 Juliet E. Chung, MD ..............................Private Ophthalmic Practice 

Los Angeles, CA 

2008–009 Lucy Shen, MD......................................Instructor in Ophthalmology 

Massachusetts Eye & Ear Infirmary/ 

Harvard Medical School - Boston, MA 

2009–10 Houman Vosoghi,MD ............................Fellow 



2009–10 Geetha G. Vedula, MD..........................Fellow 



ROBERT WOOD JOHNSON CLINICAL SCHOLARS TRAINED 

1997–99 Susannah Rowe, MD, MPH ..................Assistant Professor 


Boston University – Boston, MA 

MENTORING OF POSTDOCTORAL FELLOWS & RESEARCHERS 

2009– Gergana Kodjebacheva, PhD ...............Post-doctoral Fellow, Jules Stein Eye Institute 

[Community health; children’s vision health; 

JSEI Mobile Eye Clinic] 

2009– Oluwatoyin Fafowora, MD, MPH...........Research Fellow [Incidence of glaucoma in Nigeria] 

2009– Yahya Shaikh, MPH ..............................UCLA Medical Student 

[Effect of exercise on eye pressure and vision-specific 

quality of life; JSEI Mobile Eye Clinic] 



ALC100325 


TEACHING — NATIONAL 

Oct 91 Faculty: Basic Laser Laboratory - American Academy of Ophthalmology/American Glaucoma 

Society, Anaheim, CA 

Oct 91 Faculty: Skills Transfer Course in Interpretation of Automated Perimetry - American Academy of 

Ophthalmology/American Glaucoma Society, Anaheim, CA 

Jul 11, 92 Faculty: Didactic and Wet Lab Sessions - Glaucoma Update 1992, Irvine, CA 

Nov 92 Faculty: Basic Laser Laboratory - American Academy of Ophthalmology/American Glaucoma 

Society, Dallas, TX 

Sep 12, 92 Course Director: A Technician's Role In Ocular Trauma - JCAHPO, Dana Point, CA 

Nov 17, 93 Faculty: Basic Laser Laboratory - American Academy of Ophthalmology/American Glaucoma 

Society, Chicago, IL 

Nov 3, 94 Faculty: Laser Applications in Glaucoma: Transscleral Cyclophotoablation Laboratory - American 

Academy of Ophthalmology/American Glaucoma Society, San Francisco, CA 

Oct 30, 95 Faculty: Role of the Ahmed Glaucoma Valve in the Surgical Management of Glaucoma - American 

Academy of Ophthalmology Instruction Course, Atlanta, GA 

Oct 30, 96 Faculty: Glaucoma: News and Views - American Academy of Ophthalmology Instruction Course, 

Chicago, IL 

Oct 31, 96 Discussant: two papers on Ahmed Glaucoma Valve Implant - American Academy of 

Ophthalmology, Chicago, IL 


Academy of Ophthalmology Instruction Course, Chicago, IL 

Oct 25, 97 Faculty: Epidemiology of Glaucoma, Under Pressure: Glaucoma 1997 - American Academy of 

Ophthalmology Subspecialty Day, San Francisco, CA 

Oct 27, 97 Faculty: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology 

Instruction Course, San Francisco, CA 

Oct 28, 97 Faculty: Glaucoma: News and Views - American Academy of Ophthalmology Instruction Course, 



Academy of Ophthalmology Instruction Course, San Francisco, CA 

Feb 27-28, 98 Faculty: Advanced Anterior Segment Surgery, Special Focus Course - American Academy of 

Ophthalmology, Palm Springs, CA 

Jun 13, 98 Faculty: Quality of Life in Glaucoma - Ocular Drug & Surgical Therapy Update, Ritz Carlton Laguna 

Niguel, CA 

Nov 8, 98 Chairperson: Symposium on Pregnancy and the Eye - American Academy of Ophthalmology, 

New Orleans, LA 

Nov 8, 98 Faculty: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology 

Instruction Course, New Orleans, LA 

May 9, 99 Moderator: Clinical Research in Glaucoma/I - Association for Research in Vision and 

Ophthalmology, Ft. Lauderdale, FL 

Oct 25, 99 Faculty: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology 

Instruction Course, Orlando, FL 

Oct 26, 99 Chairperson: Symposium on Women’s Issues in Ophthalmology - American Society of Ophthalmic 

Registered Nurses, Orlando, FL 

Mar 5, 00 Moderator: American Glaucoma Society Annual Meeting, San Antonio, TX 

May 1, 00 Moderator: Optic Nerve Fiber Layer Imaging - Association for Research in Vision and 

Ophthalmology (ARVO), Fort Lauderdale, FL 



ALC100325 


Oct 22, 00 Instructor: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology, 

Dallas, TX 

Oct 23, 00 Instructor: Lab on Implantation of Glaucoma Drainage Devices, American Academy of 

Ophthalmology, Dallas, TX 

Octr 24, 00 Senior Instructor: How to Critically Interpret Research Results and Translate These Results into 

Clinical Care - American Academy of Ophthalmology, Dallas, TX 

Mar 3, 01 Moderator: American Glaucoma Society Annual Meeting, Newport Beach, CA 

Aug 5, 01 Moderator: Women in Ophthalmology Annual Meeting, Aspen, CO 

Nov 11, 01 Senior Instructor: How to Critically Interpret Research Results and Translate These Results into 

Clinical Care - American Academy of Ophthalmology, New Orleans, LA 

Nov 12, 01 Instructor: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology, 


Nov 12, 01 Instructor: Glaucoma Drainage Device Lab - American Academy of Ophthalmology, New Orleans, 

LA 

Nov 13, 01 Chairperson: Aging and the Eye Symposium - American Academy of Ophthalmology, 


Nov 14, 01 Senior Instructor: Ocular Blood Flow - American Academy of Ophthalmology, New Orleans, LA 

Aug 23, 02 Faculty: Roundtable on Ocular Hypertension Treatment Study - Pharmacia, San Francisco, CA 

Sep 21, 02 Co-Chair: Focus on Efficiency - California Academy of Ophthalmology, Santa Monica, CA 

Oct 20, 02 Instructor: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology, 

Orlando, FL 

Oct 21, 02 Lab Instructor: Implantation of Glaucoma Drainage Devices - American Academy of 

Ophthalmology, Orlando, FL 

Oct 21, 02 Senior Instructor: How to Critically Interpret Research Results and Adapt Them to Your Practice - 

American Academy of Ophthalmology, Orlando, FL 

Oct 21, 02 Senior Instructor: Ocular Blood Flow - American Academy of Ophthalmology, Orlando, FL 

Oct 22, 02 Co-Chair: Glaucoma Management 2002: Medical and Surgical State of the Art Symposium - 

American Academy of Ophthalmology, Orlando, FL 

Mar 9, 03 Instructor: Statistics Course - American Glaucoma Society, San Francisco, CA 

Nov 15, 03 Invited Instructor: Evidence-Based Ophthalmology/A Workshop on Finding, Synthesizing, and 

Applying Clinical Evidence–Cochrane Eye and Vision Group US Project - American Academy of 

Ophthalmology Annual Meeting, Anaheim, CA 

Nov 17, 03 Instructor: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology, 

Anaheim, CA 

Feb 14, 04 Invited Speaker and Workshop Chair: Review of Glaucoma Clinical Trials - 7 th Annual Ocular Drug 

and Surgical Therapy Update Meeting, Dana Point, CA 

Feb 29, 04 Workshop Moderator: Strengthening Collaborative Partnerships in Eye Health Education - NEHEP 

Education Conference, Charleston, SC 

Mar 1, 04 Moderator, Committee Member: National Eye Institute’s National Eye Health Education Conference 

- Charleston, SC 

Mar 4-7, 04 Program Committee Member: American Glaucoma Society Annual Meeting, Sarasota, FL 

Apr 24, 04 Group Leader: Evidence-based Ophthalmology/A Workshop on Finding, Synthesizing, and 

Applying Clinical Evidence - Cochrane Eyes and Vision Group - The Association for Research in 

Vision and Ophthalmology (ARVO), Fort Lauderdale, FL 

Aug 4-7, 04 Moderator, Board Member: American Eye Study Club Annual Meeting 2004, Banff, Alberta, 

Canada 

Oct 25, 04 Invited Instructor: Implantation of Glaucoma Drainage Devices - American Academy of 

Ophthalmology Annual Meeting, New Orleans, LA 



ALC100325 


Dec 14, 04 Invited Moderator: K Award Recipients/ David Cogan Clinician Scientist Symposium - National Eye 

Institute, Bethesda, MD 

Jan 22, 05 Program Chair, Moderator and Invited Speaker: Evaluating the Optic Nerve/ Clinical Frontiers in 

Otolaryngology and Controversies in Ophthalmology - 73 rd Mid-winter Conference - The Research 

Study Club of Los Angeles, Los Angeles, CA 

Feb 3-6, 05 Discussion Group Leader: Jules Stein Eye Institute 3 rd Glaucoma Summit, Yosemite, CA 

Mar 3-6, 05 Program Committee Member: American Glaucoma Society Annual Meeting, Snowbird, UT 

Mar 3-6, 05 Moderator, Mini Symposium: Glaucoma in Children - American Glaucoma Society Annual Meeting, 

Snowbird, UT 

Oct 15, 05 Invited Speaker: Diagnostic Imaging in Glaucoma Comes of Age - Heidelberg Academy Education 

Programs, Chicago, IL 

Oct 15, 05 Presenter: Glaucoma 2005: Paradigm Change in Theory and Practice - American Academy of 

Ophthalmology Annual Meeting/Subspecialty Day, Chicago, IL 

Oct 16, 05 Invited Instructor: Implantation of Glaucoma Drainage Devices - American Academy of 

Ophthalmology Annual Meeting, Chicago, IL 

Oct 17, 05 Invited Instructor: Applying Evidence-Based Medicine in Glaucoma Management - American 

Academy of Ophthalmology Annual Meeting, Chicago, IL 

Oct 17, 05 Moderator: Women: The Next Fifty Years - American Academy of Ophthalmology, Chicago, IL 

Oct 18, 05 Invited Instructor: Spotlight on Glaucoma: Glaucoma Care and Technology, Risk Assessment and 

Predicting the Future - American Academy of Ophthalmology Annual Meeting, Chicago, IL 

Jan 16, 06 Invited Instructor: How the Ocular Hypertension Treatment Study Has Changed the Diagnosis and 

Treatment of Glaucoma Workshop - Hawaiian Eye 2006, Maui, HI 

Feb 18, 06 Invited Instructor: Detecting and Managing Glaucoma Progression Workshop - 9 th Annual Ocular 

Drug and Surgical Therapy Update Meeting, Dana Point, CA 

Feb 19, 06 Invited Instructor: Glaucoma Surgery Workshop - 9 th Annual Ocular Drug and Surgical Therapy 

Update Meeting, Dana Point, CA 

Mar 1, 06 Chair: First Annual Journal Club - American Glaucoma Society Annual Meeting, Charleston, SC 

Mar 31, 06 Expert Panel Member: The Modified-RAND Method for Assessing Glaucoma Therapy - Pfizer Inc, 

Dallas, TX 

May 3, 06 Moderator: Clinical Research III: Glaucoma Poster Session - Association for Research in Vision 

and Ophthalmology Annual Meeting, Fort Lauderdale, FL 

Jun 3, 06 Invited Roundtable Participant: Preservative-Induced Ocular Surface Changes in Patients with 

Glaucoma: New Evidence, New Management Strategies, Del Mar, CA 

Nov 11, 06 Chair: Glaucoma Subspecialty Day: Beating the Odds - American Academy of Ophthalmology, 

Las Vegas, NV 

Feb 18, 07 Invited Instructor: Visual Fields in Glaucoma Workshop - 10 th Annual Ocular Drug and Surgical 

Therapy Update Meeting, Dana Point, CA 

Mar 3, 07 Moderator: Second Annual Journal Club - American Glaucoma Society Annual Meeting, 


Nov 10, 07 Co-Chair: Glaucoma Subspecialty Day: Achieving Balance - American Academy of Ophthalmology, 


Nov 11, 07 Co-Chair: Recognition of Glaucomatous Progression/Prevent Blindness America/AAO Symposium 

- American Academy of Ophthalmology, New Orleans, LA 

Feb 16, 08 Faculty: Transform Your Treatment of Ocular Disorders: Glaucoma Diagnosis, Workshop Session-I 

- 11 th Annual Ocular Drug and Surgical Therapy Update, Dana Point, CA 

Feb 17, 08 Faculty: Transform Your Treatment of Ocular Disorders: Neuroprotection in Glaucoma, Workshop 

Session-II - 11 th Annual Ocular Drug and Surgical Therapy Update, Dana Point, CA 

Mar 8, 08 Moderator: The Lobbyist, the Regulator, and the Practitioner: Three Views on Glaucoma Public 

Policy - American Glaucoma Society Mini-Symposium, Washington, DC 



ALC100325 


Jul 30-31, 08 Moderator: Scientific Session II - 51 st American Eye Study Club Annual Meeting, Ojai, CA 

Nov 9, 08 Instructor: Implantation of Glaucoma Drainage Devices - American Academy of Ophthalmology 

Annual Meeting, Atlanta, GA 

Nov 10, 08 Instructor: Surgical Decision Making In Glaucoma: An Evidence-Based Approach - American 

Academy of Ophthalmology Annual Meeting, Atlanta, GA 

Nov 11, 08 Chair: Business, Ethical, and Legal Aspects of Treating Glaucoma Patients - Prevent Blindness 

America/American Academy of Ophthalmology Symposium - American Academy of 

Ophthalmology, Atlanta, GA 

Jan 19, 09 Instructor: Pushing the Boundaries of Fourier-Domain OCT: Extensive Clinical Application for your 

Practice - Hawaiian Eye 2009, Maui, Big Island, HI 

Feb 15, 09 Workshop Chair: Glaucoma Progression - 12 th Annual Ocular Drug and Surgical Therapy Update, 

Dana Point, CA 

Mar 8, 09 Workshop Chair: Superbowl of Grand Rounds - American Glaucoma Society Annual Meeting, 

San Diego, CA 



ALC100325 


TEACHING — INTERNATIONAL 

Nov 87 Visiting Resident - Aravind Eye Institute, Madurai, India 

Mar–Apr 90 Visiting Faculty - Filatov Research Institute for Eye Diseases and Tissue Therapy, Odessa, USSR 

Jan28-Feb6, 94 Glaucoma Faculty for Orbis International, Ahmedabad, India 

Mar 22-28, 94 Ahmed Glaucoma Valve Implantation Course - Rawalpindi, Lahore; Karachi, Pakistan 

Sep 26-28, 94 Faculty: Epidemiology and Biostatistics - Peking Union Medical College, Beijing, China 

Jan 22-28, 94 Glaucoma Faculty - Orbis International, Kingston, Jamaica 

Jan 14-20, 96 Glaucoma and Epidemiology Faculty - Orbis International, Yangon, Myanmar 

Apr 97 Lecturer: Combined Cataract and Glaucoma Surgery - Pan American Academy of Ophthalmology, 

Cancun, Mexico 

May 97 Course Director: The Use of Drainage Devices in Glaucoma Patients - Pan American Academy of 

Ophthalmology, Cancun, Mexico 

Oct 5, 99 Invited Lecturer - Second Congress of Asian-Oceanic Glaucoma Society, Tokyo, Japan 

May 27, 00 Invited Lecturer - 33 rd Pan Hellenic Ophthalmological Congress, Thessaloniki, Greece 

Mar 10, 01 Invited Lecturer - Eighth International Glaucoma Congress - Greek Glaucoma Society, Athens, 

Greece 

Mar 22, 01 Chairperson: Genetics and Epidemiology Session - 3 rd International Glaucoma Symposium, 

Prague, Czechoslovakia 

Jul 13–14, 01 Invited Panel Member - Glaucoma Global Roundtable, Copenhagen, Denmark 

Jul 01 Senior Instructor: Pitfalls and Pearls in the Use of Drainage Devices - 22 nd Pan-American Congress 

of Ophthalmology, Buenos Aires, Argentina 

Apr 24, 02 Instructor: Other Clinical Trials Information in the Treatment of Glaucoma Patients - 

29 th International Congress of Ophthalmology, Sydney, Australia 

Apr 24, 02 Instructor: Vascular Epidemiology of Glaucoma - 29 th International Congress of Ophthalmology, 

Sydney, Australia 

Apr 24, 02 Instructor: Issues in the Screening for Glaucoma in Developing Countries - 29 th International 

Congress of Ophthalmology, Sydney, Australia 

May 02 Invited Speaker: Epidemiology of Glaucoma - 4 th International Course on Glaucoma, Såo Paulo, 

Brazil. 

May 02 Invited Speaker: How Multicenter Trials Help us in Clinical Practice - 4 th International Course of 

Glaucoma, Såo Paulo, Brazil 

Jun 5, 02 Invited Moderator: Management of Glaucoma - Pan Hellenic Ophthalmologic Congress, Chalkidiki, 

Greece 

Jun 7, 02 Invited Speaker: Epidemiology of Glaucoma - Pan Hellenic Ophthalmologic Congress, Chalkidiki, 

Greece 

Jun 8, 02 Invited Speaker: Randomized Clinical Trial of Lumigan versus Cosopt - 

Pan Hellenic Ophthalmologic Congress, Chalkidiki, Greece. 

Jun 8, 02 Invited Speaker: Roundtable on Glaucoma Surgery - Pan Hellenic Ophthalmologic Congress, 

Chalkidiki, Greece. 

Oct 7, 02 Co-Chair: Glaucoma and Cataract Epidemiology Symposium - 15 th International Congress of Eye 

Research, Geneva, Switzerland 

Oct 22, 02 Co-Chair: Ophthalmology for Medical Students: The How, What and When - 

Pan American Academy of Ophthalmology, Orlando, FL 

Jan 11, 03 Invited Speaker: Non-vascular Risk Factors for Glaucoma - Glaucoma Symposium, Thessaloniki, 

Greece 



ALC100325 


Jan 11, 03 Invited Speaker: Ocular Hypertension Treatment Study (OHTS) Results - Glaucoma Symposium, 


Mar 21, 03 Invited Speaker: A Three-Month Randomized Controlled Trial of Bimatoprost (Lumigan) vs. 

Timolol/Dorzolamide (Cosopt) in Patients with Glaucoma or Ocular Hypertension - Fourth 

International Glaucoma Symposium, Barcelona, Spain 

Mar 22, 03 Co-Chair: Glaucoma Epidemiology and Genetics - 4 th International Glaucoma Symposium, 

Barcelona, Spain 

Mar 28, 03 Instructor: How to Manage Very Low IOP in the Early Post-Op - 24 th Pan-American Congress of 

Ophthalmology, San Juan, Puerto Rico 

Mar 29, 03 Course Organizer: Pearls and Pitfalls in the Use of Drainage Devices - 

24 th Pan-American Congress of Ophthalmology, San Juan, Puerto Rico 

Mar 30, 03 Instructor: Approaches to the Management of Newly Diagnosed Ocular Hypertension and Open- 

Angle Glaucoma - 24 th Pan-American Congress of Ophthalmology, San Juan, Puerto Rico 

Mar 30, 03 Instructor: Cataract Surgery on Patients with Glaucoma - 24 th Pan-American Congress of 

Ophthalmology, San Juan, Puerto Rico 

May 03 Invited Speaker: Relationship between IOP and COAG and Implications for Terminology 

(NTG,LTG,OHT) - Glaucoma Society of the International Congress of Ophthalmology, Chantilly, 

France 

Dec 5, 03 Invited Speaker: The Epidemiology of Glaucoma and the Impact on Healthcare Costs - Walter 

Wright Meeting - University of Toronto, Toronto, Ontario 

Dec 5, 03 Invited Speaker: Evidence-Based Review of Cataract & Filtration Surgery - Walter Wright Meeting - 

University of Toronto, Toronto, Ontario 

Jun 1, 04 Invited Speaker: Restaging Glaucoma - Seventh Congress of the European Glaucoma Society 

Meeting, Florence, Italy 

Jun 10, 04 Invited Speaker: Evidence-based Recommendations for the Management of Glaucoma - 

37 th Panhellenic Ophthalmological Congress, Porto Carras-Chalkidiki, Greece 

Jun 10, 04 Invited Speaker: Options After Failed Primary Trabeculectomy - 37 th Panhellenic Ophthalmological 

Congress, Porto Carras-Chalkidiki, Greece 

Oct 16, 04 Invited Speaker: Glaucoma Management: The Role of Minimizing IOP Fluctuation - 

Glaucoma/Ocular Hypertension Study Meeting, Tokyo, Japan 

Feb 18, 05 Invited Speaker: Epidemiology of Glaucoma and Age-related Macular Degeneration - Master in 

Neuro-Ophthalmology Program, Lisbon, Portugal 

Feb 19, 05 Invited Speaker: Current Management of Glaucoma/Management of Ischemic Eye Disease from 

Epidemiology to the Clinic - Colóquios de Oftalmologia 2005 International Conference, Lisbon, 

Portugal 

Feb 21–26, 05 Moderator, mini symposium: Case Control, Cohort, Cross Sectional and Other non-Randomized 

Clinical Trials in Ophthalmology - Glaucoma Society International Congress of Ophthalmology, 

Salvador City, Brazil 

Mar 21, 05 Co-Chair: Update in Glaucoma/Twinning Course - 25 th Pan-American Congress of Ophthalmology, 

Santiago, Chile 

Mar 21, 05 Faculty: Ocular Hypertension Treatment Study (OHTS)-HRT Ancillary Study - 25 th Pan-American 

Congress of Ophthalmology, Santiago, Chile 

Mar 21, 05 Faculty: Current Approach to Phaco-Trabeculectomies - 25 th Pan-American Congress of 

Ophthalmology, Santiago, Chile 

Jul 6–9, 05 Co-Chair: International Instructional Poster Sessions - World Glaucoma Congress - Association of 

International Glaucoma Societies, Vienna, Austria 

Jul 7, 05 Invited Speaker: Societal Impact of Glaucoma - World Glaucoma Congress - Association of 

International Glaucoma Societies, Vienna, Austria 

Jul 7, 05 Instructor: Design, Conduct, and Interpretation of Clinical Trials: Pearls and Pitfalls - World 

Glaucoma Congress - Association of International Glaucoma Societies, Vienna, Austria 



ALC100325 


Jul 9, 05 Invited Speaker: Indications for Implants/ Glaucoma Surgery Consensus Session - World 

Glaucoma Congress - Association of International Glaucoma Societies, Vienna, Austria 

Sep 24, 05 Invited Participant: Translating the Thessaloniki Eye Study Results in Clinical Practice, From 

Research to Clinical Practice - Thessaloniki Eye Study Symposium, Thessaloniki, Greece 

Feb 22, 06 Chair: Landmark Clinical Trials in Glaucoma: How They Have Impacted Clinical Practice - 

American Academy of Ophthalmology Glaucoma Symposium - World Ophthalmology Congress, 

São Paulo, Brazil 

Feb 24, 06 Moderator, mini-symposium: Case Control, Cohort, Cross Sectional and Other non-Randomized 

Clinical Trials in Ophthalmology - Glaucoma Society International Congress of Ophthalmology, São 

Paolo, Brazil 

Jun 30, 06 Symposium participant: Cost To Patients, Countries, and Society - Symposium on Glaucoma 

Screening and Diagnosis/ Pharmacotherapy of Glaucoma: Worldwide Implications Today and 

Tomorrow - International Glaucoma Research Society Symposium, Vancouver, Canada 

Jul 28–29, 06 Invited Discussion Leader: Risk Factors and Outcomes: Are We Looking at the Right Things? - 

International Glaucoma Think Tank Meeting, Taormina, Sicily, Italy 

Aug 12, 06 Moderator: Odds and Ends - Women in Ophthalmology Summer Symposium, Montreal, Quebec, 

Canada 

Mar 27, 07 Faculty: European Heidelberg Glaucoma Symposium, Athens, Greece 

Mar 29, 07 Invited Panel Member: Reading the Literature Effectively - World Glaucoma Association 

Symposium - Sixth International Glaucoma Symposium-I.G.S., Athens, Greece 

Mar 30, 07 Invited Panel Member: Grand Rounds - Sixth International Glaucoma Symposium-I.G.S., 

Athens, Greece 

Mar 30, 07 Moderator: Surgery and Lasers in Glaucoma - Sixth International Glaucoma Symposium-I.G.S., 

Athens, Greece 

Jul 18, 07 Chair: Evidence-Based Glaucoma Symposium - World Glaucoma Congress - Association of 

International Glaucoma Societies, Singapore 

Jul 19, 07 Presenter: Screening, Blindness, and Quality of Life - World Glaucoma Congress- Association of 


Jul 19, 07 Presenter: Glaucoma Epidemiology: Therapeutics - World Glaucoma Congress - Association of 


Jul 19, 07 Chair: Poster Discussion 1 Symposium - World Glaucoma Congress - Association of International 

Glaucoma Societies, Singapore 

Jul 20, 07 Chair: Poster Discussion 2 Symposium - World Glaucoma Congress - Association of International 

Glaucoma Societies, Singapore 

Jul 21, 07 Presenter: Poster Recognitions Symposium - World Glaucoma Congress - Association of 


Jun 14, 08 Invited Speaker: Epidemiology of Aged-Related Macular Degeneration - 

Third Mediterranean Retina Meeting, Istanbul, Turkey 

Jul 24–27, 08 Moderator: Measuring Rates of Progression in Glaucoma: Identification of Highest Risk Groups - 

International Glaucoma Think Tank II, Florence, Italy 

Mar 20, 09 Invited Speaker: When Do You Decide to Treat or to Not Treat an Ocular Hypertensive Patient?” - 

15 th International Congress of Glaucoma, Greek Glaucoma Society, Athens, Greece 

Mar 21, 09 Invited Speaker: Perspectives on Glaucoma Surgery, 15 th International Congress of Glaucoma, 

Greek Glaucoma Society, Athens, Greece 

Apr 18, 09 Invited Lecturer: When to Treat or Not Treat An Ocular Hypotensive Patient - Clinical Insights into 

Glaucoma - Western Canada Glaucoma Specialist Advisory Board, Vancouver BC, Canada 

Apr 18, 09 Invited Lecturer: How to be a “Good” Reviewer of Journal Articles - Clinical Insights into Glaucoma 

- Western Canada Glaucoma Specialist Advisory Board, Vancouver BC, Canada 

Apr 18, 09 Invited Lecturer: Review of Canadian Glaucoma Study - Clinical Insights into Glaucoma - Western 

Canada Glaucoma Specialist Advisory Board, Vancouver BC, Canada 



ALC100325 


May 8, 09 Invited Lecturer: Detection of Glaucoma Progression with Imaging - Glaucoma 2009, Servico de 

Oftalmologia DO, Hospital Sao Sebastiao Santa Maria da Feira, Porto, Portugal 

May 9, 09 Invited Lecturer: Drainage Device Surgery - Glaucoma 2009, Servico de Oftalmologia DO, Hospital 

Sa Sebastiao Santa Maria da Feira, Porto, Portugal 



ALC100325 


MEMBERSHIPS : PROFESSIONAL ASSOCIATIONS 

& SCHOLARLY SOCIETIES 

American Academy of Ophthalmology 

American Eye Study Club 

American Glaucoma Society 

American Medical Women's Association 

American Ophthalmological Society 

American Public Health Association 

Association for Research in Vision and Ophthalmology 

California Association of Ophthalmology 

California Medical Association 

Glaucoma Society of the International Congress of Ophthalmology 

Johns Hopkins Medical and Surgical Association 

Los Angeles Society of Ophthalmology 

Los Angeles County Medical Association 

Pan American Association of Ophthalmology 

UCLA Department of Ophthalmology Association 

Women in Ophthalmology 



ALC100325 


NATIONAL & INTERNATIONAL COMMITTEE SERVICE 

Allergan 

2004–07 Glaucoma Academic Advisory Board, Member 

American Academy of Ophthalmology 

2009–14 Hoskins Center for Quality of Care: Secretary of Quality of Care 

2008 Quality of Care Secretariat: Assistant Secretary 

2007– Clinical Correspondent 

2007 Leadership Identification Task Force: Chair 

2006–08 AAO/Convention 

2007 & 2008 Prevent Blindness America/Glaucoma Symposium: Co-Chair 

2006–08 Board of Trustees: Trustee-at-large 

2006–08 Membership Advisory Committee: Member 

2005–09 BCSC Section 1 Statistics Section Committee: Consultant 

2002–06 Knowledge Base Development/Glaucoma: Chair 

2001–06 EyeNet Editorial Advisory Board: Member 

2001 Search Committee for Editor of Ophthalmology: Member 

2001 Strategic Assessment Planning Task Force: Member 

2000– Glaucoma EyeCare Program Committee: Member 

1999–2004 Health Policy Committee: Member 

Aug 11-13, 2000 AAO Clinical Education Leadership Retreat, Denver, CO: Invited participant 

1999–2004 Task Force on Aging: Member 

1997–2002 Interspecialty Education Committee: Chair 

1994–97 Interspecialty Education Committee: Member 

American Board of Ophthalmology 

2000– Associate Examiner 

American Geriatric Society 

2000–01 Research Agenda Setting Program: Member 



ALC100325 

American Glaucoma Society 


2008–11 Subspecialty Day/Program Committee: Member 

2008–10 Annual Program Committee: Chair 

2007–08 Guidelines Task Force: Member 

2006–07 Subspecialty Day/Program Committee: Chair 

2006–07 Annual Program Committee: Vice Chair 

2005–07 Nominating Committee: Chair 

2003–04 Strategic Planning Committee: Member 

2003–04 Nominating Committee: Member 

2002–07 Quality Care Assessment Committee: Member 

2002–11 Annual Meeting Program Committee: Member 

2000–04 Research Committee: Member 

Mar 27-28, 99 Strategic Planning Committee: Invited participant 

American Health Assistance Foundation 

2007– National Glaucoma Research Review: Member 

American Ophthalmological Society 

2010– Membership Committee: Member 

Arizona Disease Control Research Commission 

1997–98 Peer Reviewer 

Association of International Glaucoma Societies 

2005–07 Finance Committee: Member 

2003–09 Publications Guidelines Committee: Co-Chair 

California Association of Ophthalmology 

2001–05 Assistant Vice President for Professional Education 



ALC100325 


California Department of Motor Vehicles 

2000–02 Medical Advisory Board: Member 

California Medical Association 

2008–10 Medical Board of California: Expert Reviewer 

Glaucoma Foundation 

2010– World Glaucoma Week: Regional Coordinator for the United States 

Glaucoma Research Foundation 

2001– Scientific Advisory Committee: Member 

International Glaucoma Symposium 

2006–07 Scientific Program Committee Member 

Los Angeles Research Study Club 

2002–06 Board Member 

Los Angeles Society of Ophthalmology 

2003–04 President 

2002–03 Vice-President 

2001–02 Secretary 

2000–01 Treasurer 

1999–00 Program Chairman 

1998–99 Assistant Program Chairman 



ALC100325 


National Institutes of Health / National Eye Institute (NIH/NEI) 

2009–14 National Eye Health Education Program (NEHEP) 

Planning Committee: Chair 

2007–09 NIH/NEI Healthy Vision Month: Volunteer 

2007–08 NEHEP Older American Work Group: Member 

2005–08 NEHEP Glaucoma Subcommittee: Chair 

2005–07 NEHEP KAP Committee: Member 

2003–08 NEHEP: Member 

2002–09 NIH/NEI Advisory Committee for Cochrane Eyes and 

Vision Group (PI: Kay Dickerson, PhD): Member 

Jun 15, 01 NIH/NEI Ocular Hypertension Treatment Study (OHTS) 

Blue Sky Think Tank: Member 

2000–05 NIH/NEI Special Emphasis Panel: Member 

2000–02 NIH/NEI Advisory Committee for Glaucoma Surgical Outcomes Study 

(PI: Henry Jampel, MD): Member 

1999–01 NIH/NEI OHTS Executive Steering Committee: Member 

1996–97 NIH/NEI Special Emphasis Panel (formerly Vision Research Committee): Member 

U. S. Department of Health and Human Services / 

Food and Drug Administration (FDA) 

2005– U.S. Ophthalmic Devices Panel, Medical Devices Advisory Committee Panel, 

and Center for Devices and Radiological Health: Consultant 

2002–05 Ophthalmic Devices Panel: Voting Member 

2000–02 Ophthalmic Devices Panel: Consultant 

University of Arizona 

Nov 26-27, 07 University of Arizona, Tucson / 

Department of Ophthalmology Academic Program Review: External Reviewer 

Washington University 

1999-01 School of Occupational Therapy Study – 

Evaluating the Sensory Capacities of Older Adults: Consultant 

Women in Ophthalmology 

2003–06 President 

2001–04 Vice-President 

1997–00 Treasurer 

1995–97 Board of Directors: Member 



ALC100325 


LOCAL COMMITTEE SERVICE 

Jules Stein Eye Institute (JSEI) & 

Department of Ophthalmology Service 

2008– Faculty Diversity and Development Committee 

Faculty Search Committee 

2006–07 Glaucoma Specialist Search Committee 

2005– The Gerald Oppenheimer Family Foundation Center for the Prevention of 

Eye Disease: Board 

2004–05 Leonard Apt Chair in Pediatric Ophthalmology Search Committee 

2003–05 Retinal Degenerative Diseases and Infectious Diseases FTE Search Committee 

2003 Oppenheimer Brothers Foundation Chair Search Committee 

2002–03 Wasserman Chair Search Committee 

2000– Mobile Eye Clinic: Director 

1998– Center for Eye Epidemiology: Director 

1997–98 JSEI Medical Human Subject Protection Committee 

1997 Center for Eye Epidemiology: Co-Director 

1995–96 Glaucoma Division Chief and Ray Stark Endowed Chair Search Committee 

1994– Gender Sensitivity Task Force: Chair 

1994–06 Ophthalmology Peer Review and Quality Assurance Committee: Vice-Chair 

1994–96 Sepulveda Veterans Administration Hospital Faculty Chief Search Committee 

1993– Member of the Jules Stein Eye Institute 

1993–97 Center for Eye Epidemiology: Assistant Director 

1991– Optic Neuropathy Center: Member 

1991–08 Medical Student, Graduate Student, and Primary Physician Education Committee 

1991–06 Ophthalmology Inpatient and Outpatient Surgery Unit Committee:Chair 

1991–98 Department of Ophthalmology Residency Selection Committee 

1991–92 Glaucoma Fellowship Selection Committee: Director 

1990– Department of Ophthalmology Clinical Committee 

1990– Department of Ophthalmology Appointment, Academic Advancement, and Promotion 

Committee 

1990– Department of Ophthalmology Medical Student, Graduate Student, and Primary 

Physician Education Committee 

1990– Department of Ophthalmology Quality Assurance Committee 

1990– JSEI and Department of Ophthalmology Clinical Research Committee 

1990– JSEI and Department of Ophthalmology Vision Science Research Committee 

1990– Jules Stein Eye Institute Committee 



ALC100325 


1990–94 Ophthalmology Peer Review and Quality Assurance Committee: Secretary 

1990–93 Clinical Faculty Appointment, Reappointment, and Promotion Committee: Secretary 

1990–93 Associate Member of the Jules Stein Eye Institute 

UCLA Medical Center Service 

2009– Mentor for UCLA medical students (Oluwatoyin Fafowora, MD, MPH; 

Yahya Shaikh, MPH; Pamela Golchet) 

2006– Sturge-Weber Foundation Center of Excellence at UCLA: Ophthalmologist 

2006 Academic Personnel Review Committee: Chair 

2005–06 Mentor for Geriatrics Fellow (Susan Jung, MD) 

2003– Unite for Sight Medical Student Committee: Faculty Mentor 

2002–03 Mentor for 1 st year UCLA Medical Student (Gina Yoo) 

1994– UCLA School of Medicine Faculty Advisor 

1992–08 UCLA School of Med Clinical Fundamentals of Ophthalmology Course: 

Chair and Course Director 

1991–96 UCLA Hospital Utilization Committee: Member 

1990–93 UCLA Institutional Review Board/ Human Subject Protection Committee: Member 

1990– UCLA Medical Center Medical Staff/ Quality Assurance Committee of the 

Ophthalmology Service 

UCLA-University Service—Interdepartmental 

2006–09 School of Public Health/ Department of Community Health Sciences: 

Doctoral Committee (Gergana Kodjebacheva) 

2006–08 Charles Drew School of Medicine/ College of Applied Anatomy: 

Mentor/Advisor (Monika Saeedian, medical student) 

2005–06 UCLA Graduate Division 

Master of Science in Clinical Research Committee: Member 

(Kouros Nouri-Mahdavi, MD) 

2003–06 School of Public Health Doctoral Committee / 

Department of Epidemiology: Chair (Robin Seitzman) 

2002–05 Academic Senate Committee on Faculty Welfare: Member 

2001–04 UCLA Older Americans Independence Center Advisory Board: Member 

1997–99 Research Advisory Committee, Clinical Scholars Program: Member 

1997–99 School of Public Health Doctoral Committee/ 

Department of Biostatistics: Member (Fei Yu) 

1994–96 Student Research Program for UCLA: Advisor (undergraduate Rodolfo Garcia) 

1991–94 UCLA Faculty Association Board: Member 



ALC100325 


Los Angeles County Medical Association (LACMA) 

1996 LACMA Task Force on Public/Private Relationships 

1994–97 LACMA Board of Councilors: Councilor 

1993–94 LACMA Board of Councilors: Alternate 

Other Community Service 

2008–13 Helen Keller International - Board of Trustees: Member 

2006–10 Prevent Blindness America - Adult Vision Advisory Committee: Member 

2005–07 Helen Keller International - Medical Leadership Committee: Member 

2002–06 Roosevelt Elementary School, Santa Monica, CA: Classroom Volunteer 

1993–02 American Medical and Educational Services in Africa (AMES): Board Member, Vice 

President of Executive Committee, and Director of Medical Services 



ALC100325 


LECTURES & PRESENTATIONS 

1. “Ocular Sarcoidosis.” Invited lecture, Department of Ophthalmology, King's College Hospital, London, UK, 

Apr 5, 1984. 

2. “Acanthamoeba Keratitis.” Clinical Challenge Day, University of Illinois, Chicago, IL, Mar 10, 1987. 

3. “Double-perforating injuries.” Clinical Challenge Day, University of Illinois, Chicago, IL, Mar 9, 1988. 

4. “The Effect of Argon Laser Trabeculoplasty on the Distribution of Fibronectin in the Trabecular Meshwork of 

Felines.” Alumni Research Day, University of Illinois, Chicago, IL, May 10, 1988. 

5. “Cardiovascular and IOP Effects of Apraclonidine Hydrochloride and Timolol Maleate.” Wilmer Resident 

Association Meeting, Johns Hopkins School of Medicine, Baltimore, MD, Apr 25, 1989. 

6. “Contact Transscleral Cyclophotocoagulation in Human Autopsy and Non-human Primate Eyes.” Wilmer 

Resident Association Meeting, Johns Hopkins School of Medicine, Baltimore, MD, Apr 26, 1990. 

7. “Displacement of the Optic Nerve Head with Acute Changes In Intraocular Pressure in Normal and 

Glaucomatous Monkey Eyes.” Association for Research in Vision and Ophthalmology, Sarasota, FL, 

May 4, 1990. 

8. “The Role of Optic Nerve Head Imaging in the Diagnosis and Management of Glaucoma.” Invited lecturer, 

Jules Stein Eye Institute, UCLA, Los Angeles, CA, Dec 20, 1989. 

9. “Displacement of the Optic Nerve Head With Acute Changes in Intraocular Pressure in Normal and 

Glaucomatous Monkey Eyes.” Invited lecturer, Department of Ophthalmology, University of Minnesota, 

Minneapolis, MN, Mar 7, 1990. 

10. “The Future of Lasers in Ophthalmology.” Invited lecturer, Jules Stein Eye Institute Rededication, UCLA, 

Los Angeles, CA, Sep 13, 1990. 

11. “The Glaucomatous Optic Nerve Head.” Invited lecturer, Department of Ophthalmology, Shiley Eye Institute, 

University of California, San Diego, CA, Oct 8, 1990. 

12. “The Role of Optic Nerve Head Imaging in the Diagnosis and Management of Glaucoma.” Invited lecturer, 

Current Concepts in Clinical Ophthalmology and Vision Science, Jules Stein Eye Institute, UCLA, 

Los Angeles, CA, Mar 8, 1991. 

13. “Interesting Cases and Future Developments in Automated Perimetry.” Invited lecturer, Automated Perimetry 

for the Clinician, Jules Stein Eye Institute, UCLA, Los Angeles, CA, Apr 6, 1991. 

14. “Topical Carbonic Anhydrase Inhibitors.” JSEI Clinical Conference, Jules Stein Eye Institute, UCLA, 

Los Angeles, CA, May 8, 1991. 

15. “Argon and Nd: YAG Laser Iridotomies.” Invited lecturer, JSEI Laser Certification Workshop, Jules Stein Eye 

Institute, UCLA, Los Angeles, CA, Sep 7, 1991. 

16. “Topical Carbonic Anhydrase Inhibitors.” Invited lecturer, Glaucoma Society of Southern California, 

Jules Stein Eye Institute, UCLA, Los Angeles, CA, Sep 25, 1991. 

17. “Topical Carbonic Anhydrase Inhibitors.” Invited lecturer, Curso De Actualizacion de Oftalmologia en 

Espanol, University of Southern California and UCLA, Los Angeles, CA, Oct 9, 1991. 

18. “Interesting Cases and Future Developments in Automated Perimetry.” Invited lecturer, Automated Perimetry 

for the Clinician, Jules Stein Eye Institute, UCLA, Los Angeles, CA, May 16, 1992. 

19. “Topical Brimonidine or AGN 190342-LF.” Invited lecturer, Glaucoma Update 1992, University of California at 

Irvine, Irvine, CA, Jul 11, 1992. 

20. “Topical Carbonic Anhydrase Inhibitors.” Invited lecturer, Glaucoma Update 1992, University of California at 

Irvine, Irvine, CA, Jul 11, 1992. 

21. “Ophthalmologic Emergencies.” Presentation and panel participation, Tarzana Regional Medical Center 

Monday Panel Workshop Series for Physicians, Tarzana, CA, Jul 20, 1992. 

22. “Recurrent Blebitis.” Nantucket Glaucoma Meeting, Nantucket, MA, Aug 13, 1992. 



ALC100325 


23. “Management of Intractable Glaucoma.” Invited lecturer,Ventura Ophthalmologic Society, Oxnard, CA, 

Sep 24, 1992. 

24. “The Ahmed Glaucoma Valve Implant.” JSEI Clinical Conference, Jules Stein Eye Institute, UCLA, 

Los Angeles, CA, Oct 14, 1992. 

25. “Mitomycin C Trabeculectomies.” Invited lecturer, Santa Barbara Ophthalmologic Society, Santa Barbara, 

CA, Oct 15, 1992. 

26. “The Effect of Topical Timolol Maleate on Lipid Levels.” Invited lecturer, Glaucoma Update sponsored by 

Otsuka Pharmaceuticals, Dallas, TX, Nov 9, 1992. 

27. “Variability in the Detection of Glaucomatous Progression of the Optic Disc With Serial Stereoscopic 

Photographs.” Poster presentation, American Academy of Ophthalmology, Dallas, TX, Nov 9, 1992. 

28. “Difference of Prevalence of Ophthalmic Disease Among Hispanics, Blacks, and Whites in a Hospital-based 

Outpatient Clinic.” Poster presentation, JSEI Annual Research and Alumni Day, Feb 27, 1993. 

29. “Clinical Experience With the Ahmed Glaucoma Valve Implant in Intractable Glaucoma: A Pilot Study.” 

Poster presentation, JSEI Annual Research and Alumni Day, Feb 27, 1993. 

30. “Epidemiology of Glaucoma - the Whole Glaucoma Patient.” Invited lecturer, Speaker's Bureau, Otsuka 

Pharmaceuticals, Apr 3, 1993. 

31. “Alpha-2 Agonists.” Pan-American Association of Ophthalmology Lecture: Invited lecturer, University of 

Såo Paulo, Escola Paulista de Medicina, Såo Paulo, Brazil, Apr 19, 1993. 

32. “Topical Carbonic Anhydrase Inhibitors.” Pan-American Association of Ophthalmology Lecture: Invited 

lecturer, University of Såo Paulo, Escola Paulista de Medicina, Såo Paulo, Brazil, Apr 19, 1993. 

33. “Trabeculectomies with Mitomycin C and 5 Fluorouracil.” Pan-American Association of Ophthalmology 

Lecture: Invited lecturer, University of Såo Paulo, Escola Paulista de Medicina, Såo Paulo, Brazil, 

Apr 19, 1993. 

34. “The Epidemiology of Glaucoma.” Invited lecturer, Department of Ophthalmology, University of Chicago, 

Chicago, IL, Jun 16, 1993. 

35. “Ahmed Glaucoma Valve Implant.” Nantucket Glaucoma Meeting, Nantucket, MA, Aug 14, 1993. 

36. “Laser Trabeculoplasty and Cyclophotocoagulation.” Invited lecturer, JSEI Laser Certification Workshop, 


37. “The Epidemiology of Glaucoma.” Visiting professor and invited lecturer, Department of Ophthalmology, 

Kreiger Eye Institute/ Sinai Hospital, Baltimore, MD, Sep 21, 1993. 

39. “New Developments in Glaucoma Therapy: Surgical and Medical.” Visiting professor and invited lecturer, 

Department of Ophthalmology, Kreiger Eye Institute/ Sinai Hospital, Baltimore, MD, Sep 21, 1993. 

39. “The Epidemiology of Glaucoma.” Invited lecturer, Division of Ophthalmology, Richmond Eye and Ear 

Hospital, Richmond, VA, Sep 22, 1993. 

40. “New Developments in the Management of Glaucoma.” Invited lecturer, Division of Ophthalmology, 

Richmond Eye and Ear Hospital, Richmond, VA, Sep 22, 1993. 

41. “Causal Inference.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye Institute, 

UCLA, Los Angeles, CA, Oct 3, 1993. 

42. “Disease Measures.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye Institute, 


43. “Sources of Bias.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye Institute, 


44. “Changes in the Optic Nerve Head with Acute Changes in Intraocular Pressure.” First Heidelberg Retinal 

Tomograph Meeting, Vancouver, Canada, Oct 15, 1993. 

45. “New Developments in the Diagnosis and Management of Glaucoma.” Invited lecturer, Desert Valley 

Hospital, Palm Springs, CA, Oct 25, 1993. 

46. “Advances in Glaucoma.” Invited lecturer, Orbis International and Ahmedabad Ophthalmology Society, 

Ahmedabad, India, Feb 1, 1994. 



ALC100325 


47. “OHTS, An Epidemiological Perspective.” JSEI Epidemiology Eye Center, Los Angeles, CA, Feb 24, 1994. 

48. “Who are the Glaucoma Patients?” Invited lecturer, Annenberg Center at Eisenhower for a teleconference 

program on Glaucoma Management: Critical Factors in Treating the Total Patient, Rancho Mirage, CA, 

Mar 1, 1994. 

49. “The Diagnosis and Management of Glaucoma.” Invited lecturer, Department of Ophthalmology, 

Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan, Mar 22, 1994. 

50. “Initial Clinical Experience with the Ahmed Glaucoma Valve Implant.” Invited lecturer, Department of 

Ophthalmology, Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan, Mar 22, 1994. 

51. “The Diagnosis and Management of Glaucoma.” Invited lecturer, Department of Ophthalmology, 

Mayo Hospital, Lahore, Pakistan, Mar 24, 1994. 

52. “Initial Clinical Experience with the Ahmed Glaucoma Valve Implant.” Invited lecturer, Department of 

Ophthalmology, Mayo Hospital, Lahore, Pakistan, Mar 24, 1994. 

53. “The Diagnosis and Management of Glaucoma.” Invited lecturer, Institute of Clinical Ophthalmology, 

Mukhtar Eye Hospital, Karachi, Pakistan, Mar 26, 1994. 

54. “Initial Clinical Experience with the Ahmed Glaucoma Valve Implant.” Invited lecturer, Institute of Clinical 

Ophthalmology, Mukhtar Eye Hospital, Karachi, Pakistan, Mar 26, 1994. 

55. “Setons in Children.” Invited lecturer, JSEI Annual Postgraduate Seminar on Pediatric Ophthalmology and 

Strabismus, Los Angeles, CA, Apr 9, 1994. 

56. “Glaucoma: Research and Management for Lay Persons.” Southern California Indian Center, City of 

Commerce, CA, Apr 13, 1994. 

57. “Lipids and Glaucoma.” Invited lecturer, Department of Ophthalmology, Humana Hospitals, Chicago, IL, 

Jun 1, 1994. 

58. “Outcomes of Glaucoma Surgeries.” JSEI Epidemiology Eye Center, Los Angeles, CA, Jun 23, 1994. 

59. “The Epidemiology of Glaucoma.” Invited lecturer for Grand Rounds, Department of Ophthalmology, Stanford 

University, Palo Alto, CA, Jun 28, 1994. 

60. “Lipids and Glaucoma.” Invited lecturer, Bay Area Ophthalmology Society, Oakland, CA, Jun 28, 1994. 

61. “Cyclophotocoagulation.” JSEI Laser Certification Course, Los Angeles, CA, Sep 10, 1994. 

62. “Causal Inference.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye Institute, 

UCLA, Los Angeles, CA, Dec 10, 1994. 

63. “Disease Measures.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye Institute, 


64. “Correlation and Regression.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye 

Institute, UCLA, Los Angeles, CA, Dec 10, 1994. 

65. “The Diagnosis and Management of Glaucoma.” Invited faculty for panel discussion, Ophthalmology Society 

of West Indies and Orbis International, Kingston, Jamaica, Jan 21, 1995. 

66. “Initial Clinical Experience with the Ahmed Glaucoma Valve Implant.” Invited lecturer , Ophthalmology Society 

of West Indies and Orbis International, Kingston, Jamaica, Jan 25, 1995. 

67. “The Diagnosis of Glaucoma.” Avalon Municipal Hospital and Clinic, Catalina, CA, Feb 18, 1995. 

68. “The Epidemiology of Glaucoma.” Invited lecturer for grand rounds, Department of Ophthalmology, Naval 

Medical Hospital, San Diego, CA, Feb 27, 1995. 

69. “Outcomes Research: Opportunities and Limitations.” Vision Research Conference, Jules Stein Eye Institute, 

UCLA, Los Angeles, CA, Mar 15, 1995. 

70. “Combined Penetrating Keratoplasty and Tube Implantation.” Annual post-graduate seminar, Jules Stein Eye 

Institute, UCLA, Los Angeles, CA, Apr 8, 1995. 

71. “The Optic Nerve Head.” Invited lecturer for Ophthalmology Basic and Clinical Science Course, Department 

of Ophthalmology, Shiley Eye Institute, University of California, San Diego, CA, Apr 12, 1995. 



ALC100325 


72. “Congenital Glaucoma.” Invited lecturer for Ophthalmology Basic and Clinical Science Course, Department of 

Ophthalmology, Shiley Eye Institute, University of California, San Diego, CA, Apr 12, 1995. 

73. “The Development of Prediction Models in the Analysis of Outcomes of Glaucoma Surgeries.” Invited lecturer, 

Epidemiology Doctoral Seminar, School of Public Health, UCLA, Los Angeles, CA, May 1, 1995. 

74. “Clinical Efficacy, Safety, and Tolerability of Trusopt.” Invited lecturer, Merck Research Laboratories, 

Los Angeles, CA, May 23, 1995. 

75. “Our Initial Clinical Experience with the Ahmed Glaucoma Valve Implant: Results and Complications.” 

course at American Academy of Ophthalmology, Atlanta, GA, Oct 30, 1995. 

76. “Topical Carbonic Anhydrase Inhibitors: Dorzolamide.” Invited lecturer, Merck Research Laboratories, 

Palm Springs, CA, Nov 8, 1995. 

77. “Topical Carbonic Anhydrase Inhibitors: Dorzolamide.” Invited lecturer, Merck Research Laboratories, 

Riverside, CA, Nov 14, 1995. 

78. “Meta-Analysis.” Essential Epidemiology and Biostatistics for Ophthalmologists, Jules Stein Eye Institute, 


79. “The Management of Difficult Glaucomas.” Invited lecturer, Department of Ophthalmology, EENT Hospital, 

Yangon, Myanmar, Jan 18, 1996. 

80. “Sources of Bias in Clinical Studies.” Invited lecturer, Department of Ophthalmology, 1EENT Hospital, 

Yangon, Myanmar, Jan 19, 1996. 

81. “The Use of Drainage Devices in Glaucoma.” Las Vegas, NV, Feb 17, 1996. 

82. “Opportunities and Limitations of Ophthalmic Surgical Outcome Studies Using Existing Databases.” 

Invited lecturer, Research Study Club of Los Angeles, 65 th Midwinter Clinical Conference, Los Angeles, CA, 

Feb 25, 1996. 

83. “Use of Drainage Devices in Eyes with Corneal Transplants.” Invited lecturer, Research Study Club of Los 

Angeles, Sixty-fifth Midwinter Clinical Conference, Los Angeles, CA, Feb 25, 1996. 

84. “Complications Following Ahmed Valve Implantation for Uncontrolled Glaucoma.” Invited discussant, 

Centennial Annual Meeting of American Academy of Ophthalmology, Chicago, IL, Oct 31, 1996. 

85. “Krupin and Ahmed Glaucoma Valves: A Comparison of Efficacy and Safety.” Invited discussant at the 

Centennial Annual Meeting of American Academy of Ophthalmology, Chicago, IL, Oct 31, 1996. 

86. “Imaging of the Optic Nerve Head, Glaucoma: News and Views.” Invited lecturer, Centennial Annual Meeting 

of American Academy of Ophthalmology, Chicago, IL, Oct 30, 1996. 

87. “The Role of the Ahmed Glaucoma Valve in the Surgical Management of Glaucoma.” Centennial Annual 

Meeting of American Academy of Ophthalmology, Chicago, IL, Nov 1, 1996. 

88. “Combined Cataract and Glaucoma Surgery.” Invited lecturer, 21 st Congress of Pan American Academy of 

Ophthalmology, Cancun, Mexico, Apr 30, 1997. 

89. “Surgical Management of Glaucoma with Drainage Devices.” Course Director, 21 st Congress of 

Pan American Academy of Ophthalmology, Cancun, Mexico, May 2, 1997. 

90. “Outcomes Software, Eye on Digital Technology.” Jules Stein Eye Institute, UCLA School of Medicine, 


91. “Congenital Glaucoma: Diagnosis and Management.” Invited lecturer, 13 th National Symposium: Glaucoma: 

Changing Concepts in Management, Ahmedabad Academy of Ophthalmology, Ahmedabad, India, 

Sep 28, 1997. 

92. “The Modern Filtering Procedure.” Invited lecturer, 13 th National Symposium: Glaucoma: Changing Concepts 

in Management, Ahmedabad Academy of Ophthalmology, Ahmedabad, India, Sep 29, 1997. 

93. “Outcomes of Drainage Devices and Cyclodestruction Using a National Database.” Invited lecturer, 

13 th National Symposium:Glaucoma–Changing Concepts in Management, Ahmedabad Academy of 

Ophthalmology, Ahmedabad, India, Sep 29, 1997. 

94. “Vision and the Quality of Life, The Aging Eye.” Invited lecturer, Braille Institute Independence Programs Fall 

Conference, Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, Oct 9, 1997. 



ALC100325 


95. “Cyclophotocoagulation.” Laser Certification Course, Jules Stein Eye Institute, UCLA School of Medicine, 

Los Angeles, CA, Oct 18, 1997. 

96. “The Modern Filtering Procedure.” Glaucoma Conference, Jules Stein Eye Institute, UCLA School of 

Medicine, Los Angeles, CA, Oct 20, 1997. 

97. “Epidemiology of Glaucoma.” Invited lecturer, Under Pressure: Glaucoma 1997, American Academy of 

Ophthalmology, San Francisco, CA, Oct 25, 1997. 

98. “Implantation of Glaucoma Drainage Devices.” American Academy of Ophthalmology, San Francisco, CA, 

Oct 27, 1997. 

99. “Evaluation of Quality of Life in Glaucoma Patients.” Invited lecturer, Glaucoma: News and Views, American 

Academy of Ophthalmology, San Francisco, CA, Oct 28, 1997. 

100. “Implantation of Glaucoma Drainage Devices.” American Academy of Ophthalmology, San Francisco, CA, 

Oct 28, 1997. 

101. “The Role of the Ahmed Glaucoma Valve in the Surgical Management of Glaucoma.” American Academy of 


102. “The Epidemiology of Glaucoma.” Invited lecturer, American Glaucoma Society Meeting, Scottsdale, AZ, 

Dec 5, 1997. 

103. “The Epidemiology of Cataracts.” Basic science course, Jules Stein Eye Institute, UCLA School of Medicine, 

Los Angeles, CA, Dec 10, 1997. 

104. “Risk Factors and Confounders for Glaucoma.” Invited lecturer, Massachusetts Eye and Ear Infirmary, 

Harvard School of Medicine, Boston, MA, Jan 15, 1998. 

105. “Optic Nerve Evaluation for Glaucoma.” Invited lecturer, 1998 Annual Optometry Symposium, Southern 

California Permanente Medical Group, Kaiser Permanente, Long Beach, CA, Jan 31, 1998. 

106. “Imaging Techniques Related to Glaucoma.” Invited lecturer, 1998 Annual Optometry Symposium, Southern 

California Permanente Medical Group, Kaiser Permanente, Long Beach, CA, Jan 31, 1998. 

107. “Advantages and Limitations of Outcomes Research Using the Medicare Database–Ophthalmic Outcomes: 

What You Need to Know about Quality of Life and Health Services Research.” Jules Stein Eye Institute, 

UCLA School of Medicine, Los Angeles, CA, Feb 7, 1998. 

108. “Glaucoma Filtration Surgery–Advanced Anterior Segment Surgery.” Invited lecturer, Special Focus Course, 

American Academy of Ophthalmology, Palm Springs, CA, Feb 27, 1998. 

109. “Complications of Filtration Surgery.” Invited lecturer, Advanced Anterior Segment Surgery Special Focus 

Course, American Academy of Ophthalmology, Palm Springs, CA, Feb 27, 1998. 

110. “Aqueous Shunts.” Invited lecturer, Advanced Anterior Segment Surgery Special Focus Course, 

American Academy of Ophthalmology, Palm Springs, CA, Feb 28, 1998. 

111. “Primary Open Angle Glaucoma Management.” Invited lecturer, Continuing Education in Southern California, 

University of California-Berkeley, Pomona, CA, Mar 1, 1998. 

112. “Glaucoma Implants.” Comprehensive Eye Care Update for the Practitioner, Jules Stein Eye Institute, 

UCLA School of Medicine, Los Angeles, CA, Apr 3,1998. 

113. “Quality Grading for Study of Osteoporotic Fractures-Eye Survey.” SOF Steering Committee Meeting, 

University of California- San Francisco, Palm Springs, CA, Apr 17, 1998. 

114. “Are Glaucoma’s Risk Factors What You Thought?” Grand Rounds lecturer, Jules Stein Eye Institute, 

UCLA School of Medicine, Los Angeles, CA, Jun 3,1998. 

115. “Quality of Life in Glaucoma.” Invited lecturer, Ocular Drug & Surgical Therapy Update, Laguna Niguel, CA, 

Jun 13, 1998. 

116. “The Management of Intractable Glaucoma.” Invited lecturer, St. Joseph’s Hospital, Orange County, CA, 

Jul 21, 1998. 

117. “The Ahmed Glaucoma Valve in Pediatric Patients.” Invited lecturer, Ahmed Valve Breakfast, New Orleans, 

LA, Nov 8, 1998. 



ALC100325 


118. “Implantation of Glaucoma Drainage Devices.” Invited lecturer, American Academy of Ophthalmology, 

New Orleans, LA, Nov 8, 1998. 

119. “Current Research in Glaucoma.” Invited lecturer, Glaucoma Research Foundation, Los Angeles, CA, 

Jan 29, 1999. 

120. “Comparing Patient Management Patterns between Glaucoma Specialists and Non-specialists.” Invited 

lecturer, American Glaucoma Society, Amelia Island, FL, Feb 19, 1999. 

121. “Quality of Life in Glaucoma Patients.” Invited lecturer, Jules Stein Eye Institute, UCLA School of Medicine, 

Los Angeles, CA, Mar 17, 1999. 

122. “The Ahmed Glaucoma Valve Implant.” Invited lecturer, Department of Ophthalmology, Naval Medical 

Hospital, San Diego, CA, Mar 22, 1999. 

123. “Primary Congenital Glaucoma.” Invited lecturer, Glaucoma 2000 Management, Jules Stein Eye Institute, 

UCLA School of Medicine, Los Angeles, CA, Apr 9, 1999. 

124. “Ahmed Valve Implant: Long-term Results.” Invited lecturer, Glaucoma 2000 Management, Jules Stein Eye 

Institute, UCLA School of Medicine, Los Angeles, CA, Apr 10, 1999. 

125. “Aqueous Shunts.” Invited lecturer, Department of Ophthalmology, Charles Drew University School of 

Medicine, Los Angeles, CA, Apr 19, 1999. 

126. “General Concepts of Epidemiology in Ophthalmic Research.” Invited lecturer, JSEI Vision Science 

Conference, Lake Arrowhead, CA, Sep 26, 1999. 

127. “Estimation and Predictive Interval Coverage of Complications After Trabeculectomy in the Medicare 

Population from 1991–1994.” Presenter, Fifth Annual Jules Stein Eye Institute Vision Science Conference, 

Lake Arrowhead, CA, Sep 24-26, 1999. 

128. “Estimation and Predictive Interval Coverage of Complications After Trabeculectomy in the Medicare 

Population from 1991-1994 Using Hierarchical Logistic Models.” Invited lecturer, International Conference on 

Health Policy Research, Santa Monica, CA, Dec 3-5, 1999. 

129. “Management of Vascular Factors in the Protection of the Optic Nerve.” Invited lecturer, 2 nd Congress of 

Asian-Oceanic Glaucoma Society, Tokyo, Japan, Oct 5, 1999. 

130. “Surgical Management of Glaucoma Associated with Pseudophakia, Case Discussion.” Invited lecturer, 

Glaucoma 1999: Concepts and Controversies, American Academy of Ophthalmology Subspecialty Day, 

Orlando, FL, Oct 23, 1999. 

131. “Corneal Complications with the Ahmed Glaucoma Valve.” Invited lecturer, Ahmed Valve Breakfast, 

sponsored by New World Medical, Inc., Orlando, FL, Oct 24, 1999. 

132. “The Ahmed Glaucoma Valve Implant.” Invited lecturer, Implantation of Glaucoma Drainage Devices, 

American Academy of Ophthalmology Annual Conference, Orlando, FL, Oct 25, 1999. 

133. “Menopause and the Eye.” Invited lecturer, American Society of Ophthalmic Registered Nurses Annual 

Conference, Orlando, FL, Oct 26, 1999. 

134. “Glaucoma Medicine: Use and Misuse.” Invited lecturer, 69 th Midwinter Clinical Conference, Research Study 

Club, Los Angeles, CA, Jan 30, 2000. 

135. “Outcome Measures in Glaucoma.” Invited lecturer, Glaucoma: New Developments and State of the Art, 

Doheny Eye Institute, USC School of Medicine, Los Angeles, CA, Feb 19, 2000. 

136. “Detection, Diagnosis, and Management of Congenital/Juvenile Glaucoma.” Invited lecturer, 7 th Annual 

Continuing Education in Southern California Lecture and Symposium, UC Berkeley School of Optometry, 

Los Angeles, CA, Feb 27, 2000. 

137. “Detection, Diagnosis, and Management of Angle-Closure Glaucoma.” Invited lecturer, 7 th Annual Continuing 

Education in Southern California Lecture and Symposium, UC Berkeley School of Optometry, Los Angeles, 

CA, Feb 27, 2000. 

138. “Pediatric Glaucoma.” Invited lecturer, Ophthalmology Basic and Clinical Science Course, Jules Stein Eye 

Institute, UCLA School of Medicine, Los Angeles, CA, Mar 15, 2000. 

139. “The Red Eye.” Invited lecturer, Outpatient Morning Report, Department of Internal Medicine, UCLA School of 

Medicine, Los Angeles, CA, Apr 11, 2000. 



ALC100325 


140. “Indications and Surgical Techniques for Drainage Devices Implantation.” Invited speaker, 33 rd Pan Hellenic 

Ophthalmological Congress, Thessaloniki, Greece, May 24, 2000. 

141. “Glaucoma and Quality of Life.” Invited speaker, 33 rd Pan Hellenic Ophthalmological Congress, Thessaloniki, 

Greece, May 24, 2000. 

142. “Surgical Treatment of Glaucoma.” Panel discussion, invited speaker, 33 rd Pan Hellenic Ophthalmological 

Congress, Thessaloniki, Greece, May 24, 2000. 

143. “Losing Vision Increases the Risk of Falling.” Study of Osteoporotic Fractures, Steering Committee Meeting, 

Vancouver, Canada, Jun 7, 2000. 

144. “Quality of Life in Glaucoma Patients.” Invited lecturer, Doheny Eye Institute, USC School of Medicine, 

Los Angeles, CA, Jun 22, 2000. 

145. “Quality of Life in Glaucoma Patients.” Antelope Valley Country Club, Lancaster, CA, Jul 26, 2000. 

146. “Outcome Measures in Glaucoma.” Invited lecturer, Third Annual Women in Ophthalmology Conference, 

Aspen, CO, Jul 27, 2000. 

147. “Epidemiology of Glaucoma.” Invited lecturer, Ophthalmology Basic and Clinical Science Course, UCLA 

School of Medicine, Los Angeles, CA, Sep 6, 2000. 

148. “Adverse Events from Glaucoma Medications.” Invited lecturer, Merck Consultants Meeting, 

Jackson Hole, WY, Sept. 23, 2000. 

149. “Advances in Modern Tube-Shunt Surgery.” Invited speaker, Glaucoma Subspecialty Day, American 

Academy of Ophthalmology, Oct 21, 2000. 

150. “Losing Vision Increases the Risk of Multiple Falls.” Invited speaker, Jules Stein Eye Institute Glaucoma 

Specialty Service Program, Los Angeles, CA, Nov 1, 2000. 

151. “The Heidelberg Retinal Tomograph.” Invited speaker, Scanning Laser Imaging of the Optic Nerve and 

Retinal Nerve Fiber Layer, San Diego Eye Bank Meeting, San Diego, CA, Nov 4, 2000. 

152. “Uveitis and Glaucoma: Information Available from the Medicare Database.” Invited speaker, University of 

California Intercampus Ophthalmology Symposium on Glaucoma, Yosemite, CA, Jan 20, 2001. 

153. “Tube Hypotony.” Invited speaker, AGS Mini-Symposium on Aqueous Shunt Complications, 10 th Annual 

Meeting of American Glaucoma Society, Newport Beach, CA, Mar 3, 2001. 

154. “Risk Factors for Glaucoma from Epidemiology to Clinical Practice.” Invited speaker, 8 th International 

Glaucoma Congress, Greek Glaucoma Society, Athens, Greece, Mar 10, 2001. 

155. “The Management of Glaucoma in United States Elderly Population.” 3 rd International Glaucoma Society, 

Prague, Czechoslovakia, Mar 22, 2001. 

156. “New Ocular Hypotensive Lipids.” Invited speaker, Allergan, Denver, CO, Apr 17, 2001. 

157. “The Management of Glaucoma in the United States Elderly Population.” Invited Grand Rounds speaker, 

University of South Florida, Tampa, FL, Apr 19, 2001. 

158. “Pitfalls and Pearls with Drainage Devices.” Invited Grand Rounds speaker, University of South Florida, 

Tampa, FL, Apr 19, 2001. 

159. “New IOP Lowering Therapy.” Invited speaker, Allergan, Beverly Hills, CA, May 10, 2001. 

160. “Losing Vision Increases the Risk of Multiple Falls: the Study of Osteoporotic Fractures.” Invited speaker, 

Kellogg Eye Center, University of Michigan, Ann Arbor, MI, May 14, 2001. 

161. “Management of Glaucoma in U.S. Elderly.” Invited Grand Rounds speaker, Long Beach Memorial Hospital, 

Long Beach, CA, May 15, 2001. 

162. “Epidemiology of Glaucoma.” Invited speaker, UC Davis Annual Ophthalmology Symposium: Glaucoma in the 

New Millennium, Sacramento, CA, May 18, 2001. 

163. “Glaucoma in the Medicare Database.” Invited speaker, UC Davis Annual Ophthalmology Symposium: 

Glaucoma in the New Millennium, Sacramento, CA, May 18, 2001. 

164. “Practicing Evidence-Based Medicine in the Management of Glaucoma.” Merck Consultants Meeting, 

Half Moon Bay, CA, Jun 7, 2001. 



ALC100325 


165. “Does Glaucoma with Bilateral Visual Field Loss Increase the Risk of Falls and Non-spine Fractures?” 

NIH SOF Day, Bethesda, MD, Jun 17, 2001. 

166. “Vascular Epidemiology of Glaucoma.” Glaucoma Global Roundtable, Copenhagen, Denmark, Jul 13, 2001. 

167. “There is a Role for Ocular Blood Flow in Glaucoma Damage.” Clinical Applications of Ocular Blood Flow, 

Jules Stein Eye Institute and Indiana University, Beverly Hills, CA, Aug 11, 2001. 

168. “Ocular Hypotensive Lipids.” Invited Grand Rounds speaker, Moran Eye Center, University of Utah School of 

Medicine, Salt Lake City, UT, Aug 16, 2001. 

169. “Case Studies in the Management of Glaucoma.” Invited guest speaker. Merck, Berkeley, CA, Oct 11. 2001. 

170. “Ocular Hypotensive Lipids.” Invited guest speaker, Allergan, Honolulu, HI, Oct 25, 2001. 

171. “Practicing Evidence-Based Medicine in the Management of Glaucoma.” Invited speaker, Bridgeport 

Glaucoma Society, Portland, OR, Nov 1, 2001. 

172. “Managing Tube Troubles.” Invited speaker, Glaucoma 2001 Subspecialty Day, American Academy of 

Ophthalmology meeting, New Orleans, LA, Nov 10, 2001. 

173. “Randomized, Masked Clinical Trial Comparing Bimatoprost and Timolol/Dorzolamide Combination Eye 

Drops.” Invited guest speaker, Allergan Breakfast Symposium, New Orleans, LA, Nov 11, 2001. 

174. “Influence of Low Vision on Falls and Accidents in the Elderly.” Invited symposium speaker: Aging and the 

Eye- Part II, American Academy of Ophthalmology. New Orleans, LA, Nov 13, 2001. 

175. “Practicing Evidence-based Medicine in the Therapy of Ophthalmic Diseases.” Invited speaker, New Ideas in 

Glaucoma Management, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, Jan 12, 2002. 

176. “Treatment of Glaucoma in the Medicare Database.” Invited speaker, New Ideas in Glaucoma Management, 

Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, Jan12, 2002. 

177. “Glaucoma Overview.” Invited speaker, Royal Hawaiian Eye Meeting, Nursing and Allied Health Program, 

Big Island, HI, Jan 22, 2002. 

178. “The Epidemiology of Glaucoma.” Invited speaker, Royal Hawaiian Eye Meeting, Big Island, HI, Jan 23, 2002. 

179. “Vascular Epidemiology of Glaucoma and Age-related Macular Degeneration.” Invited symposium speaker, 

Royal Hawaiian Eye Meeting, Big Island, HI, Jan 25, 2002. 

180. “What’s New with Drainage Devices.” Invited speaker, Research Study Club, Los Angeles, CA, Feb 10, 2002. 

181. “Practicing Evidence-based Medicine in the Therapy of Ophthalmic Diseases.” Grand Rounds speaker, 

Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, Feb 13, 2002. 

182. “Aqueous Outflow in the Management of Glaucoma.” Invited speaker, Three Targets for Glaucoma 

Management: A New Approach Symposium, Los Angeles, CA, Mar 16, 2002. 


Management: A New Approach Symposium, Las Vegas, NV, Apr 6, 2002. 

184. “Eye Care America: Glaucoma Project.” Invited speaker, Virginia Society of Ophthalmology annual scientific 

meeting, Williamsburg, VA, Apr 12, 2002. 

185. “What Population-based Studies Reveal about Blood Flow in Glaucoma.” Invited speaker, Clinical 

Applications of Ocular Blood Flow, Tufts University School of Medicine and New England Eye Center, 

Boston, MA, Apr 13, 2002. 

186. “Other Clinical Trials Information in the Treatment of Glaucoma Patients.” Invited Speaker, 29 th International 

Congress of Ophthalmology, Sydney, Australia, Apr 24, 2002. 

187. “Vascular Epidemiology of Glaucoma.” Invited speaker, 29 th International Congress of Ophthalmology, 

Sydney, Australia, Apr 24, 2002. 

188. “Issues in the Screening for Glaucoma in Developing Countries.” Invited speaker, 29 th International Congress 

of Ophthalmology, Sydney, Australia, Apr 24, 2002. 

189. “Management of Glaucoma Patients Using the Results of Large Glaucoma Clinical Trials.” Invited speaker, 

Division of Ophthalmology, Cedars-Sinai Hospital, Los Angeles, CA, May 1, 2002. 



ALC100325 


190. “The Life of a Clinician-Scientist.” Invited speaker, Career Path Forum, ARVO Diversity Issues Committee, 

Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, May 5, 2002. 

191. “Epidemiology of Glaucoma.” Invited speaker, 4 th International Course on Glaucoma, University of Såo Paulo, 

Såo Paulo, Brazil, May 10, 2002. 

192. “How Multicenter Trials Help Us in Clinical Practice.” Invited speaker, University of Såo Paulo, 

4 th International Course of Glaucoma, Såo Paulo, Brazil, May 10, 2002. 

193. “Management of Glaucoma.” Invited moderator, 35 th Pan Hellenic Ophthalmologic Congress, Chalkidiki, 

Greece, Jun 5, 2002. 

194. “Epidemiology of Glaucoma, Invited speaker, 35 th Pan Hellenic Ophthalmologic Congress, Chalkidiki, Greece, 

Jun 7, 2002. 

195. “Randomized Clinical Trial of Lumigan Versus Cosopt.” Invited speaker, 35 th Pan Hellenic Ophthalmologic 

Congress, Chalkidiki, Greece, Jun 8, 2002. 

196. “Roundtable on Glaucoma Surgery.” Invited speaker, 35 th Pan Hellenic Ophthalmologic Congress, Chalkidiki, 


197. “Practicing Evidence-based Medicine in the Therapy of Ophthalmic Diseases.” Invited speaker, American Eye 

Study Club, Park City, UT, Jul 27, 2002. 


Management: A New Approach Symposium, St Louis, MO, Sep 14, 2002. 

199. “Ocular Hypertension Treatment Study.” Invited speaker, Santa Barbara Eye Society, Santa Barbara, CA, 

Sep 19, 2002. 

200. “Risk Factors for Blindness from Glaucoma.” Invited speaker, Glaucoma 2002 Subspecialty Day, Orlando, FL, 

Oct 19, 2002. 

201. “Risk Factors for Blindness from Glaucoma.” Invited speaker, Meet the Experts, Orlando, FL, Oct 19, 2002. 

202. “Discussion of Interventions to Retard Myopia Progression in Children: An Evidence-based Update.” Invited 

speaker, Editor’s Choices Symposium, American Academy of Ophthalmology, Orlando, FL, Oct 20, 2002. 

203. “Radiation, Electrical or Thermal Injury.” Invited speaker, Traumatic Glaucoma: Mechanisms and 

Management Symposium, American Academy of Ophthalmology, Orlando, FL, Oct 21, 2002. 

204. “Glaucoma Increases the Risk of Fractures.” Invited speaker, UCSF Grand Rounds, San Francisco, CA, 

Nov 7, 2002. 

205. “Ocular Hypertension Treatment Study.” Invited speaker, LA Women in Ophthalmology, Beverly Hills, CA, 

Nov 12, 2002. 


Management: A New Approach Symposium, Phoenix, AZ, Nov 16, 2002. 


Management: A New Approach Symposium, Houston, TX, Nov 23, 2002. 

208. “Evidence-based Medicine and the Management of OHTS.” Invited speaker, Las Vegas, NV, Jan 17, 2003. 

209. “Defining Guidelines for the Medical Management of Glaucoma.” Invited speaker, Royal Hawaiian Eye 

Meeting, Maui, HI, Jan 22, 2003. 

210. “Clinical Trials OHTS, CIGTS, EGMT, and AGIS: How Do They All Fit Together? Have We Really Learned 

Anything from Clinical Trials that We Did Not Know Before?” Invited speaker, University of California 

Intercampus Ophthalmology Symposium on Glaucoma, Yosemite, CA, Feb 8, 2003. 

211. “Is Screening for Glaucoma Cost Effective?” Invited speaker, Glaucoma 2003: Practical Solutions to 

Complicated Problems, Columbus, OH, Feb 28, 2003. 

212. “Practicing Evidence-Based Medicine in Glaucoma.” Invited speaker, Glaucoma 2003: Practical Solutions to 

Complicated Problems, Columbus, OH, Feb 28, 2003. 

213. “Glaucoma 2003: Practical Solutions to Complicated Problems.” Albert D. Frost Memorial Lecture, OHTS, 

Columbus, OH, Feb 28, 2003. 



ALC100325 


214 “Current Medical Therapies in Glaucoma.” Invited speaker, Glaucoma 2003: Practical Solutions to 

Complicated Problems, Columbus, OH, Mar 1, 2003. 

215. “Options after Failed Primary Trabeculectomy.” Invited speaker, Glaucoma 2003: Practical Solutions to 

Complicated Problems, Columbus, OH, Mar 1, 2003. 

216. “How Do You Practice When All You Have is Information from Case Series?” American Glaucoma Society, 

San Francisco, CA Mar 7, 2003. 

217. “What is Evidence-Based Medicine?” Invited speaker, Evidence-Based Medicine: A New Approach to 

Glaucoma, American Glaucoma Society, San Francisco, CA, Mar 7, 2003. 

218. “Risk Factors for Blindness in Glaucoma.” Illinois Society for the Prevention of Blindness Lecturer, 55 th Annual 

Chicago Ophthalmological Society Clinical Conference, Chicago, IL, Apr 25, 2003. 

219. “Applying Evidence-Based Medicine to Ophthalmic Practice.” Invited speaker, 55 th Annual Chicago 

Ophthalmological Society Clinical Conference, Chicago, IL, Apr 25, 2003. 

220. “Is There an Association Between Chronic Eye Disease, Falls and Fractures?” 55 th Annual Chicago 

Ophthalmological Society Clinical Conference, Chicago, IL, Apr 25, 2003. 

221. “Relationship Between IOP and COAG and Implications for Terminology (NTG,LTG,OHT).” Invited speaker, 

Glaucoma Society of the International Congress of Ophthalmology, Chantilly, France, May 29, 2003. 

222. “Facing the Fork in the Road: Following Glaucoma.” Invited speaker, Health Answers, Chicago, IL, 

Sep 6, 2003. 

223. “Evidence-Based Ophthalmology.” Wilmer Distinguished Lecturer, Johns Hopkins University, Baltimore, MD, 

Sep 12, 2003. 

224. “Making Sense of the Signs in Glaucoma: Management Strategies that Work.” Invited speaker, Health 

Answers, San Francisco, CA, Oct 25, 2003. 

225. “The Relevance of Sensitivity, Specificity, and Evidence-Based Guidelines.” Invited speaker, 1 st Global 

Association of International Glaucoma Societies (AIGS) Meeting, San Diego, CA, Nov 14, 2003. 

226. “Primary Open Angle Glaucoma: The Developing World Perspective.” Invited speaker, Glaucoma 2003 

Subspecialty Day, American Academy of Ophthalmology Annual Meeting, Anaheim, CA, Nov 15, 2003. 

227. “Implantation of Glaucoma Devices.” Invited speaker, American Academy of Ophthalmology Annual Meeting, 

Anaheim, CA Nov 17, 2003. 

228. “Visual Loss and Falls.” Invited speaker, Functional Impact of Visual Loss in the Aged Symposium, American 

Academy of Ophthalmology Annual Meeting, Nov 18, 2003. 

229. “The Epidemiology of Glaucoma & the Impact on Healthcare Costs.” Invited speaker, Walter Wright Meeting, 

University of Toronto, Ontario, Canada, Dec 5, 2003. 

230. “Evidence-Based Review of Cataract & Filtration Surgery.” Invited speaker, Walter Wright Meeting, University 

of Toronto, Ontario, Canada, Dec 5, 2003. 

231. “Applying Clinical Research to Your Practice.” Invited speaker, Research Study Club, Los Angeles, CA, 

Jan 17, 2004. 

232. “Learning the Art of Optic Nerve Evaluation: The Realities of Clinical Practice.” Invited speaker, Royal 

Hawaiian Eye Meeting, Kauai, HI, Jan 26, 2004. 

233. “Applying Clinical Research to Patient Care.” Invited speaker, Royal Hawaiian Eye Meeting, Kauai, HI, 

Jan 28, 2004. 

234. “Blood Pressure & Glaucoma.” Invited speaker, Hawaii Nursing Program, Royal Hawaiian Eye Meeting, 

Kauai, HI, Jan 28, 2004. 

235. “Medical and Surgical Advances in the Treatment of Glaucoma.” Invited speaker, Hawaii Nursing Program, 

Royal Hawaiian Eye Meeting, Kauai, HI, Jan 28, 2004. 

236. “Does Every mmHg Count?” Invited speaker, 7 th Annual Ocular Drug and Surgical Therapy Update Meeting, 

Dana Point, CA, Feb 14, 2004. 

237. “Review of Glaucoma Clinical Trials.” Invited speaker and workshop chair, 7 th Annual Ocular Drug and 

Surgical Therapy Update Meeting, Dana Point, CA, Feb 14, 2004. 



ALC100325 


238. “Trends in Retinal Detachment Surgery and Associated Reimbursement in the Medicare Database.” 

Poster presentation, Association for Research in Vision and Ophthalmology (ARVO) annual meeting, 

Fort Lauderdale, FL, Apr 25-29, 2004. 

239. “Reframing Disease Severity.” Invited speaker and panel member, Glaucoma Mini-symposium, Association 

for Research in Vision and Ophthalmology, Fort Lauderdale, FL, Apr 26, 2004. 

240. “A Discussion on the Consequence of Glaucoma and A Review of the Ann Corn Study on the 

Impact/Consequence Associated with Driving.” Ophthalmology Management® Glaucoma—Quality of 

Life/Quality of Vision Roundtable Discussion, Fort Lauderdale, FL, Apr 27, 2004. 

241. “Age-Related Eye Disease in Elderly Women.” Invited speaker, Sex -based Biology in Ocular Disease and 

Treatment Mini-symposium, Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 

Apr 29, 2004. 

242. “Eye Diseases and Care for Older Individuals.” Invited speaker, The Pre-surgical Evaluation and 

Management of the Older Patient, 3 rd Annual Meeting of the Section for Surgical and Related Medical 

Specialties, American Geriatric Society 2004 Annual Meeting, Las Vegas, NV, May 20, 2004. 

243. “Societal Relevance of Glaucoma.” Invited speaker and panel member, The Jules Stein Eye Institute Clinical 

and Research Seminar 2004, Los Angeles, CA, May 21, 2004. 

244. “Restaging Glaucoma.” Invited speaker, 7 th Congress of the European Glaucoma Society Meeting, Florence, 

Italy, Jun 1, 2004. 

245. “Evidence-based Recommendations for the Management of Glaucoma.” Invited speaker, 37 th Panhellenic 

Ophthalmological Congress, Porto Carras-Chalkidiki, Greece, Jun 10, 2004. 

246. “Options after Failed Primary Trabeculectomy.” Invited speaker, 37 th Panhellenic Ophthalmological Congress, 

Porto Carras-Chalkidiki, Greece, Jun 10, 2004. 

247. “Epidemiology and Ocular Hypertension.” Invited speaker, The Treatment of Risk in the Glaucoma Continuum 

Meeting, Boston, MA, Jul 16, 2004. 

248. “Clinically Relevant Knowledge Base Development.” Invited speaker, Women In Ophthalmology 2004 

Summer Symposium, Park City, UT, Jul 31, 2004. 

249. “Evidence-based Medicine Today: Glaucoma and Ocular Hypertension.” Invited speaker, The Treatment of 

Risk in the Glaucoma Continuum, Dallas, TX, Sep 18, 2004. 

250. “Reframing Disease Severity in Glaucoma.” Invited speaker, Focusing Ophthalmology on Reframing 

Glaucoma Evaluation, Boca Raton, FL, Sep 28-29, 2004. 

251. “Reframing Disease Severity in Glaucoma.” Invited speaker, Focusing Ophthalmology on Reframing 

Glaucoma Evaluation, Miami, FL, Sep 28-29, 2004. 

252 “Reframing Disease Severity in Glaucoma.” Invited speaker, Focusing Ophthalmology on Reframing 

Glaucoma Evaluation, Strategies to Prevent Disease Progression Regional Consultant Meeting, Phoenix, AZ, 

Oct 8–10, 2004. 

253. “Ophthalmology.” Invited speaker, Unite for Sight meeting, Los Angeles, CA, Oct 12, 2004. 

254. “Glaucoma Management: The Role of Minimizing IOP Fluctuation.” Invited speaker, Glaucoma/Ocular 

Hypertension Study Meeting, Tokyo, Japan, Oct 16, 2004. 

255. “The OHTS Ancillary Study on the HRT.” Invited instructor, American Academy of Ophthalmology, New 

Orleans, LA, Oct 23, 2004. 

256. “The Risk Calculator: How Close Are We?” Invited speaker, Glaucoma 2004 Under Pressure: The Optic 

Nerve and Glaucoma, Subspecialty Day, American Academy of Ophthalmology, New Orleans, LA, Oct 23, 

2004. 

257. “Historical Overview of Glaucoma Diagnosis.” Invited speaker, Focusing Ophthalmology on Reframing 

Glaucoma Evaluation, New Orleans, LA, Oct 23, 2004. 

258. “Implantation of Glaucoma Drainage Devices.” Invited speaker, American Academy of Ophthalmology Annual 

Meeting, New Orleans, LA, Oct 25, 2004. 

259. “Focusing Ophthalmology on Reframing Glaucoma Evaluation (FORGE).” Invited speaker, Allergan 

Educational Symposium for Ophthalmologists, Long Beach, CA, Nov 9, 2004. 



ALC100325 


260. “Intraocular Pressure Fluctuation, and Glaucoma.” Invited speaker, The Dulaney Foundation Educational 

Symposium for Glaucoma Fellows, Dallas/Fort Worth/Las Colinas, TX, Nov 10-14, 2004. 

261. “Glaucoma Implants.” Invited speaker, The Dulaney Foundation Educational Symposium for Glaucoma 

Specialists, Dallas/Fort Worth/Las Colinas, TX, Nov 11, 2004. 

262. Invited speaker, David Cogan Clinician Scientist Symposium, National Eye Institute, Bethesda, MD, Dec 13, 

2004. 

263. “Intraocular Pressure Fluctuation and Glaucoma.” Invited speaker, The Dulaney Foundation, Alcon 

Educational Symposium for Ophthalmologists, Anaheim, CA, Jan 18, 2005. 

264. “Evaluating the Optic Nerve.” Program chair, moderator, invited speaker, Clinical Frontiers in Otolaryngology 

and Controversies in Ophthalmology, 73 rd Mid-Winter Conference, Research Study Club of Los Angeles, CA, 

Jan 22, 2005. 

265. Discussion group leader, Jules Stein Eye Institute Third Glaucoma Summit, Yosemite, CA, Feb 3-6, 2005. 

266. “Managing the Glaucoma Patient in Light of Recent Clinical Trials.” Chairman’s Special Lecturer, Duke Eye 

Center, Durham, NC, Feb 8, 2005. 

267. “Epidemiology of Glaucoma and Age-related Macular Degeneration.” Invited speaker, Master in Neuro- 

Ophthalmology Program, Lisbon, Portugal, Feb 18, 2005. 

268. “Current Management of Glaucoma.” Invited speaker, Management of Ischemic Eye Disease from 

Epidemiology to the Clinic. Colóquios de Oftalmologia 2005 International Conference, Lisbon, Portugal, 

Feb 19, 2005. 

269. Moderator, mini symposium: Case Control, Cohort, Cross Sectional and Other Non-randomized Clinical Trials 

in Ophthalmology, Glaucoma Society International Congress of Ophthalmology, Salvador City, Brazil, 

Feb 21-26, 2005. 

270. “Glaucoma in Children.” Moderator, Mini-symposium, American Glaucoma Society, Snowbird, UT, Mar 3-6, 

2005. 

271. “Overview of Glaucoma Diagnosis.” Invited speaker, Focusing Ophthalmology on Reframing Glaucoma 

Evaluation, Allergan, The National Academy of Design, New York, NY, Mar 10, 2005. 

272. “Updates in Glaucoma, -Twinning Course.” Co-chair, 25 th Pan-American Congress of Ophthalmology, 

Santiago, Chile, Mar 21, 2005. 

273. “OHTS-HRT Ancillary Study.” 25 th Pan-American Congress of Ophthalmology, Santiago, Chile, Mar 21, 2005. 

274. “Current Approach to Phaco-Trabeculectomies, Updates in Glaucoma.” 25 th Pan-American Congress of 

Ophthalmology, Santiago, Chile, Mar 21, 2005. 

275. “New Advances in Scanning Laser Ophthalmoscopy, Microscopy, Retinal Edema, and Optic Nerve Analysis.” 

American Society of Cataract and Refractive Surgery Breakfast Symposium, Washington, DC, Apr 16, 2005. 

276. “Epidemiology of Intraocular Pressure.” Leader, Global AIGS Consensus Meeting on IOP, Fort Lauderdale, 

FL, May 5, 2007. 

277. “Managing the Glaucoma Patient in Light of Recent Clinical Trials.” Invited speaker, New England 

Ophthalmology Society Meeting, Boston, MA, May 20, 2005. 

278. “Glaucoma Clinical Trials: What We Expect to Learn in the Future.” Invited speaker, New England 

Ophthalmology Society Meeting, Boston, MA, May 20, 2005. 

279. “Intraocular Pressure Fluctuation and Glaucoma.” Invited speaker, Cedars-Sinai Grand Rounds Lecture, 

Westwood, CA, Jun 1, 2005. 

280. “Confocal Scanning Laser Imaging in the OHTS.” Invited speaker, Thorny Issues in Ophthalmology 

Symposium, Portland, OR, Jun 3, 2005. 

281. “Current Approach to Phaco-Trabeculectomy.” Invited speaker, Thorny Issues in Ophthalmology Symposium, 

Portland, OR, Jun 3, 2005. 

282. “Managing the Glaucoma Patients in the Light of Recent Clinical Trials.” Invited speaker, Thorny Issues in 

Ophthalmology Symposium, Portland, OR, Jun 4, 2005. 



ALC100325 


283. “IOP Fluctuation and Glaucoma.” Invited lecturer, Medical Education Speakers Alliance, San Diego, CA, 

Jun 9, 2005. 

284. “IOP Fluctuation as a Major Risk Factor.” Invited speaker, Session 3: Understanding IOP, 3 rd Annual Ocular 

Surgery News Symposium, Las Vegas, NV, Jun 17, 2005. 

285. “Societal Impact of Glaucoma.” Invited speaker, World Glaucoma Congress, Association of International 

Glaucoma Societies, Vienna, Austria, Jul 7, 2005. 

286. “Design, Conduct, and Interpretation of Clinical Trials: Pearls, and Pitfalls.” Instructor, World Glaucoma 

Congress, Association of International Glaucoma Societies, Vienna, Austria, Jul 7, 2005. 

287. “Indications for Implants.” Invited speaker, Glaucoma Surgery Consensus Session, World Glaucoma 

Congress, Association of International Glaucoma Societies, Vienna, Austria, Jul 9, 2005. 

288. “Glaucoma Prevalence and Epidemiology.” Invited speaker, Mastering Tools and Techniques for the 21 st 

Century, Glaucoma 2005, San Francisco, CA, Sep 17, 2005. 

289. “Normal Tension Glaucoma: Is it Different from POAG?” Invited speaker, Mastering Tools and Techniques for 

the 21 st Century, Glaucoma 2005, San Francisco, CA, Sep 17, 2005. 

290. “Population-based Studies: Why Do Them?” Invited speaker, From Research to Clinical Practice: 

Thessaloniki Eye Study, Thessaloniki, Greece, Sep 24, 2005. 

291. “General Comments on the Thessaloniki Eye Study.” Invited speaker, From Research to Clinical Practice: 

Thessaloniki Eye Study, Thessaloniki, Greece, Sep 24, 2005. 

292. “Introduction to the Glaucoma Continuum.” Invited speaker, Glaucoma Risk Symposium, Universal City, CA, 

Oct 8, 2005. 

293. “Main OHTS Results.” Invited speaker, Diagnostic Imaging in Glaucoma Comes of Age, Ophthalmology 

Times, Chicago, IL, Oct 15, 2005. 

294. “Point-Counterpoint II: Vitreous Tubes Improve PKP Survival.” Invited speaker, Glaucoma 2005 Under 

Pressure: Paradigm Change in Theory and Practice, 2005 Annual Meeting of the American Academy of 

Ophthalmology, Chicago, IL, Oct 17, 2005. 

295. “Doctor, What Impact Will Glaucoma Have on Me?” Invited speaker, Addressing the Patient Perspective on 

Glaucoma: What Do Patients Want to Know About Glaucoma and What Do We Tell Them? Symposium, 

combined meeting with Prevent Blindness America, 2005 Annual Meeting of the American Academy of 

Ophthalmology, Chicago, IL, Oct 17, 2005. 

296. “Women: The Next Fifty Years.” Chair/moderator, Women in Ophthalmology/AAO Committee on 

Aging/American Geriatric Association/John A. Hartford Foundation cosponsored symposium, 2005 Annual 

Meeting of the American Academy of Ophthalmology, Chicago, IL, Oct 17, 2005. 

297. “Risk Assessment and Predicting the Future.” Invited speaker, Spotlight on Glaucoma: Glaucoma Care and 

Technology symposium, 2005 Annual Meeting of the American Academy of Ophthalmology, Chicago, IL, 

Oct 18, 2005. 

298. “Introduction to the Glaucoma Continuum, Invited speaker, Treatment of Risk in the Glaucoma Continuum 

Regional Symposium, San Francisco, CA, Nov 5, 2005. 

299. “Global Glaucoma Perspective: Epidemiology.” Invited speaker, 2 nd Annual Alcon Glaucoma Specialists 

Forum, Irving, TX, Nov 19, 2005. 

300. “Introduction to the Glaucoma Continuum.” Invited speaker, Treatment of Risk in the Glaucoma Continuum 

regional symposium, Chicago, IL, Dec 3, 2005. 

301. “Managing the Glaucoma Patient in Light of Recent Clinical Trials.” Invited speaker, New York University 

Medical Center and Manhattan Eye, Ear and Throat Hospital grand rounds, New York, NY, Dec 6, 2005. 

302. “Glaucoma Societal Perspective.” Invited lecturer, New York Glaucoma Society Meeting, New York, NY, 

Dec 6, 2005. 

303. “Managing the Glaucoma Patient in Light of Recent Clinical Trials.” Invited speaker, Mount Sinai School of 

Medicine Grand Rounds, New York, NY, Dec 7, 2005. 

304. “Practical Application of Optic Nerve Imaging in Initial Diagnosis and Progression.” Invited speaker, Hawaiian 

Eye 2006, Maui, HI, Jan 18, 2006. 



ALC100325 


305. “Ahmed Glaucoma Valve Implants.” Invited speaker, Implants in Glaucoma, American Academy of 

Ophthalmology Glaucoma Symposium, World Ophthalmology Congress, São Paulo, Brazil, Feb 23, 2006. 

306. “Definition of a Population-based Study.” Invited speaker, mini-symposium: Case Control, Cohort, Cross 

Sectional and Other Non-randomized Clinical Trials in Ophthalmology, Glaucoma Society International 

Congress of Ophthalmology, São Paolo, Brazil, Feb 24, 2006. 

307. “Valved Aqueous Shunts.” Invited Speaker, Brazil 2006 Glaucoma Implant Symposium, 2006 World 

Ophthalmology Congress, São Paolo, Brazil, Feb 24, 2006. 

308. Lead facilitator: Glaucoma Networking Breakout Session; Content Expert, 8 th National Eye Health Education 

Program Conference, Santa Fe, NM, Mar 23, 2006. 

309. “Putting Vision on the Aging Agenda.” Invited speaker, 8 th National Eye Health Education Program 

Conference, Santa Fe, NM, Mar 24, 2006. 

310. “Fruits and Vegetables: Should Glaucoma Patients be Eating More of Them?” Invited speaker, Jules Stein 

Eye Institute Clinical and Research Seminar 2006, Los Angeles, CA, May 20, 2006. 

311. “Preservative-Induced Ocular Surface Changes in Patients with Glaucoma: New Evidence, New Management 

Stategies.” Invited roundtable participant, Del Mar, CA, Jun 3, 2006. 

312. “Nutrition and Glaucoma.” Invited speaker, 39 th Panhellenic Ophthalmological Congress, Thessaloniki, 


313. “Progression of Glaucoma.” Invited speaker, Glaucoma Continuum Symposium, 39 th Panhellenic 

Ophthalmological Congress, Thessaloniki, Greece, Jun 10, 2006. 

314. “Prevalence of Undiagnosed Open Angle Glaucoma and Pseudoexfoliative Glaucoma in Greece.” Invited 

speaker, 39 th Panhellenic Ophthalmological Congress, Thessaloniki, Greece, Jun 10, 2006. 

315. “Intraocular Pressure and Risk Analysis.” Symposium participant, Symposium on Glaucoma Screening and 

Diagnosis, International Glaucoma Research Society, Vancouver, Canada, Jun 29, 2006. 

316. “Nutrition and Glaucoma.” International invited speaker, 2006 Australian and New Zealand Glaucoma Club 

Meeting, Sydney, Australia, Jul 21, 2006. 

317. “Falls/Fractures, Visual Field Loss, and Glaucoma.” International invited speaker, 2006 Australian and New 

Zealand Glaucoma Club Meeting, Sydney, Australia, Jul 22, 2006. 

318. “Role of Optic Nerve Imaging in Detecting Progression of Glaucomatous Optic Nerve Damage.” International 

invited speaker, 2006 Australian and New Zealand Glaucoma Club Meeting, Sydney, Australia, Jul 22, 2006. 

319. “Risk Factors and Outcomes: Are We Looking at the Right Things?” A Critical Re-evaluation of Current 

Glaucoma Management, International Glaucoma Think Tank Meeting, Taormina, Sicily, Italy, Jul 27-29, 2006. 

320. “Perimetry in the Diagnosis and Management of Glaucoma.” Invited speaker, FORGE II: Focusing 

Ophthalmology on Reframing Glaucoma Evaluation, Los Angeles, CA, Aug 24, 2006. 

321. “Practical Guidelines to Improve Clinical Outcomes with the HRT.” Invited instructor, 2006 Heidelberg 

Academy HRT Clinician Courses, Las Vegas, NV, Nov 10, 2006. 

322. “Role of Laser Surgery in Chronic Angle Closure Glaucoma.” Invited instructor, American Academy of 

Ophthalmology annual meeting, Las Vegas, NV, Nov 12, 2006. 


Ophthalmology on Reframing Glaucoma Evaluation, Kauai, HI, Jan 15, 2007. 

324. “When to Treat?” Invited speaker, Nursing and Allied Health Program, Hawaiian Eye 2007, Kauai, HI, Jan 16, 

2007. 

325. “Tubes and Me.” Invited speaker, Hawaiian Eye 2007, Kauai, HI, Jan 17, 2007. 

326. “Controversies in Glaucoma Management.” Invited symposium participant, Glaucoma Mid-Winter 

Symposium, Battle on the Beach v. Showdown at the Gables Corral: East versus West, Coral Gables, FL, 

Jan 26-27, 2007. 

327. “Alternative Approaches to Assessing the Burden of Disease: What is the Value and Role for Mining Large 

Existing Databases?” Invited speaker, 4 th U.S. Symposium on Ocular Epidemiology, Sarasota, FL, Jan 30, 

2007. 



ALC100325 


328. “Tubes versus Trabeculectomy.” Invited Speaker, 10 th Annual Ocular Drug and Surgical Therapy Update 

Meeting, Danla Point, CA, Feb 17, 2007. 

329. “Glaucoma Journal Review, Invited speaker, 10 th Annual Ocular Drug and Surgical Therapy Update Meeting, 

Dana Point, CA, Feb 17, 2007. 


Ophthalmology on Reframing Glaucoma Evaluation, San Francisco, CA, Feb 28, 2007. 

331. “Clinical Cases and Discussions.” Invited speaker, European Heidelberg Glaucoma Symposium, Athens, 

Greece, Mar 27, 2007. 

332. “Glaucoma and the Intake of Antioxidants Among Older Women: The Study of Osteoporotic Fractures, New 

Concepts and Mechanisms.” Sixth International Glaucoma Symposium, Athens, Greece, Mar 30, 2007. 

333. “Mastering Optic Nerve Evaluation.” Invited speaker, American Society of Cataract and Refractive Surgeons 

Glaucoma Day 2007, San Diego, CA, Apr 27, 2007. 

334. “Glaucoma Risk and Antioxidants Among Older Women.” Jules Stein Eye Institute Clinical and Research 

Seminar, Los Angeles, CA, May 19, 2007. 

335. “Formal Glaucoma Screening.” Invited speaker, 2007 Ophthalmology Symposium, Kaiser Permanente, 

Anaheim, CA, Jun 2, 2007. 

336. “Confocal Scanning Laser Ophthalmoscopy: Theory and Performance Characteristics.” Invited speaker, 

2007 Ophthalmology Symposium, Kaiser Permanente, Anaheim, CA, Jun 2, 2007. 

337. “Baseline Computerized Optic Nerve Head Images Will Soon be the Standard of Care.” Invited speaker, 

2007 Ophthalmology Symposium, Kaiser Permanente, Anaheim, CA, Jun 2, 2007. 

338. “Taking Charge: Leadership Development Skills.” Invited speaker on Mentoring Process Symposium, 

European Society of Ophthalmology, Vienna, Austria, Jun 11, 2007. 

339. “Screening Blindness and Quality of Life.” Presenter, Glaucoma’s Impact on Quality of Life, World Glaucoma 

Congress, Association of International Glaucoma Societies, Singapore, Jul 19, 2007. 

340. “Glaucoma Epidemiology: Therapeutics.” Presenter, World Glaucoma Congress, Association of International 

Glaucoma Societies, Singapore, Jul 19, 2007. 

341. “Do’s and Don’ts of Being on a Board.” Invited speaker, Women In Ophthalmology Leadership Forum, 

Sedona, AZ, Aug 4, 2007. 

342. Invited faculty: Heed Ophthalmic Foundation Residency Retreat, Chicago, IL, Sep 9-10, 2007. 

343. “The Epidemiology of Glaucoma: Local and World Views.” Invited speaker, Innovations in Glaucoma, 

University of California San Francisco, Napa, CA, Sep 14, 2007. 

344. “Practical Aspects of Using Devices to Follow the Optic Nerve.” Invited speaker, Innovations in Glaucoma, 

University of California San Francisco, Napa, CA, Sep 14, 2007. 

345. “Tubes and Shunts.” Invited Speaker, Innovations in Glaucoma, University of California San Francisco, Napa, 

CA, Sep 15, 2007. 

346. “Diagnosis of Glaucoma: Optic Disc and RNFL.” Invited speaker, West Coast Glaucoma Symposium, 

Newport Beach, CA, Oct 19, 2007. 

347. “Visual Field Progression.” Invited speaker, West Coast Glaucoma Symposium, Newport Beach, CA, Oct 19, 

2007. 

348. “Trabeculectomy Complications.” Chair, West Coast Glaucoma Symposium, Newport Beach, CA, Oct 20, 

2007. 

349. “Glaucoma 2007: Achieving Balance.” Chairperson, Glaucoma Subspecialty Day, American Academy of 

Ophthalmology annual meeting, New Orleans, LA, Nov 9-10, 2007. 

350. “Applying Evidence-Based Medicine in Glaucoma.” Instructor, American Academy of Ophthalmology Annual 

Meeting, New Orleans, LA, Nov 11, 2007. 

351. “Recognition of Glaucomatous Progression.” Chair of session, American Academy of Ophthalmology Annual 




ALC100325 


352. “Guidelines for Developing Guidelines: Consensus versus Clinical Trials: Where is the Future?” World 

Ophthalmology Leaders Forum in Education, American Academy of Ophthalmology Annual Meeting, New 

Orleans, LA, Nov 12, 2007. 

353. “Implantation of Glaucoma Drainage Devices.” Invited lecturer. American Academy of Ophthalmology Annual 


354. “Consensus-based Documents are Reality When Evidence-based Medicine Doesn’t Exist.” Invited lecturer, 

American Academy of Ophthalmology Annual Meeting, New Orleans, LA, Nov 12, 2007. 

355. “Pearls of Glaucoma Consultation: A Comprehensive Review from a Tertiary Glaucoma Referral Center. 

Instructor. American Academy of Ophthalmology Annual Meeting, New Orleans, LA, Nov, 2007. 

356. “Optic Nerve and RNFL: Who Needs Imaging? Hawaiian Eye 2008, Big Island Hawaii, HI, Jan 23, 2008. 

357. “Imaging Pearls and Pitfalls Update." Hawaiian Eye 2008, Big Island Hawaii, HI, Jan 23, 2008. 

358. “Glaucoma Risk and Antioxidant Update. Hawaiian Eye 2008, Big Island Hawaii, HI, Jan 24, 2008. 

359. “Are Quality Measures Sufficiently Validated for Use as a Glaucoma Endpoint? How Can QOL be Used?.” 

Invited speaker, NEI/FDA CEDR Glaucoma Clinical Drug Trial Design and Endpoints Symposium, National 

Eye Institutes of Health, Bethesda, MD, Mar 14, 2008. 

360. “Trabectome (trabeculectomy-internal approach) as Surgical Therapy for Chronic Open-angle Glaucoma or 

Combined with Phacoemulsification.” Invited discussant, American Ophthalmology Society 2008 Annual 

Meeting, Colorado Springs, CO, May 17, 2007 

361. “What to Look for in a Clinical Trial of Neuroprotection.” Invited speaker, Transform Your Treatment of Ocular 

Disorders, 11 th Annual Ocular and Surgical Therapy Update, Dana Point, CA, Feb 16, 2008. 

362. “Incorporating Life Expectancy into Estimates of Five-Year Glaucoma Risk.” Invited speaker, American 

Glaucoma Society Annual Meeting, Washington DC, Mar 7, 2008. 

363. “Quality of Life and Glaucoma.” Invited Grand rounds Speaker, Massachusetts Eye and Ear Infirmary, 

Harvard University. Boston, MA, Mar 26, 2008. 

364. Moderator: Scientific Session II, American Eye Study Club 51 st Annual Meeting, Ojai, CA, Jul 31, 2008. 

365. “A Public Health Perspective on Glaucoma.” Invited Grand Rounds speaker, Department of Ophthalmology, 

North Shore-Long Island Medical Center, Great Neck, NY, Sep 10, 2008. 

366. “Quality of Life.” Invited Grand Rounds speaker, Department of Ophthalmology, North Shore-Long Island 

Medical Center, Great Neck, NY, Sep 10, 2008. 

367. “Nutrition and Glaucoma.” Invited speaker, Continuing Professional Education for Glaucoma Fellows 

Program, Ft. Worth, TX, Oct 4, 2008. 

368. “Risk Factors Needing More Attention.” Invited speaker, International Glaucoma Risk and Disease 

Management Symposium, University of Toronto, Toronto, Canada, Oct 18, 2008. 

369. “Screening for Glaucoma Can be Effective.” Invited speaker, Glaucoma Subspecialty Day, American 

Academy of Ophthalmology Annual Meeting, Atlanta, GA, Nov 8, 2008. 

370. “Glaucoma and Quality of Life: Vision Loss in Glaucoma and Retinal Disease.” Invited speaker, What you 

See and What the Patient Sees Symposium, American Academy of Ophthalmology Annual Meeting, Atlanta, 

GA, Nov 10, 2008. 

371. “Blindness from Glaucoma: Who’s at Risk?” Invited speaker, Hawaiian Eye 2009, Maui, Big Island HI, 

Jan 8-23, 2009. 

372. “Do Nutrition and Health Affect Risk for Glaucoma?” Discussion leader, Glaucoma Summit, Yosemite, CA, 

Jan 24, 2009. 

373. “Framing the Clinical Question.” Program chair, Evidence-Based Healthcare Workshop, Evidence-Based 

Ophthalmology Special Interest Group Session, American Glaucoma Society Annual Meeting, San Diego, 

CA, Mar 7, 2009. 



ALC100325 


374. “Ocular Perfusion Pressure.” Blood Pressure in Glaucoma Advisory Panel, Advisory Board Meeting, Allergan 

Glaucoma Roundtable, Los Angeles, CA, Mar 27, 2009. 

375. Participant, Congressional Advocacy Day, Mid-Year Forum, Washington, DC, Apr 22, 2009. 

376. “Create a Public Health Task Force.” Invited committee member, Clinical Education Leadership Forum, Mid- 

Year Forum Meeting, Washington, DC, Apr 24, 2009. 

377. “Agreement to develop one set of standards for Ophthalmology.” Invited committee member, Clinical 

Education Leadership Meeting, Mid-Year Forum, Washington, DC, Apr 25, 2009. 

378. Invited lecturer, “Speaking with One Voice.” AAO Collaboration with Subspecialty Societies, Mid-Year Forum, 

Washington, DC, Apr 25, 2009. 

379. World Glaucoma Association, Member for Information and Planning Exchange Meeting, Ft. Lauderdale, FL, 

May 3, 2009. 

380. “Overcoming Barriers to a Career in Academic Glaucoma.” Program Chair, American Glaucoma Society 

Meeting, Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 3, 2009. 

381. “Paper Discussion: Comparative Outcomes Between Newer and Older Surgeries for Glaucoma.” Invited 

discussant, Scientific Program, The American Ophthalmological Society Meeting, Half Moon Bay, CA, May 

14, 2009. 

382. “State of the Art of Quality Measurement.” Federal Affairs and Quality of Care Secretariats, Board of Trustees 

Strategic Retreat, American Academy of Ophthalmology, West Point, NY, Jun 5, 2009. 

383. “Ophthalmology and Public Health.” Invited lecturer, Pearls and Pitfalls in Patient Care Ophthalmology 

Conference 2009, West Virginia Academy of Ophthalmology and Kentucky Academy of Eye Physicians and 

Surgeons, Hot Springs, VA, Jun 12, 2009. 

384. “What are the Risk Factors for Glaucoma?” Invited lecturer, Pearls and Pitfalls in Patient Care Ophthalmology 

Conference 2009, West Virginia Academy of Ophthalmology and Kentucky Academy of Eye Physicians and 

Surgeons, Hot Springs, VA, Jun 12, 2009. 

385. “Is Blood Pressure Important in the Management of Glaucoma Patients.” Invited lecturer, Pearls and Pitfalls in 

Patient Care Ophthalmology Conference 2009, West Virginia Academy of Ophthalmology and Kentucky 

Academy of Eye Physicians and Surgeons, Hot Springs, VA, Jun 12, 2009. 

386. “Is Intraocular Pressure Fluctuation Important in the Management of Glaucoma?” Invited lecturer, Pearls and 

Pitfalls in Patient Care Ophthalmology Conference 2009, West Virginia Academy of Ophthalmology and 

Kentucky Academy of Eye Physicians and Surgeons, Hot Springs, VA, Jun 1, 2009. 

387. “What are the Risk Factors for Blindness from Glaucoma?” Invited lecturer, Pearls and Pitfalls in Patient Care 

Ophthalmology Conference 2009, West Virginia Academy of Ophthalmology and Kentucky Academy of Eye 

Physicians and Surgeons, Hot Springs, VA. Jun 13, 2009. 

388. ”Public Health and Ophthalmology.” Invited Lecturer, The Peter C. Kronfeld, MD Memorial Lecture, 33 rd 

Annual Alumni Day, University of Illinois Eye and Ear Infirmary, UIC Department of Ophthalmology and Visual 

Sciences, Chicago, IL, Jun 19, 2009. 

389. Co-Chair, Clinical Trials and Evidence-Based Glaucoma, World Glaucoma Congress and the International 

Glaucoma Symposium, Boston, MA, Jul 9, 2009. 

390. Co-Chair, Didactic Morning Session 6: Clinical Use of Risk Factor Information, World Glaucoma Congress 

and the International Glaucoma Symposium, Boston, MA, Jul 9, 2009. 

391. “Quality of Life and Glaucoma..” Invited lecturer, World Glaucoma Congress and the International Glaucoma 

Symposium, Boston, MA, Jul 9, 2009. 

392. Invited participant, Eye Health Coalition Summit, The Vision Council Eye Health Summit, Chicago, IL, Jul 21, 

2009. 

393. “Public Health and Ophthalmology.” Invited lecturer, The Bernice Brown Memorial Lectureship, Women in 

Ophthalmology Summer Symposium, San Diego, CA, Aug 6, 2009. 



ALC100325 


394. Data Monitoring and Oversight Committee Member, 1 st Annual Meeting of the Chinese-American Eye Study, 

Keck School of Medicine, University of Southern California, Los Angeles, CA, Aug 21, 2009. 

395. Committee Member and Secretary for Quality of Care, Preferred Practice Patterns Meeting, American 

Academy of Ophthalmology, Washington, DC, Sep 25-27, 2009. 

396. “Disease and Medical Treatments.” Invited speaker, The Discovery Eye Foundation–Los Angeles Vision 

Symposium/ Patient Education Seminar, Los Angeles, CA, Oct 11, 2009. 

397. “What are Some Clinically Meaningful Challenges in this Field?” Invited lecturer, National Eye Institute/Food 

and Drug Administration (NEI/FDA) Endpoints Symposium: Use of Patient-Reported Outcomes in Medical 

Product Development Symposium, Bethesda, MD, Oct 13, 2009. 

398. “From Bench to Chairside.” Invited lecturer, University of California, San Francisco, 2009 Glaucoma Summit 

Research, San Francisco, CA, Oct 23, 2009. 

399. “What’s New, What’s True?” Invited lecturer, Clinical Pearls from Clinical Trials, 2009 Annual Meeting, 

American Academy of Ophthalmology, San Francisco, CA, Oct 24, 2009. 

400. “Implantation of Glaucoma Drainage Devices.” Instructor, 2009 Annual Meeting, American Academy of 


401. “AAO Assistance Program.” Symposia presenter, Eye Care America 2009 Annual Meeting, American 


402. Symposium discussant for presentation, “Five-Year Follow-up Optic Disc Findings of the Collaborative Initial 

Glaucoma Treatment Study.” the Editors’ Choices Symposium, 2009 Annual Meeting of the American 


403. “Epidemiology of Glaucoma: A Global Perspective.” Invited lecturer, Department of Ophthalmology Grand 

Rounds Presentation, The Rocky Mountain Lions Eye Institute, University of Colorado, Denver, CO, Dec 18, 

2009. 

404. “Current Annual Estimates of Glaucoma Surgery in the United States.” Invited lecturer, American Glaucoma 

Society 2010 Annual Meeting, Ft. Myers, FL, Mar 4, 2010. 



ALC100325 


PUBLICATIONS & RELATED ACTIVITIES 

EDITORIAL SERVICE 

EDITORIAL BOARDS 

2009–11 International Glaucoma Review Editorial Board, Member 


2006– Journal of Glaucoma, Editorial Board, Member 


2002– American Journal of Ophthalmology Editorial Board, 

Executive Editor for Glaucoma 

2002–07 US Chinese Journal of Ophthalmology Editorial Board, Member 

1999–00 Eye Net Audio Editorial Board, Member 

REVIEWER 

2001– Journal of American Geriatrics Society, Reviewer 

2000–07 Eye Net Magazine Advisory Board, Member 

2000– British Journal of Ophthalmology, Reviewer 

1999– The Lancet, Reviewer 

1998– Ophthalmic Epidemiology, Reviewer 

1996– Current Eye Research, Reviewer 

1996– Ophthalmic Lasers and Surgery, Reviewer 

1995– Ophthalmology, Reviewer 

1995– Journal of Glaucoma, Reviewer 

1993– Investigative Ophthalmology and Visual Science, Reviewer 

1993– American Journal of Ophthalmology, Reviewer 

1993– Journal of Cataract and Refractive Surgery, Reviewer 

1988– Archives of Ophthalmology, Reviewer 



ALC100325 

RESEARCH PAPERS 


A. RESEARCH PAPERS (PEER-REVIEWED JOURNALS) 

1. Weinreb RN, Dreher AW, Coleman AL, Quigley HA. Histopathological validation of fourier-ellipsometry 

measurements of retinal nerve fiber layer thickness. Arch Ophthalmol. 1990;108:557-560. 

2. Coleman AL, Diehl DL, Jampel HD, Bachorik PS, Quigley HA. Topical timolol decreases plasma high-density 

lipoprotein cholesterol level. Arch Ophthalmol. 1990;108:1260-1263. 

3. Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR. Cardiovascular and intraocular 

pressure effects and plasma concentrations of apraclonidine. Arch Ophthalmol. 1990;108:1264-1267. 

4. Robin AL, Coleman AL. Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a 

comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate. Trans Am 

Ophthalmol Soc. 1990;88:149-162. 

5. Coleman AL, Quigley HA, Vitale S, Dunkelberger G. Displacement of the optic nerve head by acute changes 

in intraocular pressure in monkey eyes. Ophthalmology. 1991;98:35-40. 

6. Quigley HA, Coleman AL, Dorman-Pease ME. Larger optic nerve heads have more nerve fibers in normal 

monkey eyes. Arch Ophthalmol. 1991;109:1441-1443. 

7. Coleman AL, Jampel HD, Javitt JC, Quigley HA. Transscleral cyclophotocoagulation of human autopsy and 

monkey eyes. Ophthalmic Surg. 1991;22:638-643. 

8. Derick RJ, Robin AL, Tielsch J, Wexler JL, Kelley EP, Stoecker JF, Novack GD, Coleman AL. Once-daily 

versus twice-daily levobunolol (0.5%) therapy: A crossover study. Ophthalmology. 1992;99:424-429. 

9. Diehl DH, Coleman AL, Jampel HD, Quigley HA, Bachorick PS. Topical timolol and serum lipoproteins. 

Br J Ophthalmol. 1992;76:191-192. 

10. Barnebey HS, Robin AL, Zimmerman TJ, Morrison JC, Hersh SB, Lewis RA, Coleman AL, Cinotti DJ, Walt J, 

Chen KS, et al. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser 

trabeculoplasty. Ophthalmology. 1993;100:1083-1088. 

11. Tielsch JM, Javitt JC, Coleman A, Katz J, Sommer A. The prevalence of blindness and visual impairment 

among nursing home residents in Baltimore.The Baltimore Nursing Home Eye Survey. N Engl J Med. 

1995;332:1205-1209. 

12. The Brimonidine-ALT Study Group (Robin AL, David R, Shani L, Barneby H, Clevenger CE, Zimmerman TJ, 

Nardin G, Hersh SB, Morrison JC, Spaeth GL, Katz LJ, Perell HF, Siegel LO, Lewis RA,Henry JC, 

Coleman AL, Lee DA, Stiles MC, Passo MC, Cinotti DJ, Stamper RL, Yaldo MK, Kelley EP, Walt JG, 

Chen K). Effect of brimonidine 0.5% on intraocular pressure spikes following 360° argon laser 

trabeculoplasty. Ophthalmic Surg Lasers. 1995;26:404-409. 

13. Coleman AL, Hill R, Wilson MR, Choplin N, Kotas-Neumann R, Tam M, Bacharach J, Panek WC. Initial 

clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1995;120:23-31. 

14. Coleman AL, Greenland S. Glaucoma outcome studies using existing databases: opportunities and 

limitations. J Glaucoma. 1995;4:295-298. 

15. Coleman AL. Glaucoma screening; a golden opportunity [Editorial]. Am Fam Physician. 1995;52:2167-2173. 

16. Coleman AL, Sommer A, Enger C, Knopf HL, Stamper RL, Minckler DS. Interobserver and intraobserver 

variability in the detection of glaucomatous progression of the optic disc. J Glaucoma. 1996;5:384-389. 

17. Coleman AL, Haller JA, Quigley HA. Determination of the real size of fundus objects from fundus 

photographs. J Glaucoma. 1996;5:433-435. 

18. Coleman AL, Mondino B, Wilson MR, Casey R. Clinical experience with the Ahmed Glaucoma Valve implant 

in eyes with prior or concurrent penetrating keratoplasties. Am J Ophthalmol.1997; 123:54-61. 

19. Coleman AL, Smyth-Medina R, Tam M, Wilson MR. Initial clinical experience with the Ahmed Glaucoma 

Valve implant in pediatric patients. Arch Ophthalmol. 1997;115:186-191. 

20. Coleman AL, Morgenstern H. Use of insurance claims databases to evaluate the outcomes of ophthalmic 

surgery. Surv Ophthalmol. 1997;42:271-278. 



ALC100325 


21. Coleman AL, Yu F, Greenland S. Annual predictions of adverse outcomes after glaucoma surgery in the 

United States. Ophthalmic Epidemiol. 1998;5:29-40. 

22. Coleman AL, Yu F, Greenland S. Factors associated with elevated complication rates after partial-thickness 

or full-thickness glaucoma surgical procedures in the United States during 1994. Ophthalmology. 

1998;105:1165-1169. 

23. Wilson MR, Coleman AL, Yu F, Bing EG , Sasaki IF, Berlin K, Winter J, Lai A. Functional status and wellbeing 

in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. 

Ophthalmology. 1998;105:2112-2116. 

24. Topouzis F, Yu F, Coleman AL. Factors associated with elevated rates of adverse outcomes after 

cyclodestructive procedures versus drainage device procedures. Ophthalmology. 1998;105:2276-2281. 

25. Huang MC, Netland PA, Coleman AL, Seigner S, Moster MR, Hill RA. Intermediate-term clinical experience 

with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1999;127:27-33. 

26. Topouzis F, Peng F, Kotas-Neumann R, Garcia R, Sanguinet J, Yu F, Coleman AL. Longitudinal changes in 

optic disc topography of adult patients after trabeculectomy. Ophthalmology. 1999;106:1147-1151. 

27. Topouzis F, Coleman AL, Choplin N, Beltham, Hill R, Yu F, Panek WC, Wilson MR. Follow-up of the original 

cohort with the Ahmed Glaucoma Valve implant. Am J Ophthalmol.1999;128:198-204. 

28. Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 

1999;117:573-583. 

29. Coleman AL. Glaucoma. Lancet. 1999;354:1803-1810. 

30. Hamush N, Coleman AL, Wilson MR. Ahmed glaucoma valve implant for management of glaucoma in 

Sturge-Weber syndrome. Am J Ophthalmol. 1999;128:758-760. 

31. Devgan U, Yu F, Kim E, Coleman AL. Surgical undertreatment of glaucoma in black beneficiaries of 

Medicare. Arch Ophthalmol. 2000;118(2): 253-256. 

32. Keltner JL, Johnson CA, Quigg J, Cello K, Kass MA, Gordon MO, Spurr JO; Ocular Hypertension 

Treatment Study Group. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment 

Study (OHTS). Arch Ophthalmol. 2000;118:1187-1194. 

33. Law S, Coleman AL. Following the progress of patients with glaucoma. Compr Ophthalmol Update. 

2000;1:31-39. 

34. Piltz K, Gross R, Shin DH, Beiser JA, Dorr DA, Kass MA, Gordon MO; Ocular Hypertension Treatment 

Study (OHTS) Group. Contralateral effect of topical β-adrenergic antagonists in initial one-eyed trials in the 

Ocular Hypertension Treatment Study. Am J Ophthalmol. 2000;130: 441-453. 

35. Jatuthong O, Hoffman D, Garway-Heath DF, Coleman AL, Zeyen TG, Caprioli J. Detection of progressive 

glaucomatous damage with confocal scanning ophthalmoscopy. Invest Ophthalmol Vis Sci. 

2000;41(suppl):90, 2000. 

36. Ladas JG, Yu F, Loo R, Davis JL, Coleman AL, Levinson RD, Holland GN. Relationship between aqueous 

humor protein level and outflow facility in patients with uveitis. Invest Ophthalmol Vis Sci. 2001;42:2584-2588. 

37. Coleman AL, Brigatti L. The glaucomas. Minerva Med. 2001;92:365-379. 

38. Coleman AL. Advantages of drainage device implantation. Surv Ophthalmol. 2001;46:280-282. 

39. Brandt KD, Beiser JA, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group. Central 

corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108:1779- 

1788. 

40. Schultz JS, Slamovits TL, Rockwood EJ, Coleman AL. Surgical management of glaucoma associated with 

pseudophakia. Surv Ophthalmol. 2001;46:275-282. 

41. Greaney MJ, Hoffman DC , Garway-Heath DF, Nakla M, Coleman AL, Caprioli J. Comparison of optic nerve 

imaging methods to distinguish normal eyes from those with glaucoma. Invest Ophthalmol Vis Sci. 

2002;43:140-145. 

42. Feuer WJ, Parrish RK, Schiffman JC, et al.; Ocular Hypertension Treatment Study Group. The Ocular 

Hypertension Treatment Study: Reproducibility of cup/disc ratio measurements over time at an Optic Disc 

Reading Center. Am J Ophthalmol. 2002;133:19-28. 



ALC100325 


43. Johnson CA, Keltner JL, Cello KE, Kass MA, Gordon MO, Budenz DL, Gaasterland DE, Werner E; Ocular 

Hypertension Treatment Study Group. Baseline visual field characteristics in the Ocular Hypertension 

Treatment Study. Ophthalmology. 2002;109:432-437. 

44. Wilson MR, Coleman AL, Yu F, Sasaki IF, Bing EG, Kim MH. Depression in patients with glaucoma as 

measured by self-report surveys. Ophthalmology. 2002;109:1018-1022. 

45. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician 

services in the Medicare population from 1995 to 1998. Ophthalmology. 2002;109:1372-1376. 

46. Parwar BL, Coleman AL, Small KW. Silicone oil migration through an Ahmed valve. Retina. 2002;22:657- 

658. 

47. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, 

Parrish RK II, Wilson MR, Kass MA; Ocular Hypertension Treatment Study Group. The Ocular 

Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. 

Arch Ophthalmol. 2002;120:714-720. 

48. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson MR, 

Gordon MO; Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: 

a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of 

primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713. 

49. Keltner JL, Johnson CA, Cello KE, Edwards MA, Bandermann SE, Kass MA, Gordon MO; Ocular 

Hypertension Treatment Study Group. Classification of visual field abnormalities in the Ocular 

Hypertension Treatment Study. Arch Ophthalmol. 2003;121(5):643-650. 

50. Coleman AL, Lerner F, Bernstein P, Whitcup SM; Lumigan/Cosopt Study Group. A 3-month randomized 

controlled trial of bimatoprost (Lumigan) versus combined timolol and dorzolamide (Cosopt) in patients with 

glaucoma or ocular hypertension. Ophthalmology. 2003;110:2362-2368. 

51. Syed HM, Law SK, Nam SH, Li G, Coleman AL, Caprioli J. Baerveldt-350 implant vs. Ahmed valve for 

refractory glaucoma: A case controlled-comparison. J Glaucoma. 2004;13:38-45. 

52. Zangwill LM, Weinreb RN, Berry CC, Smith AR, Direkes KA, Liebmann JM, Brandt JD, Trick G, Cioffi GA, 

Coleman AL, Piltz-Seymour JR, Gordon MO, Kass MA; OHTS CSLO Ancillary Study Group. Racial 

differences in optic disc topography: baseline results from the Confocal Scanning Laser Ophthalmoscopy 

Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2004;122:22-28. 

53. Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA; Ocular 

Hypertension Treatment Study Group. Topical medication delays or prevents primary open-angle 

glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813-820. 

54. Zangwill LM, Weinreb RN, Berry CC, Smith AR, Direkes KA, Liebmann JM, Brandt JD, Trick G, Cioffi GA, 

Coleman AL, Piltz-Seymour JR, Gordon MO, Kass MA; OHTS CSLO Ancillary Study Group. The Confocal 

Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study: study design 

and baseline factors. Am J Ophthalmol. 2004;137:219-227. 

55. Coleman AL, Stone K, Ewing S, Nevitt M, Cummings S, Cauley J, Ensrud K, Harris E, Hochberg M, 

Mangione C; Study of Osteoporotic Fractures Group. Higher risk of multiple falls among elderly women who 

lose visual acuity. Ophthalmology. 2004;111:857-862. 

56. Lee AG, Coleman AL. Research agenda-setting program for geriatric ophthalmology. J Am Geriatr Soc. 

2004;52:453-458. 

57. Topouzis F, Coleman AL, Yu F, Mavroudis L, Anastasopouols E, Koskosas A, Papps T, Dimitrakos S, 

Wilson MR. Sensitivity and specificity of the 76-suprathreshold visual field test to detect eyes with visual field 

defect by Humphrey threshold testing in a population-based setting: the Thessaloniki Eye Study. 

Am J Ophthalmol. 2004;137:420-425. 

58. Golchet P, Yu F, Goldberg R, Coleman AL. Recent trends in upper eyelid blepharoplasties in Medicare 

patients in the United States from 1995-1998. Ophthal Plast Reconstr Surg. 2004;20:190-197. 

59. Law SK, Hoffman D, Sohn YH, Small K, Coleman AL, Caprioli J. Optic disc appearance in advanced agerelated 

macular degeneration. Am J Ophthalmol. 2004;138:38-45, 2004. 



ALC100325 


60. Tranos P, Topouzis F, Dimitrakos S, Economidis P, Stangos NT, Harris M, Coleman AL. Effects of laser 

photocoagulation treatment for diabetic macular edema on patient’s vision-related quality of life. 

Curr Eye Res. 2004;29:41-49. 

61. Weinreb RN, Friedman DS, Fechtner RD, Cioffi GA, Coleman AL, Girkin CA, Liebmann JM, Singh K, 

Wilson MR, Wilson R, Kannel WB. Risk assessment in the management of patients with ocular hypertension. 


62. Coleman AL, Singh K, Wilson R, Cioffi GA, Friedman DS, Weinreb, RN. Applying an evidence-based 

approach to the management of patients with ocular hypertension: evaluating and synthesizing published 

evidence. Am J Ophthalmol. 2004;138:S3-10. 

63. Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli J. Predictive factors for 

glaucomatous visual field progression in Advanced Glaucoma Intervention Study. Ophthalmology. 

2004;111:1627-1635. 

64. Jonescu-Cuypers C, Harris A, Wilson MR, Kagemann L, Mavroudis L, Topouzis F, Coleman AL. 

Reproducibility of the Heidelberg Retinal Flowmeter in determining low perfusion areas in peripapillary retina. 

Br J Ophthalmol. 2004;88:1266-1269. 

65. Coleman AL, Gordon MO, Beiser, JA, Kass MA; for the Ocular Hypertension Treatment Study Group. 

Baseline risk factors for the development of POAG in the Ocular Hypertension Treatment Study. 


66. Brandt JD, Beiser JA, Gordon MO, Kass MA; Ocular Hypertension Treatment Study (OHTS) Group. 

Central corneal thickness and measured IOP response to topical ocular hypotensive medication. 


67. Giaconi JA, Coleman AL, Aldave AJ, Nouri-Mahdavi K. Epithelial downgrowth following surgery for 

congenital glaucoma. Am J Ophthalmol. 2004;138:1075-1077. 

68. Lin MY, Gutierrez PR, Stone KL, Yaffe K, Ensrud KE, Fink HA, Sarkisian CA, Coleman AL, Mangione CM. 

Vision impairment and combined vision and hearing impairment predict cognitive and functional decline 

among older women. J Am Geriatr Soc. 2004;52:1996-2002. 

69. Coleman AL, Gordon MO, Beiser JA, Kass MA and the Ocular Hypertension Treatment Study. A predictive 

model for the development of POAG in the Ocular Hypertension Treatment Study excluding pattern standard 

deviation (PSD) and vertical cup/disc ratio (VC/D). Invest Ophthalmol Vis Sci. 2004;45:E-abstract 955. 

70. Coleman AL, Yu F, Rowe S. Visual field testing in glaucoma Medicare beneficiaries before surgery. 

Ophthalmology. 2005;112:401-406. 

71. Brown AF, Jiang L, Fong DS, Gutierrez PR, Coleman AL, Lee PP, Adams J, Mangione CM. Need for eye 

care among older adults with diabetes in fee-for-service and managed Medicare. Arch Ophthalmol. 

2005;123:669-675. 

72. Nouri-Mahdavi K, Caprioli J, Coleman AL, Hoffman D, Gaasterland D. Pointwise linear regression for 

evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. 

Arch Ophthalmol. 2005;123:193-1999. 

73. Law SK, Nguyen A, Coleman AL, Caprioli J. Comparison of safety and efficacy between silicone and 

polypropylene Ahmed glaucoma valve in refractory glaucoma. Ophthalmology. 2005;112:1514-1520, 2005. 

74. Coleman AL, Mosaed S, Kamal D. Medical therapy in pregnancy. J Glaucoma. 2005;14:414-416, 2005. 

75. Zangwill LM, Weinreb RN, Beiser JA, Berry CC, Cioffi GA, Coleman Al, Trick G, Liebmann JM, Brandt JD, 

Piltz-Seymour JR, Dirkes KA, Vega S, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Confocal 

Scanning Laser Ophthalmoscopy Ancillary Study Group. Baseline topographic measurements are 

associated with the development of primary open angle glaucoma: The Confocal Scanning Laser 

Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol. 

2005;123:1188-1197, 2005. 

76. Lee PP, Walt JG, Doyle JJ, Kotak SV, Evans SJ, Budenz DL, Chen PP, Coleman AL, Feldman RM, 

Jampel HD, Katz LJ, Mills RP, Myers JS, Noecker RJ, Piltz-Seymour JR, Ritch RR, Schacknow PN, Serle JB, 

Trick GL. A multi-center, retrospective pilot study of resource utilization and costs associated with severity of 

disease in glaucoma. Arch Ophthalmol. 2006;124:12-19. 



ALC100325 


77. Paikal D, Yu F, Holland GN, Coleman AL. Coding of glaucoma patients with uveitis in the Medicare 

database. J Glaucoma. 2006;15:13-16. 

78. Coleman AL, Yu F, Keeler E, Mangione CM. Treatment of uncorrected refractive error improves visionspecific 

quality of life. J Am Geriatr Soc. 2006;54:883-890, 2006. 

79. Topouzis F, Coleman AL, Harris A, Jonescu-Cuypers C, Yu F, Mavroudis L, Anastasopoulos E, Pappas T, 

Koskosas A, Wilson MR. Association of blood pressure status with optic disc structure in non-glaucoma 

subjects: the Thessaloniki Eye Study. Am J Ophthalmol. 2006;142:60-67. 

80. Coleman AL, Yu F, Evans SJ. Use of gonioscopy in Medicare beneficiaries prior to glaucoma surgery. 

J Glaucoma. 2006;15:486-493. 

81. Anastasopoulos E, Yu F, Coleman AL. Age-related macular degeneration is associated with an increased 

risk of hip fractures in the Medicare database. Am J Ophthalmol. 2006;142:1081-1083. 

82. Topouzis F, Coleman AL, Harris A, Anastasopoulos E, Yu F, Koskosas A, Pappas T, Mavroudis L, 

Wilson MR. Prevalence of age-related macular degeneration in Greece: the Thessaloniki Eye Study. 


83. Pedula KL, Coleman AL, Hillier TA, Ensrud KE, Nevitt MC, Mangione CM; Study of Osteoporotic Fractures 

Research Group. Visual acuity, contrast sensitivity, and mortality in older women: Study of Osteoporotic 

Fractures. J Am Geriatr Soc. 2006;54:1871-1877. 

84. Coleman AL, Cummings SR, Yu F, Kodjebacheva G, Ensrud KE, Gutierrez P, Stone KL, Cauley JA, Pedula 

KL, Hochberg MC, Mangione CM; Study Group of Osteoporotic Fractures. Binocular visual field loss 

increases the risk of future falls in older white women. J Am Geriatr Soc. 2007;55:357-364. 

85. Seitzman RL, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, Hochberg MC, Hillier TA, 

Yu F, Coleman AL; Study Group of Oseoporotic Fractures. Bone mineral density and age-related 

maculopathy in older women. J Am Geriatr Soc. 2007;55:740-746. 

86. Law SK, Nguyen A, Coleman AL, Caprioli J. Severe loss of central vision in patients with advanced 

glaucoma undergoing trabeculectomy. Arch Ophthalmol. 2007;125:1044-1050. 

87. Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Mavroudis L, Pappas T, Koskosas A, 

Coleman AL. Prevalence of open angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmol. 

2007;144(4):511-519. 

88. Jung S, Coleman AL, Weintraub N. Vision screening in the elderly. J Am Med Dir Assoc. 2007;8:355-362. 

89. Mavroudis L, Harris A, Topouzis F, Wilson MR, Yu F, Anastasopoulos E, Koskosas A, Siesky B, Pappas T, 

Coleman AL. Reproducibility of pixel by pixel analysis of Heidelberg retinal flowmetry (HRF) images: the 

Thessaloniki Eye Study [published online ahead of print Sep 2007]. Acta Ophthalmologica. 2008;86(1)81-86. 

90. Souza C, Tran D, Loman J, Law SK, Coleman AL, Caprioli J. Long term outcomes of glaucoma valve 

implantation in refractory glaucomas [published online Oct 2007] Am J Ophthalmol. 2007;144(6):893-900. 

91. Coleman AL. Sources of binocular suprathreshold visual field loss in a cohort of older women being followed 

for risk of falls [American Ophthalmological Society Thesis]. Trans Am Ophthalmol Soc. 2007;105:312-329. 

92. Spaeth G, Coleman AL. Risk factors and glaucoma: Are we looking at the right things? A Critical Re- 

Evaluation of Current Glaucoma Management, International Glaucoma Think Tank Meeting; Taormina, Sicily, 

Italy, Jul 27-29, 2006. Ophthalmology. 2007;114(11)(suppl):25-31. 

93. Coleman AL, Yu F. Eye-related Medicare costs for patients with age-related macular degeneration from 

1995 to 1999 [published online ahead of print Jun 2007]. Ophthalmology. 2008;115(1):18-25. 

94. Caprioli J, Coleman AL. Intraocular pressure fluctuation is a risk factor for visual field progression in patients 

with low mean intraocular pressures in the Advanced Glaucoma Intervention Study [published online ahead 

of print Feb 20, 2008]. Ophthalmology. 2008;115(7):1123-1129. 


Coleman AL. Factors associated with undiagnosed open angle glaucoma in Greece: The Thessaloniki Eye 

Study [published online ahead of print Nov 2007]. Am J Ophthalmol. 2008;145(2):327-335. 

96. Roizen A, Ela-Dalman N, Velez FG, Coleman AL, Rosenbaum A. Surgical treatment of strabismus surgery 

secondary to glaucoma drainage implant. Arch Ophthalmol. 2008;126(4);480-486. 



ALC100325 


97. Seitzman RL, Mahajan VB, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, Hochberg MC, 

Hiller TA, Sinsheimer JS, Yu F, Coleman AL; Study of Osteoporotic Fractures Research Group. Estrogen 

receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy (ARM) in older 

women [published online ahead of print March 2008]. Am. J. Epidemiol. 2008;167(10):1217-1225. 

98. Coleman AL, Stone KL, Kodjebacheva G, Yu F, Pedula KL, Ensrud KE, Cauley JA, Hochberg MC, 

Topouzis F, Badala F, Mangione CM; Study of Osteoporotic Fractures Group. Glaucoma risk and the 

consumption of fruits and vegetables among older women in The Study of Osteoporotic Fractures [published 

online ahead of print Feb 2008]. Am J Ophthalmol. 2008;145(6):1081-1089. doi:10.1016/j.ajo.2008.01.022. 

99. Wilson MR, Lee PP, Weinreb RN, Lee BL, Singh K; Coleman AL. Glaucoma modified Rand-like 

methodology for consensus in ophthalmology. Part I: Methodology and design. Am J Ophthalmol. 

2008;145:570-574. 

100. Singh K, Lee BL, Wilson MR; Glaucoma Modified Rand-Like Methodology Group (Coleman AL). 

A panel assessment of glaucoma management: Modification of existing Rand-like methodology for 

consensus in ophthalmology. Part II: Results and interpretation [published online ahead of print Jan 2008]. 

Am J Ophthalmol. 2008;145(3):575-581. 

101. Coleman AL, Kodjebacheva G, Wallace SP, Prelip M, Ortega AN, Giaconi, J, Yu F, Afifi A. Visual functioning 

of individuals and communities: a conceptual framework. Clinical Med Geriatrics. 2008;2:13-20. 

102. Seitzman RL, Mangione CM, Ensrud KE, Cauley JA, Stone KL, Cummings SR, Hochberg MC, Hillier TA, 

Yu F, Coleman AL; Study of Osteoporotic Fractures Research Group. Postmenopausal hormone therapy 

and age-related maculopathy in older women. Ophthalmic Epidemiol. 2008;15(5);308-316. 

103. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 

2008;53(Suppl 1):S3-S10. 

104. Davis K, Stolldorf H, Coleman AL. Posterior-segment considerations in glaucoma patients undergoing 

cataract surgery. Retinal Physician. 2009;March. 

http://www.retinalphysician.com/article.aspx?article=102697. 

105. Topouzis F, Harris A, Wilson MR, Koskosas A, Founti P, Yu F, Anastasopoulos E, Pappas T, Coleman AL. 

Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with 

pseudoexfoliation: the Thessaloniki Eye Study [published online ahead of print May 11, 2009]. 

Am J Ophthalmol. 2009;148(4)606-613.e1. doi:10.1016/j.ajo.2009.03.024. 

106. Coleman AL, Cummings SR, Ensrud KE, Yu F, Gutierrez P, Stone KL, Cauley JA, Pedula KL, Hochberg MC, 

Mangione CM. Visual field loss and risk of fractures in older women. J Am Geriatric Soc. 2009;57(10):1825- 

1832. 

107. Coleman AL, Kodjebacheva G. Risk factors for glaucoma needing more attention. Open Ophthalmol J. 

2009;3:38-42. 

108. Law SK, Shih K, Tran DH, Coleman AL, Caprioli J. Long-term outcomes of repeat vs initial trabeculectomy in 

open-angle glaucoma. published online Jul 13, 2009. Am J Ophthalmol. 2009;148(5)685-695.e1. 

doi:10.1016/j.ajo.2009.05.032. 

109. Griffin BA, Elliot MN, Coleman AL, Cheng EM. Incorporating mortality risk into estimates of 5-year glaucoma 

risk. Am J Ophthalmol. 2009;148(6)925-931.e7. doi:10.1016/j.ajo.2009.07.010. 

110. Coleman AL, Seitzman, RL, Cummings SlR, Yu F, Cauley JA, Ensrud KE, Stone KL, Hochberg MC, 

Pedula KL, Thomas EL, Mangione CM; The Study of Osteoporotic Fractures Research Group. 

The association of smoking and alcohol use with age-related macular degeneration in the oldest old: 

The Study of Osteoporotic Fractures.[published online ahead of print Oct 1, 2009]. Am J Ophthalmol. 

2010;149(1):160-169. doi:10.1016/j.ajo.2009.07.025. 

111. Cheng EM, Giaconi JA, Coleman AL, Lee BL, Weinreb RN, Newberry SJ, Suttorp MJ, Schonlau M, Fingeret 

M, Gupta N, Hitchings RA, Jampel HD, Lewis TL, Miglior S, Mills RP, Topouzis F, Samuelson TW; the 

Appropriateness of Treating Glaucoma Suspects RAND Study Group. For Which Glaucoma Suspects is it 

Appropriate to Initiate Treatment? Ophthalmology 2009;116:710-716. 



ALC100325 


B. RESEARCH PAPERS – PEER REVIEWED (in press) 

1. Kodjebacheva G, Coleman AL, Ensrud KE, Cauley JA, Yu F, Stone KL, Pedula KL, Hochberg MC, 

Mangione CM; The Study Of Osteoporotic Fractures Research Group. Reliability and validity of abbreviated 

surveys derived from the National Eye Institute Visual Function Questionnaire: The Study of Osteoporotic 

Fractures. Am J Ophthalmol. in press. 

2. Topouzis F, Coleman AL, Harris A, Koskosas A, Founti P, Gong G, Yu F, Anastasopoulos E, Pappas T, 

Wilson MR. Characteristics of pseudoexfoliation in the Thessaloniki Eye Study. J Glaucoma. 

C. RESEARCH PAPERS – PEER REVIEWED (submitted) 

1. Spalding JR, Coleman AL, Yu F, Globe D. Prevalence of fractures and depression and their association with 

blindness in a Medicare population with primary open-angle glaucoma: an examination of blindness-related 

comorbidities and their costs. submitted to Ophthalmic Epidemiol,. 

2. Baum CM, Perlmutter M, Bhorade A, Gordon M, Hollingsworth H, Coleman AL, Kass M. The role of vision in 

cognition, hearing, and depression in activity participation in community residing older adults. submitted to 

Gerontologist,. 

3. Law SK, Coleman AL, Caprioli J. Dynamic tube movement of Ahmed glaucoma valve. submitted to 

J Glaucoma. 

4. Coleman AL, Yu F, Ensrud KE, Stone KL, Cauley JA, Pedula KL, Hochberg MC, Mangione CM, Impact of 

age-related macular degeneration on quality of life: Follow-up from the 10-year and 15-year visits. submitted 

to Am J Ophthalmol. 

5. Griffin BA, Elliott MN, Coleman AL, Cheng EM. Incorporating Mortality Risk into Estimates of Five-year 

Glaucoma Risk. submitted to Am J Ophthalmol. 

D. RESEARCH PAPERS – NON-PEER REVIEWED 

1. Coleman AL, Gross RL, Lee PP. Expert opinions in glaucoma: a focus on monotherapy. Annenberg Center 

for Health Sciences at Eisenhower. Rancho Mirage CA, Apr 2003. 

2. Coleman AL. Pearls from the Ocular Hypertension Treatment Study. Review of Ophthalmology. 

Mar 2007(Epub). 

3. Coleman AL. Primary angle-closure glaucoma. Medscape Online. Jul 6, 2007. 

4. Cheng, EM, Newberry SJ, Coleman AL, Giaconi JA, Lee BL, Hilton L, Griffin BA, Elliott M, Suttorp MJ, 

Schonlau M, Zhou A, Carter J, Johnse B, Chen S, Smith P, Tringale C. Advancing Risk Assessment for 

Glaucoma. Review of the Literature and Findings of an Appropriateness Panel, PM 3220. Pfizer. Dec 2008. 



ALC100325 

LETTERS TO THE EDITOR 


1. Coleman AL, Diehl DL, Jampel HD, Bachorik PS, Quigley HA. [Reply to letters to editor regarding: Topical 

timolol maleate decreases plasma high-density lipoprotein cholesterol]. Arch Ophthalmol.1991;109:1342. 

2. Diehl DL, Coleman AL, Jampel HD, Quigley HA, Bachorik PS. [Letter to editor regarding: Topical timolol and 

serum lipoproteins]. Br J Ophthalmol. 1992;76:191-192. 

3. Coleman AL. [Reply to letter to editor regarding: Glaucoma screening: a golden opportunity]. Am Fam Phys. 

1996;54:1211-1212. 

4. Topouzis F, Coleman AL. [Reply to letter to editor regarding: Longitudinal changes in optic disc topography 

of adult patients after trabeculectomy]. Ophthalmology. 2000;107:407. 


Coleman AL. [Reply to letter to editor regarding: Prevalence of pseudoexfoliation in Malay population in 

Singapore]. Am J Ophthalmol. 2008;145(4):766. 

6. Caprioli J, Coleman AL. [Letter to the editor regarding: Intraocular pressure fluctuation]. Ophthalmology. 

2009;116(4):817. 

EDITORIALS 

1. Coleman AL. Applying evidence-based medicine to ophthalmic practice. Am J Ophthalmol 2002;134:599- 

601. 

2. Coleman AL. Gathering evidence from claims data: caveats. Ophthalmology. 2007;114:1597-1598. 

3. Coleman AL. Glaucoma-a diagnostic dilemma. Ophthalmology Times. September 2007;32(17). 

4. Coleman AL, Caprioli J. The logic behind target intraocular pressure. Am J Ophthalmol. 2009;147(3):379- 

380. 

5. Coleman AL. The role of statistics in ophthalmology [published online May 20 2008; first in editorial series]. 

Am J Ophthalmol. 2009;147(3):387-388. doi:10.1016/j.ajo.2008.04.026. 



ALC100325 

BOOK CHAPTERS 

CHAPTERS PUBLISHED 


1. Coleman AL, Robin AL, Pollack IP. Apraclonidine hydrochloride. In: Zimmerman TJ, Kooner KS, 

eds.Ophthalmology Clinics of North America. Philadelphia, PA: WB Saunders Co; 1989:97-108. 

2. Coleman AL. Topical carbonic anhydrase inhibitors. In: Schachat AP, ed. Current Practice in Ophthalmology. 

St Louis, MO: Mosby Year Book; 1992:241-248. 

3. Coleman AL, Morrison JC. Pitfalls and pearls in the evaluation of the optic nerve head. In: Higginbotham EJ, 

Lee DA, eds. Management of Difficult Glaucomas: A Clinician's Guide. Cambridge, MA: Blackwell Scientific 

Publications; 1994:41-49. 

4. Coleman AL, Tam M. Levobunolol hydrochloride. In: Dollery DT, ed. Therapeutic Drugs. 2 nd ed. 

Edinburgh, UK: Churchill Livingstone; 1995:L29-L34. 

5. Coleman AL. Aqueous shunts. In: Choplin N, Lundy D, eds. Atlas of Glaucoma. London, UK: 

Martin Dunitz Ltd; 1998:259-276. 

6. Coleman AL, Wilson MR. Risk factor assessment and glaucoma screening. In: Liebmann J, ed. 

Glaucoma, Clinics of North America. Philadelphia, PA: WB Saunders Co; 2000:349-359. 

7. Coleman AL. Practice of ophthalmology. In: Fong DS, Malden MA, eds. Efficient Eye Care: Manual of 

Managed Care Ophthalmology. Blackwell Science; 2001:93-96. 

8. Coleman AL, Sarraf D. Visual impairment. In: American Geriatrics Society, ed. Geriatrics Review Syllabus. 

5 th ed. Malden, MA: Blackwell Publishing; 2002:176-180. 

9. Coleman AL. Epidemiology of glaucoma.In: Morrison J, Pollack IP, eds. Glaucoma: Science and Practice. 

New York, NY: Thieme Medical Publishers Inc; 2002:2-11. 

10. Coleman AL. Morrison JC. Evaluation of the optic nerve head. In: Higginbotham E, Lee DA, eds. 

Clinical Guide to Glaucoma. Woburn, MA: Butterworth-Heinemann; 2002:5-10. 

11. Brigatti L, Coleman AL. Retina and optic nerve head tomography. In: Ciulla TA, Regillo CD, Harris A, eds. 

Retinal and Optic Nerve Imaging. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:85-104. 

12. Coleman AL, Friedman D, Gandolfi S, Singh K, Tuulonen A. Level of evidence of diagnostic studies. In: 

Weinreb RN, Greve EL, eds. Glaucoma Diagnosis,Structure and Function. The Hague, Netherlands: 

Kugler Publications; 2004:9-12. 

13. Coleman AL. Evidence-based recommendations for glaucoma management. In: Physicians’ Desk 

Reference(suppl). Montvale, NJ: Thomson PDR; 2004:1-11. 

14. Baerveldt G, Bournias TE, Cantor LB, Coleman AL, Craven ER, Dirks MS, DuBiner HB, Gross RL, 

Higginbotham EJ, Katz LJ, Noecker RJ, Samuelson TW, Schuman JS, Severin TD, Sherwood MB, 

Simmons ST, Solish AM, Doyle JJ, Lebovics G, Rosenblatt L, Cisciano J (Coleman AL, corresponding 

author). Evidence-based management of glaucoma: recommendations of an expert panel. In: 

Glaucoma Disease Management Guide; Montvale, NJ: Thomson PDR; 2004:201-215. 

15. Lee AG, Coleman AL. Research agenda setting program for geriatric ophthalmology. In: 

LoCicero J, Rosenthal RA, Solomon DH, eds. New Frontiers in Geriatrics Research: An Agenda for Surgical 

and Related Medical Specialties. New York, NY: American Geriatrics Society; 2004:177-202. 

16. Coleman AL. Does every millimeter of mercury count? In: Proceedings of the Seventh Annual Ocular Drug 

& Surgical Therapy Update Meeting. Thoroughfare, NJ: Slack; 2004:9-10. 

17. Coleman AL, Davis K. Trabeculectomy with mitomycin-C. In: Dunn JP, Langer P, eds. Basic Skills in 

Ophthalmic Surgery [monograph]. San Francisco, CA: American Academy of Ophthalmology; 2005. 

18. Coleman AL, Singh K. Aqueous shunting procedures with glaucoma drainage devices. In: Weinreb RN, 

Crowston JG, eds. Glaucoma Surgery. Open Angle Glaucoma. The Hague, Netherlands: Kugler 

Publications/SPB Academic Publishing; 2005:73-81. 



ALC100325 


19. Coleman AL. Ocular Disorders. In: Beers MH, Jones TV, eds. Merck Manual of Geriatrics. 

http://www.merck.com/mrkshared/mmg/sec15/ch127/ch127a.jsp. Updated May 2006. 

20. Coleman AL, Tielsch J, Maguire M, Varma R, Mills R, Lee PP. Using statistics in practice and work. In: 

BCSC Section 1: Update on General Medicine. San Francisco, CA: American Academy of Ophthalmology; 

2006. 

21. Lumba JD, Coleman AL. Glaucoma surgery suturing techniques. In: Macsai M, ed. Ophthalmic Microsurgical 

Suturing Techniques. Berlin, Germany: Springer-Verlag; 2007:101-106. 

22. Farzad S, Sarraf D, Coleman AL. Visual impairment in the elderly. In: Rosenthal T, Naughton B, Williams M, 

eds. Office Care Geriatrics. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:121-133. 

23. Coleman AL, Giaconi JA. Aqueous shunts. In: Choplin NT, Lundy DC, eds. Atlas of Glaucoma. 2 nd ed. 

London, UK: Informa Healthcare; 2007:297-312. 

24. Coleman AL, Sarraf D. Visual impairment. In: Auerhauhn C, Capezuti L, Flaherty E, Resnick B, eds. 

Geriatric Nursing Review Syllabus: A Core Curriculum in Advanced Practice Geriatric Nursing. 2 nd ed. 

New York, NY: American Geriatrics Society; 2007. 

25. Giangiacomo A. Coleman AL. The epidemiology of glaucoma. In: Grehn F, Stamper R, eds. Glaucoma 

Essentials. Newark, NJ: Springer; 2007. 

26. Coleman AL, Pasquale L, Girkin C, Bourne R, Iwase A. Epidemiology of intraocular pressure. In: 

Weinreb RN, Brandt D, Garway-Heath D, Medeiros FA, eds. Intraocular Pressure: Reports and Consensus 

Statements of the 4 th Global AIGS Consensus Meeting on Intraocular Pressure. The Hague, Netherlands: 

Kugler Publications; 2007:79-101. 

27. Coleman AL, Mansberger SL, Wilson MR. Epidemiology of primary open angle glaucoma. In: Albert DM, 

Miller JW, eds. Albert & Jakobiec’s Principles and Practices of Ophthalmology. 3 rd ed. Philadelphia, PA: 

Elsevier Inc; 2008:395-402. 

28. Coleman,AL. Randomized clinical trials: Keys to evidence-based management of glaucoma. In: 

Migdal C, Cioffi G, Goldberg I, eds. Glaucoma Topics and Trends. 2008;Q1(9)1-4. 

http://cme.ufl.edu/education/self-study/uf-self-study/glaucoma-topics-and-trends-series/ 

29. Coleman AL, Giaconi JA. Evidence-based medicine in glaucoma. In: Focal Points, XXVI. San Francisco, CA: 

American Academy of Ophthalmology; 2008. 

30. Coleman AL, Giangiacomo A. When is glaucoma surgery indicated? In: Heuer DK, Gedde SJ, Lewis R, eds. 

Curbside Consultation on Glaucoma. Thorofare, NJ: Slack Inc; 2008:173-175. 

31. Weinreb RN, Coleman AL. Assessment of clinical studies of glaucoma neuroprotection. In: Shaarawy TM, 

Sherwood MB, Hitchings RA, Crowston JG, eds. Medical Diagnosis and Therapy. Philadelphia, PA: 

Saunders; 2009. Glaucoma–Expert Consult Series; vol 1, chap 53. 

CHAPTERS (IN PRESS) 

1. Giaconi J, Coleman AL, Sarraf D. Visual Impairment. In: Auerhauhn C, Capezuti L, Flaherty E, Resnick B, 

eds. Geriatric Nursing Review Syllabus: A Core Curriculum in Advanced Practice Geriatric Nursing. 3 rd ed. 

New York: American Geriatrics Society; In press. 

2. Giaconi JA, Coleman AL. Pediatric Glaucoma: IOP, Axial Length and Surgery Indications. In: Giaconi JA, 

Law SK, Caprioli J, Coleman AL, eds. Pearls of Glaucoma Management. Newark, NJ: Springer; 2009:In 

press. 

3. Giangiacomo A, Coleman AL. Sturge Weber Syndrome. In: Giaconi JA, Law SK, Caprioli J, Coleman AL, 

eds. Pearls of Glaucoma Management. Newark, NJ: Springer; 2009:In press. 

4. Higginbotham EJ, Coleman AL. Edward DP, Greenidge KC, Hodapp EA, Lee PP, Wilson MR, contributors. 

Diversity in the American Glaucoma Society: how well has the society embraced its membership and 

mirrored the changing demographics of American society? In: The Hague, Amsterdam, The Netherlands: 

Kugler Publications; 2010: In press. 



ALC100325 

BOOK REVIEWS 


1. Coleman AL. Review of: Weinreb RN, Mills RP, eds. Glaucoma Surgery: Principles and Techniques 

[Ophthalmology Monograph 4, 2 nd ed. San Francisco, CA: American Academy of Ophthalmology; 1998. 

Am J Ophthalmol. 1999;127:490. 

2. Coleman AL.Review of: Lerner SF, Parrish RK II.Glaucoma Surgery. Philadelphia, PA: Lippincott Williams & 

Wilkins; 2003. Arch Ophthalmol. 2004;122:134-135. 

3. Coleman AL. Comment on: The additional yield of a periodic screening program for open angle glaucoma: 

a population-based comparison of incident glaucoma cases detected in regular ophthalmic care with cases 

detected during screening. Int. Glaucoma Review. Greve EL, Kitazawa Y, Shields MB, Weinreb RN, eds. in 

press. 

BOOK EDITORSHIP 

1. Coleman AL, Morrison J, eds. Management of Cataract and Glaucoma. London, UK: Martin Dunitz Taylor & 

Francis Group; 2005. 

2. Abbott RL, Coleman AL, Frohman LP, Lee RH, Masket S, Meredith TA, Nerad JA, Rao NA, Schallhorn SC, 

Siatkowski RM, Wilhelmus KR, eds. Core Ophthalmic Knowledge-MOC Exam Study Guide Practicing 

Ophthalmologists Curriculum. San Francisco, CA: American Academy of Ophthalmology; 2005. 

3. Coleman AL, Bacharach J, Miller EG, Durcan FJ, Grajewski AL, Henderer JD, Herndon LW, O’Connell SS, 

Tsai JC, eds. Glaucoma-MOC Exam Study Guide Practicing Ophthalmologists Curriculum. San Francisco, 

CA: American Academy of Ophthalmology; 2005. 

4. Giaconi JA, Law SK, Caprioli J, Coleman AL, eds. Pearls of Glaucoma Management. Newark, NJ: Springer; 

2009. 

AUDIOVISUALS 

1. Coleman AL. Managing Glaucoma: More Than Meets the Eye-Part 1. Otsuka Pharmaceuticals; 1993. 

2. Coleman AL. Glaucoma Management: Factors in Treating the Total Patient. Annenberg Center at 

Eisenhower; 1994. 

3. Tang R; Coleman AL, exec. ed.: Ocular Manifestations of Systemic Disease [slide script program]. 

San Francisco, CA: American Academy of Ophthalmology; 1996. 

4. Shingleton BJ; Coleman AL, exec. ed. Eye Trauma and Emergencies [slide script program]. San Francisco, 

CA: American Academy of Ophthalmology; 1996. 

5. Fong D; Coleman AL, exec. ed. The Elderly Eye [slide script program]. San Francisco, CA: American 

Academy of Ophthalmology; 1998. 

6. Coleman AL. “Fruits and Vegetables: Should Glaucoma Patients be Eating More of Them?” Audio-Digest 

Ophthalmology [audiotape].; 2006: 44(18). [ISSN 0271-1281]. 



ALC100325 

ABSTRACTS 


1. Coleman AL, Higginbotham E, Yue B, Zau X. The effect of argon laser trabeculoplasty on the distribution of 

fibronectin in the trabecular meshwork of felines. Invest Ophthalmol Vis Sci. 1988;29(3)(suppl):130. 

2. Coleman AL, Robin AL, Pollack IP, Rudikoff MT. A comparison of the cardiovascular effects and intraocular 

pressure lowering of apraclonidine and timolol. Invest Ophthalmol Vis Sci. 1989;30(3)(suppl):22. 

3. Wexler JL, Robin AL, Coleman AL, Pollack IP. Once-daily versus twice-daily levobunolol 0.5% therapy: 

a crossover study. Invest Ophthalmol Vis Sci. 1990;31(4)(suppl):18. 

4. Coleman AL, Quigley HA, Vitale S, Dunkelberger G. Displacement of the optic nerve head with acute change 

in intraocular pressure in normal and glaucomatous monkey eyes. Invest Ophthalmol Vis Sci. 1990; 31(4) 

(suppl):564. 

5. Diehl DL, Coleman AL, Jampel HD, Bachorik PS, Quigley HA. Topical timolol maleate 0.5% lowers plasma 

HDL cholesterol. Invest Ophthalmol Vis Sci. 1990;31(4)(suppl):504. 

6. Nardin G, Lewis R, Lippa EA, Keates E, Coleman A, Clineschmidt D, Panebianco D, Quigley HA, 

Zimmerman T. Activity of the topical CAI MK-507 bid when added to timolol bid. Invest Ophthalmol Vis Sci. 

1991;32(4)(suppl):989. 

7. Dorman-Pease ME, Coleman AL, Quigley HA. Larger optic nerve heads have more ganglion cell axons, 

hence neural rim area increases with increasing optic disc diameter in image analysis of glaucoma damage. 

Invest Ophthalmol Vis Sci. 1991;32(4)(suppl):1015. 

8. Coleman AL, Novack RL, Kitada S, Shapourifar-Tehrani S, Lee DA. Low dose Nd:YAG laser energy effects 

on uptake of tritiated thymidine by human tenon's fibroblasts. Invest Ophthalmol Vis Sci. 

1991;32(4)(suppl):746. 

9. Zeimer R, Mori M, Coleman AL. A method to detect subtle morphological changes in the optic disc. 

International Glaucoma Symposium; 1991. 

10. Coleman AL, Varma R, Haller JA, Quigley HA. Determination of magnification correction factors for image 

analysis systems in primate eyes with glaucoma. Invest Ophthalmol Vis Sci. 1992;33(4)(suppl):887. 

11. Bacharach J, Lee DA, Coleman AL, Panek WC, Wilson MR. Non-contact transscleral Nd:YAG laser 

cyclophotocoagulation: Midterm report. Invest Ophthalmol Vis Sci. 1993;34(4) (suppl):185. 

12. Serle JB, Podos SM, Abundo GP, Ritch R, Coleman AL, Panek WC, Mantras CE. The effect of brimonidine 

tartrate in glaucoma patients on maximal medical therapy. Invest Ophthalmol Vis Sci. 

1993;34(4)(suppl):1137. 

13. Tielsch JM, Javitt J, Coleman A, Katz J, Sommer A. Blindness and visual impairment in an urban nursing 

home population: the Baltimore Nursing Home Eye Survey. Invest Ophthalmol Vis Sci. 

1994;35(4)(suppl):1323. 

14. Smyth RJ, Tam MY, Coleman AL, Kotas-Neumann R, Wilson MR. Pediatric glaucoma valve implantation. 


15. Tam MYM, Choplin NT, Coleman AL, Hill RA, Wilson MR, Panek WC. Preliminary results of glaucoma valve 

implant clinical trial. Invest Ophthalmol Vis Sci. 1994;35(4)(suppl):1914. 

16. Kook MS, Coleman AL, Wellish K, Mondino BJ. Preliminary results of Ahmed Glaucoma Valve in 

glaucomatous eyes with corneal transplants. Invest Ophthalmol Vis Sci. 1995;36(4)(suppl):4540. 

17. Lewis JM, Coleman AL. Comparison of visual field to optic nerve head as measured by retinal tomography. 


18. Sasaki IF, Peng FD, Tam MYM, Garcia R, Sanguinet JR, Coleman AL. Changes in the appearance of the 

optic disc with changes in the intraocular pressure. Invest Ophthalmol Vis Sci. 1995;36(4)(suppl):4520. 

19. Khanna S, Flowers C, Coleman AL, Baker RS, Wilson MR. Grading glaucomatous field defects. Observer 

variability of the Aulhorn-Kalmayer classification. Invest Ophthalmol Vis Sci. 1995;36(4)(suppl):1584. 

20. Yu F, Coleman AL. National outcomes of complication rates following inpatient and outpatient glaucoma 

surgeries. Invest Ophthalmol Vis Sci. 1997;38(4)(suppl):3366. 



ALC100325 


21. Marsh JC, Garcia R, Peng FD, Coleman AL. Changes in optic nerve heads after trabeculectomy. Invest 

Ophthalmol Vis Sci. 1997;38(4)(suppl):3865. 

22. Wilson MR, Winter J, Yu F, Bing EG, Sasaki I, Coleman AL. Quality of life among patients with eye diseases. 


23. Bing EG, Winters J, Yu F, Wilson MR, Sasaki I, Coleman AL. Depression in patients with eye diseases. 

Invest Ophthalmol Vis Sci. 1997;38(4)suppl):3920. 

24. Yu F, Rowe SG, Coleman AL. Variations in rates of visual fields obtained prior to glaucoma surgery in the 

Medicare database, 1991-1994. Invest Ophthalmol Vis Sci. 1998;39(4)(suppl):51. 

25. Rowe SG, Yu F, Coleman AL. Frequency of pre- and post-operative testing for glaucoma surgery in the 

Medicare database, 1991-1994. Invest Ophthalmol Vis Sci. 1998;39(4)(suppl):52. 

26. Netland PA, Huang MC, Coleman AL, Moster MR, Hill RA. Clinical experience with the Ahmed Glaucoma 

Valve implant. Invest Ophthalmol Vis Sci. 1998;39(4)(suppl):2144. 

27. Schuman JS, Mattox C, Zonderman J, Weiss HS, Krug JH, Gross FJ, Coleman AL. A randomized 

prospective clinical trial comparing surface area modified to standard Krupin valves with disc. 


28. Topouzis F, Yu F, Coleman AL. The risk of complications after cyclodestruction versus drainage device 

surgery. Invest Ophthalmol Vis Sci. 1998;39(4)(suppl):4077. 

29. Chen PC, Schuman JS, Mattox C, Weiss HS, Krug JH, Gross FJ, Coleman AL, Zonderman J. 

A randomized prospective clinical trial comparing surface-modified with standard Krupin valves with disc. 

American Academy of Ophthalmology Annual Meeting; 1998; New Orleans, LA. Scientific Poster 33. 

30. Milauskas AT, Coleman AL. The evaluation of viscocanalostomy, a new glaucoma surgery. American 

Academy of Ophthalmology Annual Meeting; 1998; New Orleans, LA. Scientific Poster 195. 

31. Rowe S, Yu F, Coleman AL. Under-use of pre-operative and post-operative ophthalmic testing for glaucoma 

surgery among Medicare beneficiaries. Robert Wood Johnson Clinical Scholars Meeting; 1998; 

Fort Lauderdale, FL. 

32. Devgan U, Yu F, Kim E, Coleman AL. Surgical undertreatment of glaucoma in black beneficiaries of 

Medicare persists. Invest Ophthalmol Vis Sci. 1999;40(4)(suppl):931. 

33. Coleman AL, Yu F, Devgan U. Economic analysis of argon laser trabeculoplasty and trabeculectomy in the 

Medicare population from 1991 to 1994. Invest Ophthalmol Vis Sci. 1999;40(4)(suppl):1509. 

34. Sarraf D, Coleman AL. Comparison of ophthalmoscopy and fundus photography in the grading of diabetic 

retinopathy. Invest Ophthalmol Vis Sci. 1999;40(4)(suppl):1614. 

35. BB Nguyen, Nduaguba C, Lima M, Shields MB, Coleman AL, Caprioli J. Identification of glaucoma 

progression through combined use of quantitative structural and functional measures. Invest Ophthalmol 

Vis Sci. 1999;40(4)(suppl):2985. 

36. Mangione CM, Keeler EB, Adams JL, Lee PP, Coleman AL, Shapiro MF. Use of vision services and 

satisfaction with care among Medicare beneficiaries with fee-for-service versus managed Medicare. 

23 rd Annual Meeting of Society of General Internal Medicine; May 4-6, 2000. 

37. Greaney MJ, Garway-Heath D, Hoffman J, Caprioli J, Coleman AL. Comparison of imaging methods to 

distinguish normal eyes from those with early glaucoma. Poster presentation at: Association for Research in 

Vision and Ophthalmology Annual Meeting; May 1, 2000; Fort Lauderdale, FL. 

38. Heath OS, Pecora LJ, Augustin W, Yu F, Coleman AL, Jindra LF. Non-penetrating trabeculectomy, a new 

surgical procedure. Poster presentation at: Association for Research in Vision and Ophthalmology Annual 

Meeting; May 1, 2000; Fort Lauderdale, FL. 

39. Jatuthong O, Joffman, D, Garway-Heath DF, Coleman AL, Zeyeyn TG, Caprioli J. Detection of progressive 

glaucomatous damage with Confocal Scanning Laser Ophthalmoscopy. Poster presentation at: Association 

for Research in Vision and Ophthalmology Annual Meeting; May 1, 2000; Fort Lauderdale, FL. 

40. Herndon LW, Johnson DH, Coleman AL, Lee PP. Factors associated with vision loss in glaucoma. Poster 

presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; May 1, 2000; 




ALC100325 


41. Topouzis F, Coleman AL, Yu F, Tisna E, Mavroudis L, Anastasopoulos E, Dimitrakos S, Stangos NT, 

Wilson MR. Thessaloniki Eye Study: Sita versus 76-Suprathreshold (76-ST) visual field test as a screening 

test in a population-based study. Poster presentation at: Association for Research in Vision and 

Ophthalmology Annual Meeting; May 1, 2000; Fort Lauderdale, FL. 

42. Coleman AL, Herndon L, Johnson D, Lee PP. Perceptions of family members and caregivers. Poster 



43. Lee P, Coleman AL, Johnson D, Herndon L. Health care delivery system impediments to glaucoma care. 

Poster presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; May 2, 2000; 


44. Bui DP, Yu F, Kim E, Coleman AL. Geographic variability in surgical under-treatment of glaucoma in blacks 

compared to whites in the USA. Poster presentation at: Association for Research in Vision and 


45. Yu F, Belin TR, Coleman AL. Predictive interval coverage of complications after trabeculectomy in the 

Medicare population from 1991-1994. Poster presentation at: Association for Research in Vision and 


46. Ladas JG, Holland GN, Levinson RD, Coleman AL. The relationship between aqueous humor flare and 

outflow facility in patients with uveitis. Poster presentation at: Association for Research in Vision and 

Ophthalmology (ARVO) Annual Meeting; May 2, 2000; Fort Lauderdale, FL. 

47. Topouzis F, Coleman AL, Yu F, Tisna E, Mavroudis L, Anastasopoulos E, Dimitrakos S, Stangos NT, 

Wilson MR. The reliability of the 76-Suprathreshold (76-ST) visual field test as a screening test in a 

population-based study. Poster presentation at: 6 th Congress of the European Glaucoma Society; 

Jun 26, 2000; London, UK. 

48. Greaney MJ, Garway-Heath D, Hoffman J, Caprioli J, Coleman AL. Comparison of imaging methods to 

distinguish normal eyes from those with early glaucoma. Poster presentation at: 6 th Congress of the European 

Glaucoma Society; Jun 26, 2000; London, UK. 

49. Yu F, Coleman AL. Trends in the composition of the Medicare population from 1995-1998. Poster 

presentation at: 6 th Annual Jules Stein Eye Institute Vision Science Conference; Sep 9, 2000; Lake 

Arrowhead, CA. 

50. Coleman AL, Stone K, Ewing S, Nevitt M, Cummings S, Cauley J, Ensrud K, Harris E, Hochberg M, 

Mangione C. Losing vision increases the risk of multiple falls. Poster presentation at: American Academy of 

Ophthalmology Meeting; Oct 24-25, 2000; Dallas, TX. 

51. Mangione CM, Gutierrez PR, Lee PP, Coleman AL, Shapiro MF, Berry S, Keeler E. Responsiveness of the 

NEI VFQ-25 to cataract surgery. Presentation at: National Eye Institute; Nov 13, 2000; Bethesda, MD. 

52. Coleman AL, Yu F. Trends in trabeculectomies performed on the Medicare cohort from 1995 to 1998. Poster 

presentation at: 10 th Annual meeting of American Glaucoma Society; Mar 1-3, 2001; Newport Beach, CA. 

53. Coleman AL, Yu F. Treatment patterns for US Medicare patients with glaucoma. Poster presentation at: 

Association for Research in Vision and Ophthalmology Annual Meeting; Apr 30, 2001; Fort Lauderdale, FL. 

54. Mavroudis LV, Harris A, Topouzis F, Kagemann L, Yu F, Lallos N, Stantos NT, Wilson MR, Coleman AL. 

Reproducibility of the Heidelberg Retinal Flowmeter in determining low perfusion areas in peripapillary retina. 

Poster presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; Apr 30, 2001; 


55. Coleman AL. Three-month comparison of bimatoprost (Lumigan) and combination timolol-dorzolamide eye 

drops. Presentation at: International Congress of Ophthalmology; Apr 25, 2002; Sydney, Australia. 

56. Kagemann LE, Harris A, Yee AB, Coleman AL, McCranor LJ, Toft RJ, Siesky B, Shah S, Zalish M. 

Neuroprotection: The clinical importance of ocular perfusion pressure calculation with systemic medication. 





ALC100325 


57. Anastasopoulos E, Topouzis F, Yu F, Jonescu-Cuypers C, Harris A, Mavroudis L, Kagemann L, Wilson MR, 

Stangos N, Coleman AL. Normative topographic optic disc parameters as measured with the Heidelberg 

Retina Tomograph (HRT) in eyes of a population-based sample of non glaucomatous elderly people. 

Presentation at: Association for Research in Vision and Ophthalmology Meeting; May 5, 2002; Fort 

Lauderdale, FL. 

58. Coleman AL, McDonald L, Keeler E, Mangione CM. Agreement between self-report and Medicare claims 

diagnostic codes for ocular diseases and eye care service use. Presentation at: Association for Research in 

Vision and Ophthalmology Meeting; May 5, 2002; Fort Lauderdale, FL. 

59. Mavroudis LV, Harris A, Coleman AL, Topouzis F, Yu F, Kagemann L, Anastasopoulos E, Koskosas A, 

Stangos NT, Wilson MR. Distribution of areas of low flow in the retinal peripapillary blood flow of elderly 

population. Presentation at: Association for Research in Vision and Ophthalmology Meeting; May 5, 2002; 


60. Yu F, Topouzis F, Coleman AL. Detection of visual field loss with 76-Suprathreshold (76-ST) visual fields. 

Presentation at: Association for Research in Vision and Ophthalmology Meeting; May 5, 2002; 


61. Paikal D, Yu F, Coleman AL. Patients with uveitis are coded with primary open-angle glaucoma in the 1999 

Medicare population. Presentation at: Association for Research in Vision and Ophthalmology Meeting; May 5, 

2002; Fort Lauderdale, FL. 

62. Nam SH, Syed HM, Law SK, Li G, Coleman AL, Caprioli J. Baerveldt-350 Implant vs. Ahmed Valve for 

refractory glaucoma: a case-controlled comparison. Presentation at: Association for Research in Vision and 

Ophthalmology Meeting; May 5, 2002; Fort Lauderdale, FL. 

63. Pedula KL, Coleman AL, Hillier TA, Mangione CM. Visual acuity, contrast sensitivity and mortality in older 

women: The Study of Osteoporotic Fractures. Presentation at: Association for Research in Vision and 

Ophthalmology (ARVO) Meeting; May 5, 2002; Fort Lauderdale, FL. 

64. Westcott MC, Li G, Law S, Coleman AL, Hoffman D, Gaasterland D, Caprioli J. A new approach to identify 

glaucomatous visual field deterioration using time series analysis (Board). Presentation at: Association for 

Research in Vision and Ophthalmology (ARVO) Meeting; May 5, 2002; Fort Lauderdale, FL. 

65. Lee PP, Budenz DL, Chen PP, Coleman AL, Feldman RM, Jampel HD, Katz LJ, Mills RP, Myers JS, 

Noecker RJ, Piltz-Seymour JR, Ritch R, Schacknow PN, Serle JB, Trick GL, Walt JG, Casciano JP, 

Evans SJ, Kotak MS, Doyle JJ. A multicenter, retrospective study of resource utilization associated with 

severity of disease in glaucoma. American Academy of Ophthalmology Joint Meeting; Oct 20, 2002; Orlando, 

FL. 

66. Coleman AL, Lee AG. The research agenda setting process for ophthalmology. American Academy of 

Ophthalmology Joint Meeting; Oct 20, 2002; Orlando, FL. 

67. Coleman AL. Development of evidence-based treatment recommendations for the medical management of 

glaucoma. Initial findings: definitions of disease states and goals of therapy. Poster presentation at: American 

Glaucoma Society Meeting; Mar 7, 2003; San Francisco, CA. 

68. Caprioli J, Coleman AL, Hoffman D, Small K, Sohn YH. Optic disc appearance in advanced age-related 

macular degeneration. Poster presentation at: Association for Research in Vision and Ophthalmology Annual 


69. Pedula KL, Mangione CM, Coleman AL, Gutierrez PR, Hillier TA, Ensrud KE. Functional disability in older 

women: the Study of Osteoporotic Fractures. Poster presentation at: Association for Research in Vision and 


70. Mavroudis LV, Harris A, Wilson MR, Topouzis F, Yu F, Kagemann A, Pappas F, Coleman AL. Aging 

increase the areas of low capillary blood flow in the peripapillary retinal circulation of normal individuals. 



71. Yu F, Davidson J,Coleman AL. Association between age-related macular degeneration and hip fractures in 

the Medicare population. Poster presentation at: Association for Research in Vision and Ophthalmology 

Annual Meeting; May 6, 2003; Fort Lauderdale, FL. 



ALC100325 


72. Topouzis F, Coleman AL, Jonescu-Cuypers C, Yu F, Harris A, Mavroudis L, Anastasopoulos E, 

Kagemann L, Koskosas A, Wilson MR. Systemic factors affecting optic disc topographic Heidelberg Retina 

Tomograph (HRT) for optic disc imaging. Poster presentation at: Association for Research in Vision and 


73. Yoo GL, Coleman AL. Corneal endothelial cell density after drainage device implantation or trabeculectomy 

with antimetabolites. Poster presentation at: Josiah Brown Research Fair; Jul 31, 2003; Los Angeles, CA. 

74. Coleman AL, Yu, F. Frequency of gonioscopy and fundus photography prior to glaucoma surgery in the 

Medicare population from 1995 to1999. Poster presentation at: American Academy of Ophthalmology Joint 

Meeting; Nov 17, 2003; Anaheim, CA. 

75. Gordon LK, Yu F, Coleman AL, Arnold AC. Medicare database analysis of prevalence and risk factors for 

ischemic optic neuropathy. Poster presentation at: American Academy of Ophthalmology Joint Meeting; 

Nov 16, 2003; Anaheim, CA. 

76. Coleman AL, Gordon MO, Beiser JA, Kass MA; Ocular Hypertension Treatment Study. A predictive model 

for the development of POAG in the Ocular Hypertension Treatment Study excluding pattern standard 

deviation (PSD) and vertical cup/disc Ratio (VC/D). Poster presentation at: Association for Research in Vision 

and Ophthalmology Annual Meeting; Apr 25, 2004; Fort Lauderdale, FL. 

77. Law SK, Hoffman DC, Caprioli J, Coleman AL. Short-term intraocular pressure control of silicone versus 

polypropylene Ahmed Valve implants in refractory glaucoma. Poster presentation at: Association for 

Research in Vision and Ophthalmology Annual Meeting; Apr 25, 2004; Fort Lauderdale, FL. 

78. Yu F, Coleman AL, Gutierrez PR, Stone KL, Cauley JA, Hochberg MC, Ensrud KE, Pedula KL, 

Cummings SR, Mangione CM. Binocular visual field loss increases risk of hip and non-spine, non-hip 

fractures. Poster presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; 

Apr 26, 2004; Fort Lauderdale, FL. 

79. Seitzman R, Yu F, Coleman AL. Cost of blindness in patients with age-related macular degeneration in the 

Medicare population. Poster presentation at: Association for Research in Vision and Ophthalmology Annual 

Meeting; Apr 26, 2004; Fort Lauderdale, FL. 

80. Topouzis F, Coleman AL, Jonescu-Cuypers C, Yu F, Harris A, Mavroudis L, Anastasopoulos E, 

Kagemann L, Pappas T, Wilson MR. Comparison of optic disc Heidelberg Retina Tomography (HRT) 

parameters between subjects with normal blood pressure (BP) and subjects with systemic hypertension. 

Poster presentation at: Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting; 

Apr 26, 2004; Fort Lauderdale, FL. 

81. Spalding JR, Coleman AL, Yu F, Buchholz P, Globe D. Prevalence of fractures and depression and their 

association with blindness in a Medicare population with primary open-angle glaucoma: an examination of 

blindness-related comorbidities and their costs. Poster presentation at: International Society for 

Pharmacoeconomics and Outcomes Research 7 th Annual European Congress; Oct 24-26, 2004; Hamburg, 

Germany. 

82. Coleman AL, Yu F, Stone K, Hochberg MC, Ensrud K, Cauley J, Pedula K, Mangione CM; Study of 

Osteoporotic Fractures Group. 15-year decline in visual function in older women. Paper presentation at: 

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting; May 2, 2005; Fort 

Lauderdale, FL. 

83. Yu F, Coleman AL. Eye-related Medicare cost for patients with age-related macular degeneration in the 

elderly population from 1995 to 1999. Poster presentation at: Association for Research in Vision and 

Ophthalmology (ARVO) Annual Meeting; May 2, 2005; Fort Lauderdale, FL. 

84. Siesky BA, Harris A, Abbasi R, Cantor L, Catoira Y, Yung C, Wudunn D, Jonescu-Cuypers C, Coleman AL. 

Racial differences in ocular hemodynamics between African-American and Caucasian patients with 

glaucoma. Poster presentation at: Association for Research in Vision and Ophthalmology (ARVO) Annual 


85. Baum M, Gordan M, Perlmutter M, Coleman AL, Hollingsworth, Kass M. Distance visual acuity of 20/40 or 

worse associated with decreased participation in daily activities. Poster presentation at: Association for 

Research in Vision and Ophthalmology (ARVO) Annual Meeting; May 2, 2005; Fort Lauderdale, FL. 



ALC100325 


86. Seitzman R, Coleman AL, Yu F, Cauley J, Hochberg MC, Ensrud K, Hillier T, Cummings SR, Mangione CM; 

Study of Osteoporotic Fractures Research Group. Sex hormone exposure and age-related maculopathy in 

elderly women. Poster presentation at: Association for Research in Vision and Ophthalmology Annual 


87. Anastasopoulos E, Yu F, Coleman AL. Non-neovascular age-related macular degeneration associated with 

increased incident risk of hip fractures in the Medicare population. Poster presentation at: Association for 

Research in Vision and Ophthalmology Annual Meeting; May 3, 2005; Fort Lauderdale, FL. 

88. Zangwill LM, Weinreb RN, Beiser JA, Cioffi GA, Coleman AL, Trick G, Liebmann JM, Kass MA, Gordon MO; 

OHTS CSLO Ancillary Study Group. Baseline topographic optic disc measurements are associated with the 

development of primary open angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study 

to the OHTS. Paper presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; 

May 3, 2005; Fort Lauderdale, FL. 

89. Anastasopoulos E, Yu F, Coleman AL. Association of age-related macular degeneration with increased risk 

of hip fractures in the elderly population. Poster presentation at: UCLA Center on Aging and the Multicampus 

Program in Geriatric Medicine and Gerontology 10 th Annual UCLA Research Conference on Aging; Jun 22, 

2005; Los Angeles, CA. 

90. Anastasopoulos E, Yu F, Coleman AL. Age-related macular degeneration as a risk factor for mortality in the 

Medicare population. Poster presentation at: American Academy of Ophthalmology Annual Meeting; Oct 15- 

18, 2005; Chicago, IL. 

91. Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Koskosas A, Pappas T, Mavroudis L, 

Coleman AL. Prevalence of open angle glaucoma in Greece: the Thessaloniki Eye Study. Poster 

presentation at: American Glaucoma Society Annual Meeting; Mar 2-5, 2006; Charleston, SC. 

92. Seitzman R, Coleman AL, Mahajan VB, Yu F, Cauley J, Ensrud K, Hillier T, Stone K, Mangione C; Study of 

Osteoporotic Fractures Research Group. Estrogen receptor alpha polymorphisms and age-related 

maculopathy in older Caucasian women. Poster presentation at: Association for Research in Vision and 


93. Anastasopoulos E, Topouzis F, Wilson M, Harris A, Yu F, Koskosas A, Pappas T, Mavroudis L, Karkamani G, 

Coleman AL. Prevalence of late age-related maculopathy in Greece: the Thessaloniki Eye Study. Poster 



94. Topouzis F, Coleman AL, Harris A, Anastasopoulos E, Yu F, Koskosas A, Pappas T, Wilson MR. Prevalence 

of undiagnosed primary open angle glaucoma and pseudoexfoliative glaucoma in Greece: the Thessaloniki 

Eye Study. Poster presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; 


95. Yu F, Coleman AL, Stone KL, Pedula KL, Ensrud KE, Cauley J, Hochberg MC, Mangione CM; Study of 

Osteoporotic Fractures Research Group. Association of fruits and vegetable consumption and glaucoma 

among older women. Poster presentation at: Association for Research in Vision and Ophthalmology Annual 


96. Lee AC, Santiago-Turla CM, McGwin G Jr, Coleman AL, Jampel HD, Mills RP, Lee PP. Conformance with 

the Preferred Practice Pattern for Glaucoma: Survey of the American Glaucoma Society. Poster presentation 

at: Association for Research in Vision and Ophthalmology Annual Meeting; May 3, 2006; Fort Lauderdale, FL. 

97. Pappas T, Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Koskosas A, Mavroudis L, 

Coleman AL. Thessaloniki Eye Study: Design, participation rate, data completeness. Poster presentation at: 

29 th Panhellenic Ophthalmological Congress; Jun 10, 2006; Thessaloniki, Greece. 

98. Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Koskosas A, Pappas T, Mavroudis L, 

Coleman AL. Prevalence of open angle glaucoma in Greece: the Thessaloniki Eye Study. Poster 

presentation at: 29 th Panhellenic Ophthalmological Congress; Jun 10, 2006; Thessaloniki, Greece. 

99. Coleman AL, Topouzis F, Harris A, Anastasopoulos E, Yu F, Koskosas A, Pappas T, Wilson MR. Prevalence 

of undiagnosed primary open angle glaucoma and pseudoexfoliative glaucoma in Greece: the Thessaloniki 

Eye Study. Poster presentation at: 29 th Panhellenic Ophthalmological Congress; Jun 10, 2006; Thessaloniki, 

Greece. 



ALC100325 


100. Koskosas A, Topouzis F, Coleman AL, Harris A, Jonescu-Cuypers C, Yu F, Mavroudis L, Anastasopoulos E, 

Pappas T, Wilson MR. Association of blood pressure status with the optic disc structure in non-glaucoma 

subjects: the Thessaloniki Eye Study. Poster presentation at: 29 th Panhellenic Ophthalmological Congress; 

Jun 10, 2006; Thessaloniki, Greece. 

101. Coleman AL, Seitzman RL, Yu F, Cauley JA, Ensrud KE, Stone KL, Cummings SR, Hochberg MC, 

Pedula K, Mangione CM; Study of Osteoporotic Fractures Research Group. Incidence of and risk factors for 

age-related macular degeneration in older women: the Study of Osteoporotic Fractures. Paper presented at: 

4 th US Symposium on Ocular Epidemiology; Jan 29-31, 2007; Sarasota, FL. 

102. Kodjebacheva G, Coleman AL, Stone KL, Hochberg MC, Pedula KL, Ensrud KE, Badali JA, Mangione CM. 

Glaucoma risk and the intake of antioxidants among older women: the Study of Osteoporotic Fractures. 

Paper presented at: 4 th US Symposium on Ocular Epidemiology; Jan 29-31, 2007; Sarasota, FL. 

103. Kodjebacheva G, Coleman AL, Stone KL, Yu F, Pedula KL, Ensrud KE, Cauley JA, Topouzis F, 

Mangione CM. Glaucoma and the intake of fat among older women: the Study of Osteoporotic Fractures. 



104. McClure TM, Becker TM, Coleman AL, Cioffi GA, Mansberger SL. Changes in vision-related quality of life in 

Native American/Alaska Native populations after best-correction. Poster presentation at: Association for 


105. Anastasopoulos E, Topouzis F, Harris A, Wilson MR, Yu F, Koskosas A, Pappas T, Founti P, Coleman AL. 

Comparison of characteristics of pseudoexfoliative versus non-pseudoexfoliative subjects in a populationbased 

study: the Thessaloniki Eye Study. Paper presentation at: Association for Research in Vision and 


106. Loman JV, Hoffman D, Tran D, Zien T, Law S, Coleman AL, Caprioli J. Visual field progression in glaucoma: 

Prevalence and concordance of visual field progression in fellow eyes. Poster presentation at: Association for 


107. Yu F, Anastasopoulos E, Coleman AL. Association between age-related macular degeneration and five-year 

mortality among Medicare patients. Poster presentation at: Association for Research in Vision and 


108. Seitzman R, Coleman AL, Yu F , Cauley JA, Ensrud KE, Stone K, Pedula K, Thomas G, Mangione CM; 

Study of Osteoporotic Fractures Research Group. Reproductive hormone exposures and five-year incidence 

of age-related macular degeneration in older women. Poster presentation at: Association for Research in 


109. Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Pappas T, Koskosas A, Founti P, Coleman AL. 

Prevalence of primary open-angle glaucoma and pseudoexfoliative glaucoma (PEXG) by IOP level in a 

population-based study: the Thessaloniki Eye Study. Poster presentation at: Association for Research in 


110. Momi RS, Coleman AL, Yu F, Smith KL, Ensrud KE, Cauley J, Pedula KL, Hochberg MC, Mangione CM; 

Study of Osteoporotic Fractures Research Group. Association between cataracts and incident fractures 

among older women from the Study of Osteoporotic Fractures (SOF). Poster presentation at: Association for 


111. Huang LL, Coleman AL, Yu F, Stone KL, Ensrud KE, Cauley JA, Pedula KL, Hochberg MC, Mangione CM; 

Study of Osteoporotic Fractures Research Group. Association of selenium supplement use and intraocular 

lens (IOL) among older women. Poster presentation at: Association for Research in Vision and 


112. Fafowora O, Coleman AL, Gorin MB, Cummings SR, Sinsheimer JS, Stone KL, Yu F. Investigation of 

selected candidate genes for five-year incidence of age-related maculopathy (ARM) in older women. Poster 

presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; Apr 27, 2008; 

Fort Lauderdale, FL. [Invest Ophthalmol Vis Sci. 49;ARVO E-Abstract 248]. 

113. Ahn J, Souza C, Coleman AL, Law SK, Hoffman DC, Caprioli J. Comparison of disc photographs, scanning 

laser tomography and visual fields to identify progression of glaucoma. Poster presentation at: Association for 

Research in Vision and Ophthalmology Annual Meeting; Apr 27, 2008; Fort Lauderdale, FL. 



ALC100325 


114. Ou Y, Law SK, Coleman AL, Caprioli J. Outcomes of Ahmed Glaucoma Valve implantation in primary 

congenital glaucoma. Poster presentation at: Association for Research in Vision and Ophthalmology Annual 

Meeting; Apr 28, 2008; Fort Lauderdale, FL. 

115. Kodjebacheva G, Yu F, Oelrich F, Coleman AL. Factors affecting pediatric visual impairment: the UCLA 

Mobile Eye Clinic Study. Poster presentation at: Association for Research in Vision and Ophthalmology 

Annual Meeting; Apr 28, 2008; Fort Lauderdale, FL. 

116. Dzau JR, Lee PP, Herndon LW, Coleman AL, Johnson DH. Perceived causes of loss of vision in glaucoma 

from patient, family member and eye care provider perspectives: a focus group study. Poster presentation at: 


117. Topouzis F, Coleman AL, Harris A, Yu F, Anastasopoulos E, Pappas T, Koskosas A, Founti P, Wilson MR. 

Management patterns of glaucoma treatment in the Thessaloniki Eye Study. Poster presentation at: 


118. Shih K, Tran DH, Souza C, Law SK, Coleman AL, Caprioli J. Outcomes and risk factors for failure of repeat 

versus initial trabeculectomy in open-angle glaucoma. Poster presentation at: Association for Research in 

Vision and Ophthalmology Annual Meeting; Apr 30, 2008; Fort Lauderdale, FL. 

119. Coleman AL, Wilson MR, Harris A, Anastasopoulos E, Yu F, Koskosas A, Pappas T, Founti P, Topouzis F. 

Risk factors for open-angle glaucoma in the Thessaloniki Eye Study. Poster presentation at: Association for 


120. Giaconi J, Coleman AL, Yu F, Stone KL, Pedula KL, Ensrud KE, Cauley JA, Hochberg MC, Mangione CM; 

Study of Osteoporotic Fractures Research Group. Nutritional association with glaucoma among older Black 

women. Poster presentation at: Association for Research in Vision and Ophthalmology Annual Meeting; 


121. Giaconi J, Cheng E, Lee B, Newberry S, Suttorp M, Coleman AL. For which glaucoma suspects is it 

appropriate to initiate treatment? Poster presentation at: 8 th European Glaucoma Society Congress; 

Jun 1-6, 2008; Berlin, Germany. 

122. Yu F, Coleman AL. Statistical analysis of visual field and visual field loss data in ophthalmic research. 

Paper presentation Aug 3, 2008; Denver, CO. 

123. Griffin BA, Elliot MN, Cheng E, Medeiros F, Coleman AL, Weinreb RN. Impact of clinical measurement error 

on predicted 5-year risk of glaucoma. Poster presentation at: American Academy of Ophthalmology Annual 

Meeting; Nov 9, 2008; Atlanta, GA. 

124. Giaconi JA, Cheng E, Lee BL, Newberry S, Schonlaw M, Coleman AL, Weinreb RN. For which glaucoma 

suspects is it appropriate to initiate treatment? Poster presentation at: American Academy of Ophthalmology 

Annual Meeting; Nov 10, 2008; Atlanta, GA. 

125. Shen LQ, Gonzalez M, Yu F, Bhat A, Marvasti A, Sami M, Law SK, Caprioli J, Coleman AL. Relative 

deficiency of vitamins may be associated with primary open angle glaucoma. Poster presentation at: 

Association for Research in Vision and Ophthalmology Annual Meeting; May 4, 2009; Fort Lauderdale, FL. 

126. Kodjebacheva G, Yu F, Oelrich F, Coleman AL. Race/Ethnicity and Visual Impairment in First-graders: 

The UCLA Mobile Eye Clinic Study. Poster presentation at: Association for Research in Vision and 


PAPERS IN PREPARATION 

1. Huang LL, Coleman AL, Yu F, Stone KL, Guitierrez P, Ensrud KE, Cauley JA, Pedula KL, Hochberg MC, 

Mangione CM. Study of osteoporotic fractures research group. Nutrient intake and cataract risk in older 

women. In preparation. 

2. Griffin BA, Elliott MN, Cheng EM, Medeiros F, Coleman AL, Weinreb RN. Impact of clinical measurement 

error on predicted five-year risk of glaucoma. In preparation.

Anne Louise Coleman, MD, PhD - Jules Stein Eye Institute

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?